<SEC-DOCUMENT>0001140361-23-029854.txt : 20230614
<SEC-HEADER>0001140361-23-029854.hdr.sgml : 20230614
<ACCEPTANCE-DATETIME>20230614163929
ACCESSION NUMBER:		0001140361-23-029854
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230608
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Termination of a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230614
DATE AS OF CHANGE:		20230614

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ANGIODYNAMICS INC
		CENTRAL INDEX KEY:			0001275187
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				113146460
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50761
		FILM NUMBER:		231014643

	BUSINESS ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
		BUSINESS PHONE:		5187981215

	MAIL ADDRESS:	
		STREET 1:		14 PLAZA DRIVE
		CITY:			LATHAM
		STATE:			NY
		ZIP:			12110
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>brhc20054314_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:ango="http://angiodynamics.com/20230608" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_7f2310eebefa42dea4e79bed9cd055f8" contextRef="c20230608to20230608" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_e666d032772a4f4791bcb4e795a34a3d" contextRef="c20230608to20230608">0001275187</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="ango-20230608.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230608to20230608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001275187</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-08</xbrli:startDate><xbrli:endDate>2023-06-08</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-size: 10pt;"> </span></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
      <hr style="height: 2px; width: 10%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_9bd1a0af0efb4b1fb03e15cf1a4b5f7e" contextRef="c20230608to20230608">8-K</ix:nonNumeric></div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Securities Exchange Act of 1934</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Date of Report (Date of earliest event reported):&#160; <span style="font-weight: bold;"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_a589e0744e104d95b2696c497912b12e" contextRef="c20230608to20230608" format="ixt:date-monthname-day-year-en">June 8, 2023</ix:nonNumeric></span></div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_b5ac18b575524f888ce0afb490008a95" contextRef="c20230608to20230608">AngioDynamics, Inc.</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact Name of Registrant as Specified in Charter)</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_7b362d60a6ce416db51233b3cae0c753" contextRef="c20230608to20230608" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_6812f995445c4cf5afb79f7fedbd411c" contextRef="c20230608to20230608">000-50761</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 33.35%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_320a795c45994f22a62ad78a9d0e1f0e" contextRef="c20230608to20230608">11-3146460</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 33.33%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 34%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 33.35%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">(State or Other Jurisdiction of Incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 33.35%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td colspan="1" style="width: 49%; vertical-align: top; font-size: 10pt; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_693416b0ae1345b58df72a9dbe92dbc9" contextRef="c20230608to20230608">14 Plaza Drive</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_accc128d94284e27a6460a920db45b33" contextRef="c20230608to20230608">Latham</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_683982c8a8b94a73a1a335e376712870" contextRef="c20230608to20230608" format="ixt-sec:stateprovnameen">New York</ix:nonNumeric></td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_9cc890dfc6584739b6c0b9e2af8f8c9e" contextRef="c20230608to20230608">12110</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" colspan="1" style="width: 49%; vertical-align: top; font-size: 10pt; text-align: center; font-weight: bold;">&#160;</td>

    <td rowspan="1" colspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 49%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td colspan="1" style="width: 49%; vertical-align: top; font-size: 10pt; text-align: center;">(Address of Principal Executive Offices)</td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; font-family: 'Times New Roman';">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_4a45b3228e7a434c90534c4d36ab008c" contextRef="c20230608to20230608">518</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_f6da9534cdd64aeb835aada8bc53a457" contextRef="c20230608to20230608">795-1400</ix:nonNumeric></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Registrant&#8217;s telephone number, including area code)</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</span><span style="font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to
        simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_31cccc1a7c434f36a6d09f97373d8092" contextRef="c20230608to20230608" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_d387839b7bd84e2ab611c640fe906607" contextRef="c20230608to20230608" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_5d58972fa4e848a8b4157e566605e893" contextRef="c20230608to20230608" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_121cfebeec5b4c69a40ce89b11651c80" contextRef="c20230608to20230608" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 40%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Title of each class</span></div>
          </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 20%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Trading Symbol(s)</span></div>
          </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 36%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">Name of each exchange on which registered</span></div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 40%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="1" rowspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 20%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="1" rowspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 36%; vertical-align: top;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 40%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_8ce8650cde7e4a81bbbb6e2703e12fc0" contextRef="c20230608to20230608">Common Stock, par value $0.01 per share</ix:nonNumeric><br />
            </div>
          </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 20%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_15963d72694940c49175d8c2d5cebbb7" contextRef="c20230608to20230608">ANGO</ix:nonNumeric><br />
            </div>
          </td>

    <td colspan="1" style="width: 2%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 36%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_e882436fe299497687d7a63eaa441b8f" contextRef="c20230608to20230608" format="ixt-sec:exchnameen">NASDAQ Global Select Market</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of
      the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_0c2045b1bab84e23a769d613cc9ab602" contextRef="c20230608to20230608" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /> </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.01 &#8211; Entry into a Material Definitive Agreement.</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On June 8, 2023, AngioDynamics, Inc., a Delaware corporation (&#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">AngioDynamics</span></span>&#8221; or the "<span style="text-decoration: underline;">Company</span>"),

      entered into an asset purchase agreement (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Asset Purchase Agreement</span></span>&#8221;) with Merit Medical Systems, Inc., a Utah corporation (&#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Merit</span></span>&#8221;),


      <span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">pursuant to which Merit acquired the dialysis product portfolio and BioSentry tract sealant system biopsy product of AngioDynamics (the &#8220;<span style="text-decoration: underline;">Business</span>&#8221;) for a purchase price equal
        to $100,000,000 in cash, subject to the terms and conditions of the Asset Purchase Agreement (the &#8220;<span style="text-decoration: underline;">Transaction</span>&#8221;).&#160; The Transaction was effective as of 12:01 a.m. mountain time on June 8, 2023 (the &#8220;<span style="text-decoration: underline;">Closing</span>&#8221;).</span></div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Asset Purchase Agreement contains customary representations and warranties which did not survive the Closing, as well as customary
      covenants, including, among others, AngioDynamics&#8217; agreement not to compete with the Business for five years after the Closing, subject to certain exceptions.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Asset Purchase Agreement also provides for indemnification rights, in the case of Merit, with respect to (a) breaches of covenants
      by AngioDynamics and (b) liabilities retained by AngioDynamics and, in the case of AngioDynamics, with respect to (i) breaches of covenants by Merit, (ii) liabilities assumed by Merit and (iii) Merit&#8217;s operation of the Business after the Closing.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">At the Closing, AngioDynamics and Merit also entered into various agreements to facilitate the transition of the Business to Merit,
      including a Transition Services Agreement&#160; and Contract Manufacturing Agreement.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">The foregoing description of the Asset Purchase Agreement does not
        purport to be complete and is subject to, and qualified in its entirety by, the full text of the Asset Purchase Agreement, which is included as Exhibit 2.1 hereto and is incorporated herein by reference.&#160; The representations, warranties and
        covenants contained in the Asset Purchase Agreement were made only for the purposes of the Asset Purchase Agreement, were made as of specific dates, were made solely for the benefits of the parties to the Asset Purchase Agreement and may not have
        been intended to be statements of fact but, rather, as a method of allocating risk and governing the contractual rights and relationships among the parties to the Asset Purchase Agreement.&#160; The assertions</span><span style="font-size: 10pt; font-family: 'Times New Roman';">&#160;</span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">embodied in those representations and warranties may be subject to important qualifications and limitations agreed to by
        AngioDynamics and Merit in connection with negotiating their respective terms.&#160; Moreover, the representations and warranties may be subject to a contractual standard of materiality that may be different from what may be viewed as material to
        stockholders.&#160; For the foregoing reasons, none of AngioDynamics&#8217; stockholders or any other person should rely on such representations and warranties, or any characterizations thereof, as statements of factual information at the time they were made
        or otherwise.</span></div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 1.02 &#8211; Termination of a Material Definitive Agreement.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">On June 8, 2022, AngioDynamics used a portion of the consideration received in connection with the Transaction to repay all amounts owed under
      AngioDynamics&#8217; existing Credit Agreement, dated as of August 30, 2022, with the lenders party thereto, JPMorgan Chase Bank, N.A., as administrative agent, Bank of America, N.A. and KeyBank National Association, as co-syndication agents, and JPMorgan
      Chase Bank N.A., as sole bookrunner and sole lead arranger (the &#8220;<span style="font-family: 'Times New Roman';"><span style="text-decoration: underline;">Credit Agreement</span></span>&#8221;), and as a result, the Credit Agreement was terminated. Pursuant to the terms of the Credit Agreement,
      AngioDynamics had the option to repay this facility prior to the maturity date without penalty.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 2.01 &#8211; Completion of Acquisition or Disposition of Assets.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The information disclosed in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01 &#8211; Financial Statements and Exhibits.</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';">(b)</span><span style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; font-style: italic;">Pro forma financial information</span>.</span></span></div>

    <div style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman';"> <br />
        </span></span></div>

    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Attached hereto as Exhibit 99.1 and incorporated by reference is the following unaudited pro forma financial information, in each case giving pro
      forma effect to the sale of the Business:</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 20.7pt; font-size: 10pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">unaudited pro forma consolidated balance sheet as of February 28, 2023;</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 20.7pt; font-size: 10pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">unaudited pro forma consolidated statements of operations for the nine months ended February 28, 2023 and the fiscal year ended May 31, 2022; and</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 20.7pt; font-size: 10pt;"><br />
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">notes to the unaudited pro forma consolidated financial statements.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman';">(d)</span><span style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<span style="font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; font-style: italic;">Exhibits</span>.</span></span></div>

    <div style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman';"> <br />
        </span></span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Exhibit No.</span></div>
          </td>

    <td style="width: 2.73%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 87%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman';"><span style="text-decoration: underline;">Description</span></div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 2.73%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 87%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman';"><a href="brhc20054314_ex2-1.htm">2.1</a></div>
          </td>

    <td style="width: 2.73%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 87%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman';">Asset Purchase Agreement dated as of June 8, 2023 by and between AngioDynamics, Inc. and Merit Medical Systems, Inc.*</div>
          </td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 10%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 2.73%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 87%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 10%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman';"><a href="brhc20054314_ex99-1.htm">99.1</a></div>
          </td>

    <td style="width: 2.73%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 87%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: justify; font-family: 'Times New Roman';">Pro forma financial information.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">* </span><span style="font-size: 10pt;">Certain exhibits and schedules have been omitted in
        accordance with Item 601(a)(5) of Regulation S-K. The registrant agrees to furnish supplementally a copy of all omitted exhibits and schedules to the Securities and Exchange Commission upon its request.</span></div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br />
      </span></div>

    <div style="text-align: left; text-indent: 36pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
      behalf by the undersigned hereunto duly authorized.</div>

    <div style="font-size: 10pt;"><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">ANGIODYNAMICS, INC.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">(Registrant)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="2" rowspan="1" style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman';">Date:&#160; June 14, 2023</div>
          </td>

    <td style="width: 3%; vertical-align: top; font-size: 10pt; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
          </td>

    <td style="width: 47%; vertical-align: top; font-size: 10pt; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman';">/s/ Stephen A. Trowbridge</div>
          </td>

  </tr>


</table>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
          </td>

    <td rowspan="1" style="width: 45%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Stephen A. Trowbridge</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
          </td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Executive Vice President and</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Chief Financial Officer</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br />
    </div>

    <div style="font-size: 10pt;"><br />
    </div>

    <div style="font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>brhc20054314_ex2-1.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div>
      <div>
        <div style="text-align: right;"><font style="font-weight: bold; font-size: 10pt;">Exhibit 2.1</font><font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
          <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXECUTION VERSION</div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ASSET PURCHASE AGREEMENT</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">BY AND BETWEEN</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><br>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">MERIT MEDICAL SYSTEMS, INC.</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AND</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ANGIODYNAMICS, INC.</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Dated as of June 8, 2023</div>
        <div style="font-size: 10pt;">&#160;</div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); clear: both; background-color: rgb(0, 0, 0);"></div>
        </div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">TABLE OF CONTENTS</div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <font style="font-size: 10pt;"><br>
          </font></div>
        <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z8d2ff2cc862343bdbf7f475ed7eb1865">

              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 1</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">THE TRANSACTIONS</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">1.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Purchased Assets</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">1</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">1.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Excluded Assets</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">2</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">1.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Assumed Liabilities</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">3</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">1.4</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Excluded Liabilities</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">4</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">1.5</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Non-Assignable Assets</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">5</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">1.6</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Shared Contracts</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">6</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 2</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">CONSIDERATION FOR TRANSFER</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">2.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Purchase Price and Assumption of Assumed Liabilities</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">2.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Withholding Taxes</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">6</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 3</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">CLOSING AND CLOSING DELIVERIES</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">3.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Closing; Time and Place</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">3.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Deliveries by Seller</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">6</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">3.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Deliveries by Purchaser</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">7</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 4</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">REPRESENTATIONS AND WARRANTIES OF SELLER</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Organization and Good Standing</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Authority; Binding Nature of Agreements</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">8</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">No Conflicts; Required Consents</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">9</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.4</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Financial Information; No Undisclosed Liabilities</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">9</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.5</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Purchased Inventory</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">10</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.6</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Absence of Changes</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">10</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.7</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Taxes</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">11</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.8</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Intellectual Property</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.9</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Material Contracts</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">14</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.10</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Insurance</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">15</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.11</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Compliance with Laws</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">15</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.12</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Governmental Approvals; Product Liability</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.13</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Proceedings and Orders</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">16</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.14</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Title, Condition and Sufficiency of Assets</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">17</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.15</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Brokers</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">17</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">4.16</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">Trade Control Laws</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; text-align: right; background-color: rgb(204, 238, 255);">17</td>
              </tr>

          </table>
          <div style="font-size: 10pt;"><br>
          </div>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">ii</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z5f5d5928787849ae8336bd05ab4d411e">

              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.17</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Anti-Corruption Laws</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">18</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.18</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Distributors, Customers and Suppliers</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">18</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.19</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Intercompany Arrangements</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">18</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.20</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Product Warranties</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">18</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.21</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">FDA and Regulatory Matters</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">18</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.22</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Environmental, Health, and Safety Matters</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">19</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">4.23</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">No Other Representations and Warranties</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">19</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 5</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">REPRESENTATIONS AND WARRANTIES OF PURCHASER</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">5.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Organization and Good Standing</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">19</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">5.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Authority; Binding Nature of Agreements</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">19</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">5.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">No Conflicts; Required Consents</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">20</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">5.4</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Brokers</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">20</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">5.5</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Proceedings and Orders</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">20</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">5.6</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">R&amp;W Insurance Policy</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">20</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">5.7</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Condition of the Business</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">21</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt;">&#160;</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 6</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;&#160;&#160;</td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">[RESERVED]</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 7</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;&#160;&#160;</td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">POST-CLOSING COVENANTS</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Cooperation</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">21</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Return of Assets; Transfer of Purchased Assets</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">22</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Records and Documents</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">22</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.4</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Confidentiality</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">23</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.5</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Non-Competition; Non-Solicitation</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">23</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.6</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Product Recalls</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">24</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.7</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Licensed Intellectual Property</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">25</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.8</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Post-Closing Proceedings; Privilege Matters</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">25</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.9</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Customer Inquiries</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">25</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">7.10</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Misplaced Mail and Communications</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">25</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 8</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">CONDITIONS TO CLOSING</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">8.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Conditions to the Obligations of Each Party to Close</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">26</div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font></div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">ii</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); clear: both; background-color: rgb(0, 0, 0);"></div>
        </div>
        <div>
          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z812a335819d7468a9c1a126e0a1970c1">

              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 9</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: center; font-family: 'Times New Roman';">TAX MATTERS</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt;">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">9.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Purchase Price Allocation</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">26</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">9.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Transfer Taxes</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">26</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">9.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Property Taxes</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">9.4</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Tax Contests</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">9.5</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Tax Cooperation</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">27</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">9.6</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Tax Priority Provision.</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">28</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 10</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">[RESERVED]</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 11</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">INDEMNIFICATION</div>
                </td>
              </tr>
              <tr>
                <td colspan="3" rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Indemnification by Seller</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">28</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Indemnification by Purchaser</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">28</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">[Reserved]</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">28</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.4</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Procedures for Indemnification</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">28</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.5</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Limits on Indemnification; Payment of Indemnifiable Damages</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">29</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.6</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Remedies Exclusive</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">30</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.7</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Adjustment to Damages.</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">30</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.8</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Tax Treatment of Indemnification</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">31</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">11.9</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Reimbursement</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">31</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td rowspan="1" style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">ARTICLE 12</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td colspan="3" style="vertical-align: top; font-size: 10pt;">
                  <div style="text-align: center; font-family: 'Times New Roman';">MISCELLANEOUS PROVISIONS</div>
                </td>
              </tr>
              <tr>
                <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">&#160;</td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.1</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Expenses</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">31</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.2</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Interpretation</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">31</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.3</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Entire Agreement</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">31</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.4</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Amendment, Waivers and Consents</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">31</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.5</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Successors and Assigns</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.6</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Governing Law</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.7</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Jurisdiction; Waiver of Jury Trial</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.8</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Rules of Construction</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.9</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Severability</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.10</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Exhibits and Schedules</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">32</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.11</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Notices</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">33</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.12</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Rights of Parties</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">34</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.13</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Public Announcements</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">34</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.14</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Counterparts</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">34</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.15</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Specific Performance</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">34</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.16</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Electronic Data Room Materials</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">34</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.17</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: left; font-family: 'Times New Roman';">Further<font style="font-family: 'Times New Roman'; font-weight: bold;">&#160;</font>Assurances</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                  <div style="text-align: right; font-family: 'Times New Roman';">34</div>
                </td>
              </tr>
              <tr>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">12.18</div>
                </td>
                <td style="width: 90%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: left; font-family: 'Times New Roman';">Bulk Transfers</div>
                </td>
                <td style="width: 5%; vertical-align: top; font-size: 10pt; background-color: rgb(204, 238, 255);">
                  <div style="text-align: right; font-family: 'Times New Roman';">34</div>
                </td>
              </tr>

          </table>
        </div>
        <div> <font style="font-size: 10pt;"><br>
          </font></div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">iii</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); clear: both; background-color: rgb(0, 0, 0);"></div>
        </div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 5.4pt;">EXHIBITS</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <table cellspacing="0" cellpadding="0" id="ze0d0081116bd43c39e490e96cd1eeac7" style="width: 100%; text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; border-collapse: collapse;">

            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit A</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Certain Definitions</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top;">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit B</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Products</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit C</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">General Assignment and Bill of Sale</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top;">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit D</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Purchaser Assignment and Assumption Agreements</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit E</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Patent Assignment</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top;">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit F</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Trademark Assignment</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit G</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Transition Services Agreement</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top;">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit H</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Contract Manufacturing Agreement</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit I</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; font-family: 'Times New Roman';">Intellectual Property License Agreement</div>
              </td>
            </tr>
            <tr>
              <td style="width: 5.76%; font-size: 10pt; vertical-align: top;">&#160;</td>
              <td style="width: 17.32%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Exhibit J</div>
              </td>
              <td style="width: 76.92%; font-size: 10pt; vertical-align: top;">
                <div style="text-align: left; font-family: 'Times New Roman';">Sublicense Agreement</div>
              </td>
            </tr>

        </table>
        <div style="font-size: 10pt;"><br>
        </div>
        <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
          <div class="BRPFPageNumberArea" style="text-align: center; font-size: 10pt;"><font style="font-family: 'Times New Roman'; font-weight: normal; font-style: normal;">iv</font></div>
          <div class="BRPFPageBreak" style="page-break-after: always;">
            <hr noshade="noshade" style="border-width: 0px; margin: 4px 0px; width: 100%; height: 2px; color: rgb(0, 0, 0); clear: both; background-color: rgb(0, 0, 0);"></div>
        </div>
        <!--PROfilePageNumberReset%Num%1%%%--></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ASSET PURCHASE AGREEMENT</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">THIS ASSET PURCHASE AGREEMENT (this &#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221;) is dated as of June 8, 2023, by and
        between MERIT MEDICAL SYSTEMS, INC., a Utah corporation (&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser</u></font>&#8221;), and ANGIODYNAMICS, INC., a Delaware corporation (&#8220;<font style="font-family: 'Times New Roman';"><u>Seller</u></font>&#8221;).&#160;




        The capitalized terms used in this Agreement are defined in <font style="font-family: 'Times New Roman';"><u>Exhibit A</u></font> hereto, unless otherwise defined herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">RECITALS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, Seller is engaged
          in, among other things, manufacture and commercialization of the dialysis catheter and tract sealant system products identified on <font style="font-family: 'Times New Roman';"><u>Exhibit B</u></font> hereto (together, the &#8220;<font style="font-family: 'Times New Roman';"><u>Products</u></font>&#8221;); and</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">WHEREAS</font><font style="font-size: 10pt;">, Seller desires to
          sell to Purchaser, and Purchaser desires to purchase from Seller, the Purchased Assets (including the Products), on the terms and conditions set forth herein.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">NOW, THEREFORE</font><font style="font-size: 10pt;">, in
          consideration of the foregoing recitals and the mutual representations, warranties, covenants and promises contained herein, the adequacy and legal sufficiency of which are hereby acknowledged, the parties hereto agree as follows:</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 1</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">THE TRANSACTIONS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Purchased Assets</u></font></font>.&#160; Subject to the terms and conditions of this Agreement, at the Closing Seller shall sell, transfer, convey, assign and deliver to Purchaser, and Purchaser shall
        purchase from Seller, all of its right, title and interest in, to and under the following assets, free and clear of any Encumbrances (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchased Assets</u></font>&#8221;):</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Purchased Inventory</u></font></font>.&#160; All inventories, including raw materials, works in process, semi-finished and finished products, stores, replacement and spare parts, packaging materials,
        operating supplies, inventory on consignment, and other inventories, in transit or deposited in warehouse, in each case to the extent primarily related to the Products, including, without limitation, the items set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 1.1(a)</u></font> (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchased Inventory</u></font>&#8221;);</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Intellectual Property</u></font></font>.&#160; The Purchased Intellectual Property;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><u>Contracts</u></font></font>.&#160; The Contracts identified on <font style="font-family: 'Times New Roman';"><u>Schedule 1.1(c)</u></font> and Licenses identified on <font style="font-family: 'Times New Roman';"><u>Schedule 4.8(c)(ii)</u></font> (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Assigned Contracts</u></font>&#8221;);</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Contract Claims</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; All claims and other rights arising under the Assigned Contracts from and after the Closing (other than
              the Accounts Receivable) and all rights under or pursuant to warranties, representations, covenants, indemnities or guarantees made by suppliers, manufacturers or contractors in connection with products or services provided to Seller from
              third parties to the extent primarily related to the Products and arising from and after the Closing, including any rights to credits or claims for refunds or reimbursements (but excluding (i) cash security or other deposits and (ii) Tax
              assets) from third parties to the extent primarily related to the Products;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Governmental Approvals</u></font></font>.&#160; The Governmental Approvals and Permits (and pending applications therefor), filings and notifications that are necessary for the manufacturing, marketing,
        distribution and sale of the Products in all countries in which such Products are used, made, marketed, distributed or sold (although the transfer of some such Governmental Approvals and Permits will occur after the Closing pursuant to other
        Transaction Agreements) identified on <font style="font-family: 'Times New Roman';"><u>Schedule 1.1(e)</u></font>;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Books and Records</u></font></font>.&#160; All information, including customer and supplier lists and details (including information reasonably necessary to enable Purchaser to fulfill any supplier due
        diligence obligations related to the Products with respect to conflict minerals and supply chain management), product and pricing information, account histories, research data and commercial data, on whatever medium (including paper and electronic
        media) and all books of account, general, financial, quality system, regulatory and tax records (other than minute books, organizational documents, stock records and similar records of Seller), in each case to the extent primarily relating to the
        Products or the other Purchased Assets and in Seller&#8217;s possession (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Books and Records</u></font>&#8221;); <font style="font-family: 'Times New Roman'; font-style: italic;">provided,
          however</font>, that if any Books and Records contain any information of Seller or any of its Subsidiaries not primarily related to the Products or the other Purchased Assets, Seller may elect to redact those portions of such Books and Records to
        the extent the redaction solely pertains to information not related to the Products or Purchased Assets or, in Seller&#8217;s sole and absolute discretion, Seller may deliver unredacted copies of such Books and Records containing information not related
        to the Products or the other Purchased Assets but such information shall be subject to the confidentiality provisions of this Agreement, shall remain the property of Seller, and Purchaser shall have no rights with respect to such information;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Equipment and Machinery</u></font></font>.&#160; All equipment and machinery (including all tooling and molds) identified on <font style="font-family: 'Times New Roman';"><u>Schedule 1.1(g)</u></font>, and
        the spare parts related to such equipment and machinery; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, that the expense of moving any such equipment shall be borne by Purchaser;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Sales, Promotional and Training Items</u></font>.&#160; All sales and promotional literature and other sales-related materials, all labels and product inserts, all training videos and other
            training-related materials, and all patient forms, testimonials, and other patient-related materials, in each case in any medium (including paper and electronic media) to the extent used, formerly used or held for use in connection with the
            Products (&#8220;<font style="font-family: 'Times New Roman';"><u>Promotional Material</u></font>&#8221;);</font></font></div>
      <div style="font-size: 10pt;">&#160; <br>
      </div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><u>Goodwill</u></font></font>.&#160; All goodwill of Seller of every kind and description to the extent primarily related to the Products or Purchased Assets, together with the exclusive right of Purchaser to
        represent itself as carrying on the Products in succession to Seller;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><u>Claims</u></font></font>.&#160; All of Seller&#8217;s rights, causes of action, claims, defenses, counterclaims, rights of offset, deposits, prepayments, refunds, judgments, deductions, accounting rights, and
        demands of whatever nature, known or unknown, to the extent primarily related to the Products, the other Purchased Assets or the Assumed Liabilities; and</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><u>Other Assets</u></font></font>.&#160; The other assets of Seller identified on <font style="font-family: 'Times New Roman';"><u>Schedule 1.1(k)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Excluded Assets</u></font></font>.&#160; Notwithstanding any other provision of this Agreement, the Purchased Assets shall not include, and Seller hereby retains and shall not sell,
        transfer, convey, assign or deliver to Purchaser, any property or assets of Seller not expressly set forth in <font style="font-family: 'Times New Roman';"><u>Section 1.1</u></font> hereof (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Excluded Assets</u></font>&#8221;), including without limitation, the following property and assets:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any cash, checks, money orders, marketable securities, short-term instruments and other cash equivalents, funds in time and demand deposits or similar accounts (whether or not arising from the Products);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any accounts receivable of Seller, including any accounts receivable of the Products as of the Closing (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Accounts Receivable</u></font>&#8221;);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">the Seller Licensed Intellectual Property;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any Intellectual Property Rights other than the Purchased Intellectual Property and Third Party Intellectual Property;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any software, laptops, desktops, computer peripherals or related computer hardware;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Tax losses and credits, Tax loss and credit carry forwards and other Tax attributes, recoveries, all deposits or advance payments with respect to Taxes, and any claims, rights and interest in and to any refund, credit or reduction
            of Taxes (i) relating to the Purchased Assets for a Pre-Closing Tax Period and (ii) relating to the other assets of Seller for all periods;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Tax Returns and other Tax records of Seller not relating solely to the Purchased Assets and the Assumed Liabilities;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any claims under insurance policies maintained by Seller;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Contracts (included all Shared Contracts as provided in <font style="font-family: 'Times New Roman';"><u>Section 1.6</u></font>) other than the Assigned Contracts;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">any assets related to any business or product lines of Seller other than the Products or the Purchased Assets;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all real property interests held by Seller (including leases of real property and leasehold interests);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(l)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Employee Plans and assets related thereto;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(m)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Seller&#8217;s ownership or other equity interests in any Person;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(n)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">other than the Books and Records, all information, including customer and supplier lists and details, product and pricing information, account histories, research data and commercial data, on whatever medium (including paper and electronic
            media) and all books of account, general, financial, quality system, regulatory and tax records of Seller or any of its Subsidiaries not primarily related to the Purchased Assets;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(o)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all rights of Seller under this Agreement and any other Transaction Agreement; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(p)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman';">without
            limiting the generality of the foregoing, t<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">he other assets of Seller identified on <u>Schedule 1.2(p)</u>.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Assumed Liabilities</u></font></font>.&#160; Following the Closing, in accordance with and pursuant to the terms of this Agreement, Purchaser shall, pay, perform and discharge when due, and neither Seller
        nor any of its Affiliates shall have any responsibility or obligations with respect to the following Liabilities (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Assumed Liabilities</u></font>&#8221;):</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">all <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Liabilities to the extent arising out of, resulting from or related to the Products or the Purchased Assets after the Closing or Purchaser&#8217;s use or operation of the Products or the
              Purchased Assets after the Closing, including to the extent arising out of or relating to the design, testing, marketing, labeling, manufacture, distribution, use or sale of any Products after the Closing;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Liabilities under the Assigned Contracts arising after the Closing, except to the extent such Liabilities arise out of or relate to any breach by Seller of, or failure to comply with, prior to the Closing, any covenant or obligation in
            any such Assigned Contract;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Liabilities related to Product warranty claims (i) with respect to Products sold prior to the Closing or (ii) arising with respect to or related to any return, refund or Recall with respect to Products manufactured prior to the
            Closing, including all Liabilities for any credits, rebate or other amounts payable in respect of any return of Products sold prior to the Closing (regardless of whether the applicable warranty is express or implied and whether made before or
            after the Closing to the extent not resolved as of the Closing), in each case of clauses (i) and (ii), in an aggregate amount up to Seventy-Five Thousand Dollars ($75,000) (the &#8220;<font style="font-family: 'Times New Roman';"><u>Assumed
                Pre-Closing Warranty and Recall Liabilities Amount</u></font>&#8221;);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Liabilities related to Product warranty claims (i) with respect to Products sold after the Closing, or (ii) arising with respect to or related to any return, refund or Recall with respect to Products manufactured after the Closing,
            including all Liabilities for any credits, rebate or other amounts payable in respect of any returned Products sold after the Closing;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all obligations of Purchaser under this Agreement or any other Transaction Agreement; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Liabilities for Taxes arising out of, related to, or with respect to the Purchased Assets or the Assumed Liabilities that are attributable to a Post-Closing Tax Period, including the portion of any Straddle Period beginning after
            the Closing Date.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Excluded Liabilities</u></font></font>.&#160; Notwithstanding anything to the contrary in this Agreement, Seller shall retain, and shall be responsible for paying, performing and discharging when due, and
        Purchaser shall not assume or have any responsibility for, any Liabilities of Seller other than the Assumed Liabilities, including without limitation, the following Liabilities (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Excluded
            Liabilities</u></font>&#8221;):</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">all <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Liabilities to the extent arising out of, resulting from or related to the Products or the Purchased Assets prior to the Closing or Seller&#8217;s use or operation of the Products or the
              Purchased Assets prior to the Closing, including to the extent arising out of or relating to the design, testing, marketing, labeling, manufacture, distribution, use or sale of any Products prior the Closing (other than the Assumed
              Pre-Closing Warranty and Recall Liabilities Amount);</font></font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt;"><font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> <br>
            </font></font></font></div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';">all
            Liabilities, whether arising before, on or after the Closing arising out of, resulting from or related to the Excluded Assets;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">all Liabilities related to Product warranty claims (i) with respect to Products sold prior to the Closing or (ii) arising with respect to or related to any return, refund or Recall with respect to Products manufactured prior to the
            Closing, including all Liabilities for any credits, rebate or other amounts payable in respect of any return of Products sold prior to the Closing, in each case of clauses (i) and (ii), to the extent the aggregate amount of such Liabilities
            exceeds the Assumed Pre-Closing Warranty and Recall Liabilities Amount;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman';">all Liabilities
            of Seller for borrowed money;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">all
            outstanding accounts payable under the Assigned Contracts arising prior to the Closing Date;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">all
            Liabilities under any Assigned Contract (i) arising prior to the Closing or (ii) that arise after the Closing and arise out of or relate to any breach by Seller of, or failure to comply with, prior to the Closing, any covenant or obligation in
            any such Assigned Contract;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">all Liabilities
            of Seller and its Affiliates for Taxes related to the Purchased Assets, the Products or the Assumed Liabilities that are attributable to a Pre-Closing Tax Period <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">and all
              liabilities for Taxes that are otherwise transferred to Purchaser by operation of law under this Agreement that are attributable to a Pre-Closing Tax Period</font>;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> and </font>all




            Liabilities for Transfer Taxes pursuant to <font style="font-family: 'Times New Roman';"><u>Section 9.2</u></font>;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">all Liabilities
            arising under or in connection with any Employee Plan including but not limited to (A) any Liability for severance payments, commissions, bonuses, continuing welfare plan coverage or similar remuneration or benefits payable to employees of
            Seller or its Affiliates; and (B) any liability imposed on Purchaser or any of its Affiliates by a Governmental Authority or any other Person resulting from successor liability or similar concepts;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">all Liabilities in any way related to the employment or retention of any employees, former employees, directors or independent contractors of Seller;</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</font><font style="font-family: 'Times New Roman';">and</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">all
            obligations of Seller under this Agreement or any other Transaction Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Non-Assignable
              Assets</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">Notwithstanding the foregoing, if any Assigned Contract or other Purchased Asset, including any Governmental Approval identified on <u>Schedule 1.1(e)</u>, is not assignable or transferable (each, a &#8220;<u>Non-Assignable





                Asset</u>&#8221;) without the Consent of, or waiver by, a third party or action by a Governmental Authority (each, an &#8220;<u>Assignment Consent</u>&#8221;), either as a result of the provisions thereof or applicable Legal Requirements, and any such
              Assignment Consent is not obtained on or prior to the Closing Date, this Agreement and the related instruments of transfer shall not constitute an assignment or transfer of such Non-Assignable Asset, and such Non-Assignable Asset shall not be
              included in the Purchased Assets.&#160; Instead, for a period of three (3) years after the Closing, each of the parties hereto shall use commercially reasonable efforts to obtain all such Assignment Consents after the Closing Date; </font><font style="font-family: 'Times New Roman'; font-style: italic;">provided, however</font><font style="font-family: 'Times New Roman';">, that in connection therewith neither party nor any of its Affiliates shall be required to pay any sums of
              money (other than customary filing and application fees typically paid by a transferee) or make any concession therefor</font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;or otherwise agree to any action that would
              adversely affect such party or its Affiliates, or such party&#8217;s or its Affiliates&#8217; businesses or operations</font><font style="font-family: 'Times New Roman';">.&#160; After any such Assignment Consents are obtained Seller shall assign to Purchaser
              or its designee such Non-Assignable Assets for no additional consideration.&#160; Following any such assignment, such assets shall be deemed Purchased Assets for purposes of this Agreement.&#160; </font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The fact of a failure to obtain any Consent, including an Assignment Consent shall not, in and of itself, result in a breach of this Agreement.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">For a period of three (3) years after the Closing and subject to payment of the Purchase Price by Purchaser pursuant to <font style="font-family: 'Times New Roman';"><u>Section 2.1</u></font>, the parties shall and shall cause their
            respective controlled Affiliates to, cooperate with each other in any commercially reasonable arrangement designed to provide Purchaser or its designee with all of the rights, benefits, burdens and obligations of the Non-Assignable Assets after
            the Closing as if the appropriate Assignment Consents had been obtained (including enforcement for the benefit of Purchaser of any and all rights of Seller or any of its Affiliates against any other party arising out of any breach or
            cancellation of any such Non-Assignable Assets by such other party and, if requested by Purchaser, acting as an agent on behalf of Purchaser or as Purchaser shall otherwise reasonably require), including by granting subleases or other rights
            and establishing arrangements whereby Purchaser or its designee shall undertake the obligation to perform under Assigned Contracts.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">1.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Shared Contracts</u></font></font>.&#160; For a period of three (3) years after the Closing and subject to payment of the Purchase Price by Purchaser pursuant to <font style="font-family: 'Times New Roman';"><u>Section 2.1</u></font>, Seller shall use commercially reasonable efforts to cause the counterparty to each Shared Contract set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 1.6</u></font> to consent to the
        partial assignment of those rights of Seller under such Shared Contract related to a Product, or to otherwise reasonably cooperate with Purchaser in Purchaser&#8217;s efforts to enter into a new contract with such counterparty on substantially the same
        terms as exist under such Shared Contract, in each case at Purchaser&#8217;s sole cost and expense, in which case such partial assignment shall be deemed an Assigned Contract; <font style="font-family: 'Times New Roman'; font-style: italic;">provided,
          however</font>, that in connection therewith in no event shall Seller or any of its Affiliates be required to pay any sums of money or make any concession therefor or otherwise agree to any action that would adversely affect in any material
        respect Seller or its Affiliates, or Seller&#8217;s or its Affiliates&#8217; businesses or operations, including its relationship with such counterparty to the Shared Contract.&#160; The portion related to the Products of each such Shared Contract for which the
        parties have received consent to such partial assignment shall thereafter be deemed to be an Assigned Contract hereunder and, if applicable, Seller shall wholly assign, or partially assign, such portion to Purchaser as of the Closing.&#160; Any Shared
        Contract for which the arrangements described in this <font style="font-family: 'Times New Roman';"><u>Section 1.6</u></font> have not been entered into shall be a Non-Assignable Asset subject to <font style="font-family: 'Times New Roman';"><u>Section
            1.5</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 2</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CONSIDERATION FOR TRANSFER</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">2.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Purchase Price and Assumption of Assumed Liabilities</u></font></font>.&#160; As full consideration for the sale, transfer, conveyance, assignment and delivery to Purchaser of the Purchased Assets by
        Seller, Purchaser shall (i) deliver to Seller at the Closing an amount equal to One Hundred Million Dollars ($100,000,000) (the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchase Price</u></font>&#8221;) and (ii) assume at the Closing and, in due
        course in accordance with the terms applicable thereto, pay, perform and discharge the Assumed Liabilities.&#160; The Purchase Price shall be paid by wire transfer of immediately available funds to the wire transfer address of Seller as provided to
        Purchaser prior to the Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">2.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Withholding Taxes</u></font></font>.&#160; Purchaser or any of its designated Affiliates shall be entitled to deduct and withhold (without duplication) from the Purchase Price or other payments required to
        be made in accordance with this Agreement, such amounts as Purchaser is required to deduct and withhold with respect to the making of such payment under any provision of federal, state, local or foreign Tax Legal Requirement. Any such withheld
        Taxes shall be treated as having been paid to Seller as part of the Purchase Price.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 3</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CLOSING AND CLOSING DELIVERIES</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">3.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Closing; Time and Place</u></font></font>.&#160; The closing of the Transactions (the &#8220;<font style="font-family: 'Times New Roman';"><u>Closing</u></font>&#8221;) shall occur remotely by the exchange of documents
        and signatures (or their electronic counterparts) on the date hereof following the satisfaction or waiver of the conditions to closing set forth in <font style="font-family: 'Times New Roman';"><u>Article 8</u></font>, or at such other date, time
        or place as the parties may agree (the &#8220;<font style="font-family: 'Times New Roman';"><u>Closing Date</u></font>&#8221;).&#160; The Closing shall be effective as of 12:01 a.m. mountain time on the Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">3.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Deliveries by Seller</u></font></font>.&#160; At the Closing, Seller shall deliver, or cause to be delivered, to Purchaser, each of the following items, duly executed and delivered by Seller as applicable:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160; &#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>General Assignment and Bill of Sale</u></font></font>.&#160; General Assignment and Bill of Sale covering all of the applicable Purchased Assets, substantially in the form attached hereto as <font style="font-family: 'Times New Roman';"><u>Exhibit C</u></font> (the &#8220;<font style="font-family: 'Times New Roman';"><u>General Assignment and Bill of Sale</u></font>&#8221;);</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Purchaser Assignment and Assumption Agreements</u></font></font>.&#160; A Purchaser Assignment and Assumption Agreement between Seller and Purchaser enforceable in various jurisdictions, substantially in
        the form attached hereto as <font style="font-family: 'Times New Roman';"><u>Exhibit D</u></font> (&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Assignment and Assumption Agreements</u></font>&#8221;);</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><u>Intellectual Property Assignments</u></font></font>.&#160; (i) A patent assignment (the &#8220;<font style="font-family: 'Times New Roman';"><u>Patent Assignment</u></font>&#8221;) substantially in the form of <font style="font-family: 'Times New Roman';"><u>Exhibit E</u></font> hereto, for all of the Patents listed on <font style="font-family: 'Times New Roman';"><u>Schedule 4.8(a)</u></font> and (ii) a trademark assignment (the &#8220;<font style="font-family: 'Times New Roman';"><u>Trademark Assignment</u></font>&#8221;), substantially in the form of <font style="font-family: 'Times New Roman';"><u>Exhibit F</u></font> attached hereto, for all of the Trademarks listed on <font style="font-family: 'Times New Roman';"><u>Schedule 4.8(a)</u></font>;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><u>Transition Services Agreement</u></font></font>.&#160; A transition services agreement, substantially in the form attached hereto as <font style="font-family: 'Times New Roman';"><u>Exhibit G</u></font>
        (the &#8220;<font style="font-family: 'Times New Roman';"><u>Transition Services Agreement</u></font>&#8221;), obligating Seller and certain of its Affiliates to provide certain transition services to Purchaser and certain of its Affiliates after the Closing;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Contract Manufacturing Agreement</u></font></font>.&#160; A contract manufacturing agreement, substantially in the form attached hereto as <font style="font-family: 'Times New Roman';"><u>Exhibit H</u></font>
        (the &#8220;<font style="font-family: 'Times New Roman';"><u>Contract Manufacturing Agreement</u></font>&#8221;) obligating Seller to supply Purchaser certain products;</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><u>Intellectual




              Property License Agreement</u></font></font>.<font style="font-size: 10pt;"> <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The license agreement governing Seller Licensed Intellectual Property and Purchaser Licensed
            Intellectual Property, substantially in the form of Exhibit I (the &#8220;<font style="font-family: 'Times New Roman';"><u>Intellectual Property License Agreement</u></font>&#8221;);</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Sublicense Agreement</u></font>.&#160; The Sublicense Agreement of the Evonik License and Supply Agreement between the Parties, substantially in the form attached hereto as <font style="font-family: 'Times New Roman';"><u>Exhibit J</u></font> (the &#8220;<font style="font-family: 'Times New Roman';"><u>Sublicense Agreement</u></font>&#8221;), to entered into contemporaneously with this Agreement;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Books and Records</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; The Books and Records;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Promotional Material</u></font>. The Promotional Material;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Officer Certificate</u></font>. A certificate executed by an executive officer of Seller certifying that attached thereto are true and complete copies of all resolutions adopted by the board
            of directors of Seller authorizing the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby and thereby, and that all such resolutions are in full force and effect and are all
            resolutions adopted in connection with the transaction contemplated hereby and thereby; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(k)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>IRS Form W-9</u></font>.&#160; A properly completed and executed IRS Form W-9 with respect to Seller.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">3.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Deliveries by Purchaser</u></font></font>.&#160; At the Closing, Purchaser shall deliver to Seller the following items, duly executed by Purchaser as applicable:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Wire Transfer</u></font>.&#160; A wire transfer in the aggregate amount equal to (x) the Purchase Price <font style="font-family: 'Times New Roman'; font-style: italic;">less</font> (y) the
            Seller R&amp;W Premium Amount in immediately available funds in accordance with <font style="font-family: 'Times New Roman';"><u>Section 2.1</u></font>;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>General Assignment and Bill of Sale</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; The General Assignment and Bill of Sale;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Purchaser Assignment and Assumption Agreement</u></font>.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160; The Purchaser Assignment and Assumption Agreement;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Intellectual Property Assignments</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; The Patent Assignment and the Trademark Assignment;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Transition Services Agreement</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; The Transition Services Agreement;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Contract Manufacturing Agreement</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; The Contract Manufacturing Agreement;</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Intellectual Property License Agreement</u></font>.&#160; The Intellectual Property License Agreement;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Sublicense Agreement</u></font>.&#160; The Sublicense Agreement; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Officer Certificate</u></font>. A certificate executed by an executive officer of Purchaser certifying that attached thereto are true and complete copies of all resolutions adopted by the
            board of directors of Purchaser authorizing the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated hereby and thereby, and that all such resolutions are in full force and effect and are
            all resolutions adopted in connection with the transaction contemplated hereby and thereby.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 4</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">REPRESENTATIONS AND WARRANTIES OF SELLER</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Except as set forth on Schedule 4 (the &#8220;<font style="font-family: 'Times New Roman';"><u>Seller Disclosure Schedule</u></font>&#8221;) attached to this
        Agreement (it being agreed that disclosure of any item in any schedule shall be deemed disclosure with respect to any other section of this Agreement to which the relevance of such item is reasonably apparent on its face), Seller hereby represents
        and warrants to Purchaser as follows as of the Closing (except for those representations and warranties made as of a particular date, in which case Seller represents to Purchaser as follows as of such date):</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Organization and Good Standing</u></font></font>.&#160; Seller is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization. (a) Seller is duly qualified to
        conduct business and in good standing under the laws of each jurisdiction in which the manufacture and commercialization of the Products and assets (including the Purchased Assets) that Seller conducts or owns requires such qualification and (b)
        Seller has full power and authority required to own, lease and operate its assets and to carry on the manufacture and commercialization of the Products as now being conducted, in each case except where the failure to be so qualified or to have such
        power and authority would not reasonably be expected to be, individually or in the aggregate, material to the Products or the Purchased Assets.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Authority; Binding Nature of Agreements</u></font></font>.&#160; Seller has all requisite corporate power and authority to execute and deliver this Agreement and the other Transaction Agreements to which
        Seller is a party. The execution, delivery and performance by Seller of this Agreement and the other Transaction Agreement to which Seller is a party has been duly and validly authorized and approved by all requisite corporate action on the part of
        Seller.&#160; The execution, delivery and performance by Seller of this Agreement and the other Transaction Agreements does not require the approval of the shareholders of Seller. This Agreement has been duly and validly executed and delivered by
        Seller.&#160; Each of this Agreement and the other Transaction Agreements to which Seller is a party constitutes, or upon execution and delivery will (assuming due authorization, execution and delivery by Purchaser or its Affiliates, as applicable)
        constitute, the legal, valid and binding obligation of Seller, enforceable against Seller in accordance with its terms, except as may be limited by bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium and other similar laws and
        equitable principles related to or limiting creditors&#8217; rights generally and by general principles of equity.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>No Conflicts; Required Consents</u></font></font>.&#160; Neither the execution, delivery or performance of this Agreement nor any other Transaction Agreement by Seller nor the
        consummation of any of the Transactions will:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">conflict with,
            violate, result in any breach of or constitute a default under (with or without notice or lapse of time) any of the provisions of the organizational documents of Seller,</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">conflict with,
            violate, result in any breach of or constitute a default under (with or without notice or lapse of time) any provision of any Material Contract, or require a Consent under any Material Contract;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; <font style="font-family: 'Times New Roman';">(i) give any
            Governmental Authority or other Person the right to exercise any remedy or obtain any relief under any Legal Requirement or any Order to which Seller is bound or any of the Purchased Assets is subject, (ii) violate or conflict with any
            provision of, or result in the breach of, any Legal Requirement applicable to Seller or require any Consent of any Person under any Legal Requirement or (iii) constitute a default under or give any Person the right to declare a default of,
            exercise any remedy under, accelerate the performance of, cancel, terminate, modify or receive any payment under any Material Contract or otherwise result in the termination of a Material Contract;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">result in the
            imposition or creation of any Encumbrance upon or with respect to, or result in the imposition of additional obligations or loss of rights under, any Purchased Asset (other than Liens resulting from any facts or circumstances relating to
            Purchaser or its Affiliates); or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">require Seller
            to make or deliver any filing or notice to a Governmental Authority, other than reporting under the Securities Exchange Act of 1934, as amended or any filings or notices required to record the transfer of ownership of the Purchased Intellectual
            Property or any required <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">updates to an FDA registration and medical device listing</font>;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">except, with respect to clauses (b) and (c), for any violations, conflicts, defaults, terminations, cancellations, accelerations or impositions as
        would not reasonably be expected to be, individually or in the aggregate, material to the Products or the Purchased Assets.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Financial
              Information; No Undisclosed Liabilities</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Schedule 4.4(a)</u></font> hereto includes unaudited net revenue and standard costs, in each case for the period commencing on June 1, 2020 and ending on May 31, 2023 for certain assets
            exclusively related to the final assembly and packaging of the Products (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Financial Information</u></font>&#8221;).&#160; The Financial Information (i) has been prepared from and in
            accordance with the Books and Records of Seller and (ii) has been maintained in accordance with the business and accounting practices and internal controls and policies of Seller.&#160; The Financial Information fairly presents in all material
            respects the revenues and cost of goods sold with respect to the Products as of the dates and for the periods indicated therein.&#160; Otherwise, the Financial Information (x) includes information with respect to the Products as of the dates and for
            the periods indicated therein only with respect to the financial statement line items identified in <font style="font-family: 'Times New Roman';"><u>Schedule 4.4(a)</u></font> (and not other line items that would be required to be included in
            an income statement or balance sheet prepared in accordance with GAAP) and (y) does not include &#8220;Operating Expenses&#8221; line items identified in the Financial Information, such as costs allocated to the Products based on a percentage of the
            revenue of the operating segment of which the Products business unit is a part, and does not include allocations of corporate overhead expenses, including costs of information technology, legal, finance and accounting, human resources,
            regulatory and quality, tax or treasury functions, or other similar shared costs or allocations that would be attributable to the Products in an income statement prepared in accordance with GAAP.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">Except (i) as
            set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 4.4(b)</u></font>, (ii) Liabilities reflected in the Financial Information, (iii) Liabilities incurred by Seller in the Ordinary Course of Business since the date of the
            Financial Information<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, and (iv) Liabilities set forth in any Contract which was entered into in the Ordinary Course of Business and which does not result from any breach of
              contract, breach of warranty, tort, claim or lawsuit arising as of or prior to Closing</font>, Seller has, with respect to the Products or the Purchased Assets, no Liabilities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">Seller
            maintains a system of internal accounting controls designed to provide reasonable assurance that transactions are recorded in a timely manner and as necessary to permit preparation of Financial Information in accordance with GAAP and to
            maintain accountability for earnings and assets.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Purchased Inventory</u></font></font>.&#160; <font style="font-family: 'Times New Roman';"><u>Schedule 1.1(a)</u></font> is a complete and accurate list of the Purchased Inventory as of June 7, 2023.&#160; All
        of the items in the Purchased Inventory are (a) of a quality and quantity saleable in the Ordinary Course of Business, (b) meet current industry standards and specifications, (c) are not adulterated or misbranded and are in compliance with all
        Legal Requirements (including without limitation the Federal Food, Drug, and Cosmetic Act, and (d) have been acquired in <font style="font-family: 'Times New Roman'; font-style: italic;">bona fide</font> transactions in the Ordinary Course of
        Business, in each case except as would not reasonably be expected to be, individually or in the aggregate, material to the Products or the Purchased Assets.&#160; All Purchased Inventory is owned by Seller free and clear of all Encumbrances (other than
        Permitted Encumbrances), and no Purchased Inventory is held on a consignment basis. The quantities of each item of Purchased Inventory (whether raw materials, work-in-process or finished goods) are reasonable and sufficient for the manufacture and
        commercialization of the Products under present circumstances. No items of Purchased Inventory are held by any bailee, warehouseman or other third party (other than inventory in route for delivery in the Ordinary Course of Business).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Absence of
              Changes</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Since December
            31, 2022 through the date hereof, the Products have been manufactured and commercialized in the Ordinary Course of Business and Seller has not, with respect to the Products:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">made any capital
            expenditures or entered into any commitment therefore with respect to the Products in an amount greater than $100,000, except in the Ordinary Course of Business;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160; <font style="font-family: 'Times New Roman';">mortgaged,
            pledged or subjected to any Encumbrance any of its assets (whether tangible or intangible) or properties with a fair market value in excess of $100,000 in the aggregate;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">incurred,
            assumed or guaranteed any indebtedness for borrowed money except as would not constitute an Assumed Liability;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">made any loan (or
            forgiven any loan to), or entered into any other transaction with, any of its current or former Representatives other than employment or consulting relationships in the Ordinary Course of Business or as would not constitute an Assumed
            Liability;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">sold, assigned,
            transferred, conveyed, licensed, leased or otherwise disposed of or agreed to sell, assign, transfer, convey, license, lease or otherwise dispose of any material portion of its assets or properties, except for the sale of inventories in the
            Ordinary Course of Business;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">cancelled or
            compromised any material debt or material claim, or waived, compromised or released any material right, except with respect to any Excluded Asset or Excluded Liability;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">entered into,
            accelerated, terminated, materially modified or cancelled any Material Contract or Governmental Approval, other than in the Ordinary Course of Business;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">with respect to
            the Purchased Assets, in each case, to the extent such action could materially affect Purchaser in a taxable period (or portion thereof) ending after the Closing Date, (A) changed any material Tax election or accounting method, (B) consented to
            the extension of any waiver of the limitation period applicable to any material Tax claim or assessment, or (C) settled or comprised any material Tax claim or assessment; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">committed in
            writing to take any of the foregoing actions.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Since December
            31, 2022 through the date hereof no event, development or circumstance has occurred that has had, or would reasonably be expected to have, a Material Adverse Effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Taxes</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 4.7(a)</u></font>, all Tax Returns in respect of or in relation to the Purchased Assets required to be filed have been timely filed (taking into account
            any extensions of time in which to file).&#160; All such Tax Returns are correct and complete in all material respects and all Taxes in respect of or in relation to the Purchased Assets (whether or not shown on such Tax Returns) have been timely
            paid.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Except as set
            forth on <font style="font-family: 'Times New Roman';"><u>Schedule 4.7(b)</u></font>, there is no pending dispute, audit or claim regarding Taxes pending against Seller or its Affiliates with respect to or in relation to any Purchased Asset
            claimed or raised by any Tax Authority <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">and no Tax Authority has given written notice of the commencement of (or its intent to commence) any such actions, suits, claims,
              investigations or other legal proceedings</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">There are no
            outstanding Encumbrances <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">that have been proposed, asserted, or assessed by any Tax Authority </font>for Taxes other than Permitted Encumbrances on the Purchased Assets.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Except as set
            forth on <font style="font-family: 'Times New Roman';"><u>Schedule 4.7(d)</u></font>, the Assigned Contracts impose no Liability on Seller or its Affiliates, and following Closing will impose no Liability on Purchaser, for or with respect to
            the Taxes of any other Person.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">Seller has not
            extended any statute of limitations period in respect of Taxes that<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</font>relates to the Purchased Assets, or agreed to any extension of time with respect to an assessment or<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</font>deficiency relating to such Taxes, for any taxable period with respect to which the statute of limitations<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</font>has




            not expired (after giving effect to any extension or waiver).</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Intellectual
              Property</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Schedule 4.8(a)</u></font> sets forth a correct and complete list of the following, in each case that Seller owns or purports to own and that in each case is used primarily in connection
            with any Product: (i) Registered Intellectual Property Rights; (ii) unregistered Trademarks; (iii) unregistered Copyrights, including all Promotional Materials; and (iv) summaries of Trade Secrets (collectively, &#8220;Product Intellectual
            Property&#8221;), and in each case setting forth, for each item: the title; full legal name of the owner(s) of record; jurisdiction in which such item has been issued or registered or filed or applied for; status; registration number, serial number,
            or application number; and date of application, registration, or issuance, as applicable (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchased Intellectual Property</u></font>&#8221;).&#160; Seller solely owns, and possesses all
            rights, titles and interests in and to all Purchased Intellectual Property, free and clear of all Encumbrances and upon Closing, Purchaser will be the sole owner of, and will have valid title to, and will have the full right to use, license,
            and transfer all of the Purchased Intellectual Property.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">All of the
            Purchased Intellectual Property is valid, subsisting, enforceable and in full force and effect (other than any Intellectual Property Rights which have been expired, abandoned or cancelled, as indicated on <font style="font-family: 'Times New Roman';"><u>Schedule 4.8(a)</u></font>).&#160; Seller has timely (i) paid any and all renewal and maintenance fees, annuities or other fees to any Governmental Authority to maintain the Product Intellectual Property and (ii) made any and all
            filings, submissions and responses to any Governmental Authority or other organization necessary to maintain the <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Product Intellectual Property. Except as disclosed on<u>
                Schedule 4.8(a)</u>, no payments are owed and no filings, submissions, or responses are due to be made during the period of ninety </font>(90) days following Closing for any Purchased Intellectual Property.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Schedule 4.8(c)(i)</u></font> sets forth a correct and complete list of the following, in each case that are licensed to or used by, but not solely owned by, Seller in connection with any Product:
            (A) Registered Intellectual Property Rights; (B) unregistered Trademarks; (C) material unregistered Copyrights; and (D) Trade Secrets and other know-how (&#8220;<font style="font-family: 'Times New Roman';"><u>Third Party Intellectual Property</u></font>&#8221;).&#160;




            Seller has a valid and enforceable license to all of the Third Party Intellectual Property as necessary in connection with the development, design, making, use, offer, sell, service, importation, or exportation of any Products, which such
            licenses <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(other than generally commercially available, &#8220;off-the-shelf&#8221; software programs and non-exclusive licenses&#160; with an annual spend of less than $20,000 granted in the
              ordinary course of business which do not contain any material restriction or condition on the use or exploitation of any Purchased Intellectual Property) and such licenses for Third Party Intellectual Property that are to be assigned to
              Purchaser are </font>set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 4.8(c)(ii)</u></font> (&#8220;<font style="font-family: 'Times New Roman';"><u>Licenses</u></font>&#8221;).&#160; Each party to a License is and has been in
            compliance with, and has not, to Seller&#8217;s Knowledge, breached or defaulted under, any of such License, and no License has been threatened in writing to be terminated.&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Seller
              does not owe any royalties, fees, honoraria, or other payment to any Person by reason of the ownership, development, modification, use, license, sublicense, sale, distribution or other disposition of Products, Third Party Intellectual
              Property or Purchased Intellectual Property, other than fees set forth in Licenses.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Other than Purchased Intellectual Property, Third Party Intellectual Property and Seller Licensed Intellectual Property, Seller has not used, utilized, or exploited any Intellectual Property Rights in connection with any Product. The
            Purchased Intellectual Property, Seller Licensed Intellectual Property and the Third Party Intellectual Property constitute all of the Intellectual Property Rights necessary for any use, manufacturing, development, selling, offering for sale,
            importation, exportation, marketing, or exploitation of any Product in all material respects.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Seller has not
            licensed, agreed to license or granted any other rights in or to any Purchased Intellectual Property, Third Party Intellectual Property, or Seller Licensed Intellectual Property to any Person except as listed on <font style="font-family: 'Times New Roman';"><u>Schedule 4.8(e)</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(f)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">As of the date
            hereof, no Product, no use, manufacture, development, sale, offer for sale, importation, exportation, marketing, or exploitation of any Product, and no Purchased Intellectual Property (i) to Seller&#8217;s Knowledge infringes, misappropriates,
            dilutes, or otherwise violates any Intellectual Property Right of any third party, <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">and, to Seller&#8217;s Knowledge, there is no valid basis for such claim, </font>(ii) no
            investigation is pending or threatened in writing with respect to any possible infringement, misappropriation, dilution, or other violation of any Intellectual Property Right of any third party.&#160; Except as listed on Schedule 4.8(f), (A) Seller
            has not received written, or to Seller&#8217;s Knowledge, oral notice of any allegation of any infringement, misappropriation, or violation of any Intellectual Property Right of any third party with respect to the Products or Purchased Assets, and
            (B) Seller has not requested or received any opinions of counsel related to any of the foregoing.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(g)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">To Seller&#8217;s
            Knowledge no Person is, or since June 1, 2020 has been, infringing, misappropriating, diluting, or otherwise violating any Purchased Intellectual Property. Seller has not given notice to any third party, and no Proceeding has been initiated,
            threatened, or is pending against any third party, asserting any infringement, misappropriation, dilution, or violation of any Purchased Intellectual Property<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; Since June 1,
              2020, except as set forth on Schedule 4.8(g), Seller is not subject to any claim by any other Person seeking indemnification, defense or otherwise to be held harmless , and has not agreed to indemnify, defend or otherwise hold harmless any
              other Person, with respect to any Purchased Intellectual Property.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(h)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">As of the date
            hereof, other than applications for Patents, Copyrights, Trademarks or other Intellectual Property Rights listed on <font style="font-family: 'Times New Roman';"><u>Schedule 4.8(a)</u></font>, (i) there are no Proceedings before any
            Governmental Authority (including before the United States Patent and Trademark Office or United States Copyright Office) in any jurisdiction related to any of the Purchased Intellectual Property, and (ii) to Seller&#8217;s Knowledge, no Proceeding
            has, been initiated, threatened or is pending against Seller.&#160; Since June 1, 2020, no notice from any Person has been received by Seller that challenges the validity, enforceability or use of, or any ownership or right of Seller regarding, any
            Purchased Intellectual Property.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Each current and former employee and contractor of Seller involved in the invention, development, creation, reduction to practice, or discovery of any Purchased Intellectual Property has signed and executed a valid and enforceable
            assignment irrevocably transferring all rights, title, and interest of such employee or contractor in or to such Purchased Intellectual Property to Seller, except as would not reasonably be expected to be, individually or in the aggregate,
            material to the Products or the Purchased Intellectual Property.&#160; Seller has taken commercially reasonable measures to preserve and maintain the confidentiality of all Trade Secrets and other information of Seller included in the Purchased
            Assets that is confidential, secret, or subject to any disclosure limitation.&#160; Seller has taken commercially reasonable measures to preserve and maintain the confidentiality of all Trade Secrets and other confidential information of any other
            Person in the possession and control of Seller in connection with the Products, including in compliance with all confidentiality, non-disclosure, and similar Contracts, duties, and obligations of Seller related thereto.&#160; All Persons that have
            received Trade Secrets and other information of Seller included in the Purchased Assets that is confidential, secret, or subject to any disclosure limitation have agreed to preserve and maintain the confidentiality thereof, and to Seller&#8217;s
            Knowledge no Person has defaulted under or breached any such Contract.&#160; To Seller&#8217;s Knowledge, no current or former employee or contractor has any patents issued or applications pending for any device, process, design, or invention of any kind
            now used or needed by Seller in furtherance of the Products, which patents or applications are not part of the Purchased Intellectual Property.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(j)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">With respect to
            the Products and Purchased Assets, Seller is in compliance in all material respects with all applicable Legal Requirements and its posted privacy policies regarding the collection, receipt, use, privacy and protection of any information and
            data from customers or other Persons (including personally identifiable information and data) collected or otherwise obtained by Seller that are part of the Purchased Assets (the &#8220;<font style="font-family: 'Times New Roman';"><u>Collected
                Information</u></font>&#8221;).&#160; Since June 1, 2020, Seller has used commercially reasonable security measures and safeguards in place to detect and prevent any security breaches and to protect the Collected Information from illegal or
            unauthorized access, use or processing by its personnel or third parties, or access, use, or processing by its personnel or third parties in a manner in violation of, or inconsistent with applicable Legal Requirements and the applicable posted
            privacy policies of Seller.&#160; Since June 1, 2020, no Person has gained unauthorized access to or made any unauthorized use or processing of any Collected Information.&#160; Without limiting the foregoing, Seller has in effect commercially reasonable
            information security, backup, disaster recovery and incident response policies with respect to any company system on which any Collected Information is stored.&#160; Since June 1, 2020, no claims have been asserted or, to Seller&#8217;s Knowledge,
            threatened against Seller by any Person alleging any material violation of any individual&#8217;s privacy, personal or confidentiality rights related to any Collected Information.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Material
              Contracts</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Schedule 4.9(a)</u></font> sets forth an accurate, correct and complete list of any Contracts in effect as of the date of this Agreement entered into by Seller that apply to the manufacture
            or commercialization of the Products and to which any of the descriptions set forth below apply (the Contracts required to be so listed, the &#8220;<font style="font-family: 'Times New Roman';"><u>Material Contracts</u></font>&#8221;):</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract for
            capital expenditures in excess of $50,000 individually, or $200,000 in the aggregate;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract with
            an agent, customer or distributor that resulted or would reasonably be expected to result in sales of greater than $50,000 per annum.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract with
            a vendor or supplier that resulted<font style="font-family: 'Times New Roman';">&#160;</font>or would reasonably be expected to result in payments by Seller of greater than $50,000 per annum;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any lease or other
            Contract under which Seller, with respect to the Products, is a lessee of, or holds or operates, any machinery, equipment, vehicle or other tangible personal property owned by a third party that requires rental payments in excess of $50,000 per
            annum;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">any mortgage,
            indenture, security agreement, pledge, note, loan agreement or guarantee in respect of indebtedness for borrowed money or any agreement that creates an Encumbrance (other than a Permitted Encumbrance) on any Product or Purchased Asset;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">any Contract that
            limits or purports to limit the ability of Seller to compete in any line of business or with any Person or in any geographic area or during any period of time;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(vii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract that
            is a license by Seller to a third party of Purchased Intellectual Property;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(viii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract
            related to the acquisition of a business or the equity of, or joint venture with, any other Entity;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ix)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract for
            the joint development of any product;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">any Contract for
            the sale of any of the Purchased Assets or for the grant to any Person of any option, right of first refusal or preferential or similar right to purchase any of the Purchased Assets, in each case, excluding acquisitions or dispositions of
            supplies, inventory, merchandise or products in the Ordinary Course of Business;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xi)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract with
            a Governmental Authority;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any Contract for
            the distribution of any of the Products in any jurisdiction; and</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(xiii)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">any proposed
            arrangement of a type that, if entered into, would be a Contract described in any of (i) through (xii) above.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Each Material Contract is, assuming the due execution and delivery of the counterparties thereto, valid and binding on Seller in accordance with its terms and is in full force and effect. None of Seller or any other party thereto is in
            breach of or default under (or, to Seller&#8217;s Knowledge, is alleged to be in breach of or default under) in any material respect, or since June 1, 2020 has provided or received any written, or to Seller&#8217;s Knowledge, oral notice of any intention
            to terminate, any Material Contract.&#160; No event or circumstance has occurred that, with notice or lapse of time or both, would constitute an event of default by Seller or, to Seller&#8217;s Knowledge, any other party thereto under any Material
            Contract or result in a termination thereof or would cause or permit the acceleration or other changes of any material right or obligation or the loss of any material benefit thereunder.&#160; Complete and correct copies of each Material Contract
            (including all modifications, amendments, and supplements thereto and waivers thereunder) have been made available to Purchaser.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Insurance</u></font></font>.&#160; There are no insurance policies or fidelity bonds that are part of the Purchased Assets or which will continue to provide insurance for the Purchased Assets subsequent to
        the Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt; text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Compliance with Laws</u>.&#160; Since June 1, 2020, Seller has been, and is now, in compliance in all material respects with all applicable Legal Requirements and Orders (including all applicable Environmental Laws and health, and safety
            Legal Requirements) with respect to the Products (including the manufacturing, sale and delivery of the Products) and Purchased Assets.&#160; Seller has in effect all approvals, clearances, authorizations, certificates, filings, franchises,
            licenses, notices, permits, clearances, exemptions and registrations of, with or from all Governmental Authorities (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Permits</u></font>&#8221;) that are required in all material respects
            for Seller&#8217;s manufacture and commercialization of the Products.&#160; <font style="font-family: 'Times New Roman';"><u>Schedule 4.11</u></font> contains a complete listing of all Permits required for the conduct of Seller&#8217;s business of
            manufacturing and commercializing the Products as currently conducted.&#160; No violation, loss or expiration of any of such Permits is pending or, to Seller&#8217;s Knowledge, threatened other than expiration in accordance with the terms thereof.&#160; No
            event has occurred that, with or without notice or lapse of time or both, would reasonably be expected to result in the revocation, suspension, lapse or limitation of any Permit.&#160; Since June 1, 2020, no notice, citation, summons or order has
            been issued to Seller, no complaint has been filed with Seller, no penalty has been assessed against Seller and to Seller&#8217;s Knowledge no review or investigation, is pending or threatened, by any Governmental Authority with respect to any
            alleged failure by Seller to have any such Permit.</font></font> </div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.12</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Governmental
              Approvals; Product Liability</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Since June 1, 2020, (i) there has not been conducted or requested in writing, nor, to Seller&#8217;s Knowledge, threatened by any Governmental Authority, any Recall in respect of any Product and (ii) no report of any death, injury, material
            defect or malfunction involving any Product has been filed or is required to have been filed with any Regulatory Authority under any United States or foreign Legal Requirement.&#160; There are no pending, and since June 1, 2020, there have not been
            any, Proceedings or written threats thereof related to product liability involving any Products, and no such Proceedings or written threats have been settled, adjudicated or otherwise disposed of since June 1, 2020.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">As of the date
            hereof, there are no citations, decisions, adjudications or statements, in each case issued in writing by any Regulatory Authority and affecting the Products, and Seller is not subject to any Order, asserting that any Product is defective or
            unsafe in any material respect or fails in any material respect to meet any Legal Requirement.&#160; Seller is not under any duty to recall or correct any Product in the field.&#160; Seller, with respect to the Products, (i) has obtained all applicable
            Governmental Approvals required by any Regulatory Authority to develop, test, manufacture, market, store, distribute and sell each of the Products in compliance with applicable Legal Requirements, including without limitation all clearances
            under Federal Food, Drug, and Cosmetic Act &#167; 510(k), and all approvals, authorizations, registrations, or clearances in any jurisdiction where the Seller currently conducts such activities with respect to each of the Products and (ii) has made
            all filings with, and given all notifications to, all Regulatory Authorities in all material respects as required by all applicable Legal Requirements, and all such filings, reports and notifications were complete and accurate on the date filed
            (or were corrected in or supplemented by a subsequent filing), in each case of clauses (i) and (ii), <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">except as would not reasonably be expected to be, individually or in the
              aggregate, material to the Products or the Purchased Assets, or Purchaser&#8217;s right or ability to promote, distribute, and sell any Product</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">There is no
            Proceeding pending or, to Seller&#8217;s&#160; Knowledge, threatened in writing that would reasonably be expected to result in the suspension, termination, revocation, cancellation, material limitation or material impairment of any Governmental Approval
            or Permit, filing or notification, or any currently conducted Product research, development, testing, manufacturing, marketing, distribution or sales activities.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Seller has made
            available to Purchaser accurate and complete copies of all of the Governmental Approvals and Permits, filings and notifications identified on <font style="font-family: 'Times New Roman';"><u>Schedule 1.1(e)</u></font>, including all renewals
            thereof and all amendments thereto.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Seller, and, to Seller&#8217;s Knowledge, any officer, employee or agent of Seller, has not been excluded or threatened in writing by any Governmental Authority with exclusion from participation in any federal health care program or engaged in
            any conduct for which a person could be excluded from participating in any federal healthcare program under Section 1128 of the Social Security Act.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.13</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Proceedings and Orders</u></font></font>.&#160; There is no Proceeding pending or, to Seller&#8217;s Knowledge, threatened against Seller or any of its Affiliates with respect to the Purchased Assets, including,
        without limitation, the Products or the Assumed Liabilities.&#160; To Seller&#8217;s Knowledge, no event has occurred that would reasonably be expected to serve as a basis for the commencement of any such Proceeding.&#160; Neither Seller nor any of its Affiliates
        is in default with respect to any Order related to the Products or the Purchased Assets.&#160; None of Seller&#8217;s (with respect to the Products or Purchased Assets) properties, assets, operations or businesses, nor any of the Purchased Assets or Assumed
        Liabilities, is subject to any Order or any proposed Order.&#160; There are no Proceedings pending or threatened in writing relating to the Products, the Purchased Assets or the Assumed Liabilities.&#160; The foregoing sentences include, without limiting
        their generality, actions pending or threatened against Seller involving the employment (prior or present) of any of Seller&#8217;s officers&#8217; or employees&#8217; use of any information or techniques related to the Products, Purchased Assets or the Assumed
        Liabilities allegedly proprietary to such officer or employee.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.14</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Title, Condition and Sufficiency of Assets</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Seller is the
            sole and exclusive owner of, and has good and valid title to, all Purchased Assets, free and clear of all Encumbrances, other than Permitted Encumbrances. The Seller is the sole and exclusive owner of all&#160; Governmental Approvals and Permits set
            forth on <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Schedule 1.1(e)</u></font>, and the Seller has not previously sold or transferred in any manner, in whole or in part, directly or indirectly, any of such
            Governmental Approvals.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">Each piece of
            machinery and equipment included in the Purchased Assets is in good operating condition and repair (subject to normal wear and tear) and is adequate and suitable in all material respects for its use in connection with the manufacture or
            commercialization of the Products<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">, meets current industry standards and specifications, and is in compliance with all Legal Requirements</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The Purchased
            Assets used in the manufacture and commercialization of the Products, together with (i) the administrative, back-office and professional services from accounting, audit, compliance, customs, legal, treasury, finance, tax, human resources,
            payroll, benefits, information technology, maintenance, insurance, logistics, marketing, sales, supply chain, customer service/allocation or other administrative groups, in each case that are currently provided by Seller, any of its Affiliates
            or any third party to the Products as well as to Seller or one or more of its Affiliates generally, (ii) the services from any employees of Seller or its Affiliates, (iii) the services to be provided by Seller and its Affiliates to Purchaser
            and its Affiliates pursuant to this Agreement, the Transition Services Agreement, the Contract Manufacturing Agreement and the other agreements contemplated hereby, (iv) the Shared Contracts and (v) any real property used in the manufacture and
            commercialization of the Products, and assuming all consents, permits and licenses have been obtained or transferred, constitute all of the assets used to manufacture and commercialize the Products in all material respects as operated during
            the twelve (12) months prior to the date hereof by Seller and its Affiliates.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.15</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Brokers</u></font></font>.&#160; Other than UBS Securities LLC, Seller has not retained any broker or finder or incurred any Liabilities for any brokerage fees, commissions or finders fees with respect to
        this Agreement or the Transactions, and no broker, finder, investment banker or other Person is entitled to any fees or commissions in connection with the Transactions.</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.16</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Trade Control Laws</u></font></font>.&#160; Neither Seller (with respect to the Products), nor to Seller&#8217;s Knowledge any of its officers, directors or employees, nor any Representative acting on behalf of
        Seller (with respect to the Products), is currently, or has been since June 1, 2020: (a) a Sanctioned Person, (b) organized or resident in a Sanctioned Country, (c) except as set forth on <font style="font-family: 'Times New Roman';"><u>Schedule
            4.16</u></font>, engaged in any dealings or transactions, directly or indirectly, with any Sanctioned Person or in or with any Sanctioned Country, or (d) otherwise in violation of applicable Sanctions Laws, Export-Import Laws, or the
        anti-boycott Laws administered by the United States Department of Commerce, the United States Customs and Border Protection and the United States Department of Treasury&#8217;s Office of Foreign Assets Control (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Trade Control Laws</u></font>&#8221;).&#160; Since June 1, 2020, Seller has not (with respect to the Products) received from any Governmental Authority or, to Seller&#8217;s Knowledge, any other Person any notice, inquiry, or internal or
        external allegation; made any voluntary or involuntary disclosure to a Governmental Authority; or conducted any internal investigation or audit, in each case concerning any actual or potential violation of any Trade Control Laws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.17</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Anti-Corruption Laws</u></font></font>.&#160; Since June 1, 2020, Seller has not (with respect to the Products), nor to Seller&#8217;s Knowledge, any of its officers, directors or employees, nor any
        Representative acting on behalf of Seller (with respect to the Products), (a) has made any unlawful payment or given, offered, promised, or authorized or agreed to give, any money or anything of value, directly or indirectly, to any Governmental
        Authority or other Person in violation of any applicable Anti-Corruption Laws, (b) otherwise violated any applicable Anti-Corruption Laws, or (c) engaged in off-label, false or misleading&#160; promotion, advertising&#160; or marketing of medical devices.&#160;
        Since June 1, 2020, Seller (with respect to the Products) has not received from any Governmental Authority or, to Seller&#8217;s Knowledge, any other Person, any notice, inquiry, or internal or external allegation; made any voluntary or involuntary
        disclosure to a Governmental Authority; or conducted any internal investigation or audit, in each case concerning any actual or potential violation of applicable Trade Control Laws or Anti-Corruption Laws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.18</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Distributors, Customers and Suppliers</u></font></font>.&#160; <font style="font-family: 'Times New Roman';"><u>Schedule 4.18(a)</u></font> sets forth a list of the names of the top ten (10) distributors
        of the Products, each by dollar value of sales to such distributors for the fiscal year ended December 31, 2022.&#160; <font style="font-family: 'Times New Roman';"><u>Schedule 4.18(b)</u></font> sets forth a list of the names of the top ten (10)
        customers of the Products, each by dollar value of sales to such customers for the fiscal year ended December 31, 2022.&#160; <font style="font-family: 'Times New Roman';"><u>Schedule 4.18(c)</u></font> sets forth a list of the names of the top ten
        (10) suppliers of the Products, each by dollar value of net purchases from such suppliers, for the fiscal year ended December 31, 2022.&#160; Seller has not received any written, or to Seller&#8217;s Knowledge, oral notice (a) from any of the distributors
        listed on <font style="font-family: 'Times New Roman';"><u>Schedule 4.18(a)</u></font> that any such distributor intends to stop, materially decrease the rate of, or materially change the payment or price terms with respect to, distributing any
        products included in the Products, (b) from any of the customers listed on <font style="font-family: 'Times New Roman';"><u>Schedule 4.18(b)</u></font> that any such customer intends to stop, materially decrease the rate of, or materially change
        the payment or price terms with respect to, buying any products included in the Products, or (c) from any of the suppliers listed on <font style="font-family: 'Times New Roman';"><u>Schedule 4.18(c)</u></font> that any such supplier intends to
        stop, materially decrease the rate of, or materially change the payment or price terms with respect to, supplying products or services for the Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.19</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Intercompany Arrangements</u></font></font>.&#160; Set forth on <font style="font-family: 'Times New Roman';"><u>Schedule 4.19</u></font> is a true and complete list of all Contracts between or among
        Seller or its Affiliates with respect to the Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.20</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Product Warranties</u></font></font>.&#160; Since June 1, 2020, each Product sold by Seller prior to the Closing has been manufactured, sold, and delivered in compliance with all
        express warranties set forth in any Contract to which such products are subject. Seller has furnished or made available to Purchaser complete and correct copies of the standard terms and conditions of sale for the Products (containing applicable
        guaranty, warranty and indemnity provisions).&#160; Except for the written warranties set forth in the agreements furnished or made available to Purchaser, there are no legally binding warranties (written or oral) granted by Seller with respect to any
        Product.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.21</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>FDA and Regulatory Matters</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';">Seller is</font> in compliance in all material respects with all applicable Legal Requirements regarding registration, license and certification for each site at which a Product is
            manufactured, labeled, sold, or distributed.&#160; Since June 1, 2020, to the extent that any Product is exported from the United States, Seller has exported such Product in compliance in all material respects with applicable Legal Requirements.&#160;
            All design, development and manufacturing operations performed by or on behalf of Seller are being conducted in material compliance with the Quality Systems Regulations of the FDA (21 C.F.R. Part 820), Good Manufacturing Practices at 21 C.F.R.
            210, 211, and, to the extent applicable to Seller, counterpart regulations in the European Union and all other countries where compliance is required.&#160; Seller is in material compliance with all applicable Legal Requirements applicable to the
            maintenance, compilation and filing of reports, including Medical Device Reports (as defined in 21 CFR Part 803), with regard to the Products.&#160; Since June 1, 2020, Seller has not received from the FDA or any other applicable Governmental
            Authority (i) any written notice contesting the pre-market clearance or approval of, the uses of or the labeling and promotion of any of the Products, or (ii) any notice of adverse findings, FDA Form 483s, notices of violations, warning
            letters, criminal proceeding notices under any Legal Requirement, or other similar communication from the FDA or other Governmental Authority alleging or asserting material noncompliance with any Legal Requirement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%19%%%-->
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">All of the Seller&#8217;s labeling or other promotional or informational material regarding coding or billing relating to any Product is accurate in all material respects, and the Seller has not caused any health care provider or other entity to
            submit any false claims under 31 U.S.C. &#167;&#167; 3729-3733 or any similar Legal Requirement.&#160; The Seller&#8217;s marketing practices regarding any Product are in compliance in all material respects with the federal open payments rules, 42 U.S.C. &#167; 1320a-7h
            and 42 C.F.R Part 403, Subpart I, and any similar medical device marketing Legal Requirements or any other jurisdiction in which the Seller does business.&#160; Seller has not been excluded, suspended or debarred from participating in any federal
            health care program (as defined in 42 U.S.C. &#167;1320a-7b(f)) or been subject to sanction pursuant to 42 U.S.C. &#167;1320a-7a or 1320a-8 or been convicted of a crime described at 42 U.S.C. &#167;1320a-7b.&#160; To Seller&#8217;s Knowledge, no such exclusions are
            threatened.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.22</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Environmental, Health, and Safety Matters</u></font></font>.&#160; Seller and its predecessors and Affiliates have complied with all applicable environmental, health, and safety Legal
        Requirements the failure of which to comply with would have a Material Adverse Effect or which could create any Encumbrance on the Purchased Assets.&#160; Without limiting the generality of the foregoing, Since June 1, 2020, Seller and its predecessors
        and Affiliates have obtained and complied in all material respects with all permits, certificates, licenses, filings, approvals, and other authorizations of any Governmental Authority that are required pursuant to any applicable, environmental,
        health, and safety Legal Requirements for Seller&#8217;s manufacture and commercialization of the Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="font-size: 10pt; text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">4.23</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>No Other Representations and Warranties</u>.&#160; Except for the representations and warranties expressly set forth in this <font style="font-family: 'Times New Roman';"><u>Article 4</u></font> as qualified by
            the Seller Disclosure Schedules, neither Seller nor any other Person has made any other representation or warranty, expressed or implied, as to Seller, its Affiliates, the Products, the Purchased Assets or the Assumed Liabilities.</font></font>
      </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 5</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">REPRESENTATIONS AND WARRANTIES OF PURCHASER</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Purchaser hereby represents and warrants to Seller as follows:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Organization and Good Standing</u></font></font>.&#160; Purchaser is duly organized, validly existing and in good standing under the laws of its jurisdiction of organization.&#160; Purchaser
        (a) is duly qualified to conduct business under the laws of each jurisdiction in which the nature of its business, the operation of its assets or the ownership or leasing of its properties requires such qualification; and (b) has full power and
        authority required to carry on its business as now being conducted, in each case except where the failure to be so qualified or to have such power and authority would not reasonably be expected to have, individually or in the aggregate, a Purchaser
        Material Adverse Effect.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Authority; Binding Nature of Agreements</u></font></font>. Purchaser has all requisite corporate and other power and authority to execute and deliver this Agreement and all other Transaction Agreements
        to which it is a party and to carry out the provisions of this Agreement and the other Transaction Agreements.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">The execution,
            delivery and performance by Purchaser of this Agreement and the other Transaction Agreements have been duly and validly authorized and approved by all requisite action on the part of Purchaser.&#160; The execution, delivery and performance by
            Purchaser of this Agreement and the other Transaction Agreements does not require the approval of the shareholders of Purchaser.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">This Agreement
            has been duly and validly executed and delivered by Purchaser.&#160; Each of this Agreement and the other Transaction Agreements to which Purchaser is a party constitutes, or upon execution and delivery will (assuming due authorization, execution
            and delivery by Seller, as applicable) constitute, the legal, valid and binding obligation of Purchaser, enforceable against Purchaser in accordance with its terms, except as may be limited by <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium and other similar laws and equitable principles related to or limiting creditors&#8217; rights generally and by general principles of equity</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">19</font></div>
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>No Conflicts; Required Consents</u></font></font>.&#160; Neither the execution, delivery or performance of this Agreement nor any other Transaction Agreement by Purchaser nor the consummation of any of the
        Transactions will:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">conflict with,
            violate, result in any breach of or constitute a default under (with or without notice or lapse of time) (i) any of the provisions of the organizational documents of Purchaser; (ii) any resolution or corporate action of Purchaser; (iii) any of
            the terms or requirements of any Governmental Approval held by Purchaser or that otherwise relates to the Transactions; or (iv) any provision of any Contract binding upon Purchaser or require a Consent under any such Contract, other than such
            conflicts, violations, breaches or defaults that, alone or in the aggregate, would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">(i) give any
            Governmental Authority or other Person the right to exercise any remedy or obtain any relief under any Legal Requirement or any Order to which Purchaser or any of its assets is bound, (ii) violate or conflict with any provision of, or result in
            the breach of, any Legal Requirement applicable to Purchaser or require any Consent of any Person; or (iii) constitute a default under or give any Person the right to <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">declare a
              default of, exercise any remedy under, accelerate the performance of, cancel, terminate, modify or receive any payment under any Contract binding upon Purchaser; or</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">require
            Purchaser to make or deliver any filing or notice to a Governmental Authority, other than reporting under the Securities Exchange Act of 1934, as amended.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Brokers</u></font></font>.&#160; Other than Piper Sandler &amp; Co., Purchaser has not retained any broker or finder or incurred any Liabilities for any brokerage fees, commissions or finder&#8217;s fees with
        respect to this Agreement or the Transactions for which Seller or any of its Affiliates is liable.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Proceedings and Orders</u></font></font>.&#160; There is no material Proceeding or Order pending or, to the knowledge of Purchaser, threatened in writing against Purchaser or any of its Affiliates that
        would not reasonably be expected to have, individually or in the aggregate, a Purchaser Material Adverse Effect.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>R&amp;W Insurance Policy</u></font></font>.&#160; Purchaser has as of the date of this Agreement obtained the R&amp;W Insurance Policy, which requires the R&amp;W Insurance Company to waive any right of
        subrogation against Seller except in cases of Fraud by Seller in connection with the representations and warranties set forth in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">20</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">5.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Condition of the Business</u></font></font>.&#160; Purchaser acknowledges that it is a sophisticated purchaser and, together with its Affiliates and Representatives, has made its own investigation, review
        and analysis regarding the Products, the other Purchased Assets, the Assumed Liabilities and the Transactions.&#160; Purchaser is purchasing the Purchased Assets based on the results of its investigation, review and analysis and on the representations
        and warranties of Seller specifically set forth in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font>.&#160; Any claims Purchaser may have for breach of representation or warranty in connection with this Agreement shall be based
        solely on the representations and warranties of Seller set forth in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font> hereof as qualified by the Seller Disclosure Schedules.&#160; Purchaser acknowledges that none of Seller, its
        Affiliates or Representatives is making, and Purchaser is not relying on, any statement, representation or warranty, oral or written, express or implied, except to the extent expressly set forth in <font style="font-family: 'Times New Roman';"><u>Article
            4</u></font> as qualified by the Seller Disclosure Schedules, including without limitation any projections, forecasts, estimates or budgets made available to Purchaser, its Affiliates or any of their respective Representatives of future
        revenues, future results of operations (or any component thereof), future cash flows or future financial condition (or any component thereof) of the business relating to the Products (including the reasonableness of the assumptions underlying any
        of the foregoing), whether or not included in any management presentation or in any other information made available to Purchaser, its Affiliates or any of their respective Representatives or any other Person and none of Seller or any of its
        Affiliates or Representatives shall have any liability to Purchaser or any of its Affiliates or Representatives pursuant to this Agreement in connection with the use of, any information, documents or materials made available to Purchaser or its
        Affiliates or Representatives, whether orally or in writing, in any confidential information memoranda, virtual data rooms, management presentations, projections, due diligence discussions, question and answer responses (whether written or oral),
        or in any other form in expectation of the Transactions, except to the extent expressly set forth in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font> hereof as qualified by the Seller Disclosure Schedules. Purchaser
        acknowledges that, should the Closing occur, Purchaser shall acquire the business relating to the Products, the Purchased Assets and the Assumed Liabilities without any representation or warranty as to merchantability or fitness thereof for any
        particular purpose or other warranties arising under the Uniform Commercial Code (or similar foreign Laws), except as expressly set forth in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 6</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[RESERVED]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 7</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">POST-CLOSING COVENANTS</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Cooperation</u></font></font>.&#160; After the Closing, upon the request of Purchaser, Seller shall, and shall cause its controlled Affiliates to, use commercially reasonable efforts to (i) execute and
        deliver any and all further materials, documents and instruments of conveyance, transfer or assignment as reasonably requested by Purchaser to effect, record or verify the transfer to, and vesting in Purchaser of, Seller&#8217;s right, title and interest
        in and to the Purchased Assets in accordance with the terms of this Agreement, (ii) cooperate with Purchaser to enforce the terms of any Assigned Contracts, including terms relating to confidentiality and Intellectual Property Rights, and to
        transfer all Governmental Approvals (to the extent transferable) to Purchaser, and (iii) cooperate with reasonable requests from Purchaser to ensure an orderly transfer of customer relationships involving the Products to Purchaser.&#160; After the
        Closing, Seller shall, and shall cause its controlled Affiliates to, promptly deliver to Purchaser (w) any mail, packages, orders, inquiries and other communications addressed to Seller and relating to the Products and (x) any property that Seller
        receives and that properly belongs to Purchaser or any of its Affiliates.&#160; After the Closing, Purchaser shall, and shall cause its controlled Affiliates to, promptly deliver to Seller (y) any mail, packages, orders, inquiries and other
        communications addressed to a Seller or any of its Affiliates and relating to a business of Seller or its Affiliates other than the Products and (z) any property that Purchaser or such Affiliate receives and that properly belongs to Seller or any
        of its Affiliates.&#160; The provisions of this <font style="font-family: 'Times New Roman';"><u>Section 7.1</u></font> are not intended to, and shall not be deemed to, constitute an authorization by a party to permit another party to accept service of
        process on its behalf, and no party is or shall be deemed to be the agent of another party for service of process purposes. Promptly upon the Closing, the parties shall reasonably cooperate to facilitate any required updates to an FDA registration
        and medical device listing to de-list the Seller as the manufacturer or distributor of any of the Products, and shall cooperate with Purchaser to facilitate Purchaser updating its FDA registration and listing to list Purchaser as the manufacturer
        or distributor of each of the Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">21</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Return of
              Assets; Transfer of Purchased Assets</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">In the event
            that any Excluded Asset or Excluded Liability is discovered by Purchaser or any of its Affiliates or identified to Purchaser in writing by Seller at any time after the Closing Date, possession or ownership of which or responsibility for which
            previously has been transferred to, or assumed by, Purchaser or any of its Affiliates in connection with the Transactions (i) Purchaser shall return or transfer and convey or assign (without further consideration) to Seller, and Seller shall
            accept or assume, as applicable, such Excluded Asset or Excluded Liability; (ii) Seller shall assume (without further consideration) any Liabilities associated with such Excluded Assets or Excluded Liabilities; and (iii) Purchaser and Seller
            shall execute such documents or instruments of conveyance or assumption and take such further acts which are reasonably necessary to effect the transfer or assignment of such Excluded Asset or Excluded Liability back to, or assumption of such
            Excluded Liability by, Seller.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">In the event
            that any Purchased Asset or Assumed Liability is discovered by Seller or any of its Affiliates or identified to Seller in writing by Purchaser at any time after the Closing Date, possession or ownership of which has not been transferred to, or
            assumed by, either Purchaser or its Affiliates at such time, <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(i) Seller shall promptly take such steps as may be required to transfer and convey or assign, or cause to be
              transferred or assigned (without further consideration) to Purchaser, and Purchaser shall accept or assume, as applicable, such Purchased Asset or Assumed Liability; (ii) Purchaser shall assume (without further consideration) any Liabilities
              associated with such Purchased Assets or Assumed Liabilities; and (iii) Purchaser and Seller shall execute such documents or instruments of conveyance or assumption and take such further acts which are reasonably necessary to effect the
              transfer or assignment of such Purchased Asset or Assumed Liability by Purchaser</font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Records and Documents</u></font></font>.&#160; For a period of seven (7) years after the Closing, at the other party&#8217;s request, each party shall provide the other party and its Representatives with access
        to and the right to make copies (at the sole expense of the requesting party) of those records and documents related to the Products (possession of which is retained by Seller or transferred to Purchaser, as applicable), as may be necessary in
        connection with any third-party litigation, the preparation of financial statements, any accounting or Tax purposes, or the conduct of any audit or investigation by a Governmental Authority (excluding claims under this Agreement in which case the
        parties shall comply with <font style="font-family: 'Times New Roman';"><u>Article 9</u></font> and <font style="font-family: 'Times New Roman';"><u>Article 11</u></font>, as applicable, instead of this <font style="font-family: 'Times New Roman';"><u>Section 7.3</u></font>); <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that no party shall be required to violate
        any obligation of confidentiality to which such party or any of its Affiliates is subject or to waive any privilege which any of them may possess in discharging its obligations pursuant to this <font style="font-family: 'Times New Roman';"><u>Section
            7.3</u></font>; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">further</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that in any such case, each party shall, and shall cause its controlled Affiliates to, reasonably cooperate with the requesting party to implement alternative arrangements to permit the access contemplated hereby.&#160; The
        foregoing will not require any party to permit any inspection, or to disclose any information, that in its reasonable judgment, upon the advice of outside counsel, is commercially sensitive or reasonably likely to result in the waiver of any
        attorney-client privilege.&#160; If at any time after the Closing, Seller becomes aware that it or any of its controlled Affiliates has in its or their possession any business records, financial books and records, minute books, sales order files,
        purchase order files, engineering order files, warranty and repair files, supplier lists, customer lists, dealer, representative and distributor lists, studies, surveys, analyses, strategies, plans, forms, designs, diagrams, drawings,
        specifications, technical data, information relating to any Governmental Approvals, or production and quality control records and formulations, in each case, to the extent related to the Products or the Purchased Assets (collectively &#8220;<font style="font-family: 'Times New Roman';"><u>Business Records</u></font>&#8221;), Seller shall promptly forward such Business Records to Purchaser.&#160; If, following the Closing, Purchaser contacts Seller to inquire as to whether any specific Business
        Records are in the possession of Seller or any of its Affiliates, Seller will use commercially reasonable efforts to determine whether such Business Records are in its possession or the possession of any of its controlled Affiliates and, to the
        extent Seller locates any such Business Records, Seller will promptly forward such Business Records to Purchaser.&#160; If any such Business Records contain any information of Seller or any of its Subsidiaries not related to the Products or the other
        Purchased Assets, Seller may elect to redact those portions of such Business Records to the extent pertaining to such other information or, in Seller&#8217;s sole and absolute discretion, Seller may deliver unredacted copies of such Business Records
        containing information not related to the Products or the other Purchased Assets but such information shall be subject to the confidentiality provisions of this Agreement, shall remain the property of Seller, and Purchaser shall have no rights with
        respect to such information.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">22</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Confidentiality</u></font></font>.&#160; Except as required by law or administrative process and except for information which is now or hereafter becomes public other than as a result of a breach of this
        Section 7.4, without limitation to any other rights or obligations under the Confidentiality Agreement, for a period of five (5) years after the Closing Date, except that with regard to each Trade Secret for which the relevant period will be as
        long as such Trade Secret remains otherwise protectable as a trade secret, Seller shall not disclose to any other Person any Confidential Information used in or relating to the Products, the Purchased Assets, Purchaser or Purchaser&#8217;s business,
        whether in written, oral or other form; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that nothing in this <font style="font-family: 'Times New Roman';"><u>Section 7.4</u></font> shall in any way limit the
        disclosure of any such information to the Representatives of Seller in order to assist Seller with respect to the Transactions and the Transaction Agreements.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Non-Competition; Non-Solicitation</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">For a period of
            five (5) years commencing on the Closing Date <font style="font-weight: normal;">(the &#8220;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Restricted Period</u>&#8221;</font></font>)</font>, Seller shall
            not, and shall not permit any of its Subsidiaries to, directly or indirectly: (i) engage in or assist others in engaging in the Restricted Business anywhere in the world; or (ii) have an interest in any Person that engages directly or
            indirectly in the Restricted Business anywhere in the world in any capacity, including as a partner, shareholder, member, employee, principal, agent, trustee or consultant; <font style="font-family: 'Times New Roman'; font-style: italic;">provided,</font>
            that nothing in this <font style="font-family: 'Times New Roman';"><u>Section 7.5(a)</u></font> shall preclude Seller or any of its Affiliates from:</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(A)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">owning, directly or indirectly, securities of any Person if Seller or its Affiliate is not a controlling Person of, or a member of a group which controls, such Person and does not, directly or indirectly, own 5% or
            more of any class of securities of such Person;</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(B)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">entering into and consummating an agreement with any Person with respect to a merger, share exchange or other business combination transaction with respect to Seller immediately following which the beneficial owners of the
            voting capital stock of Seller immediately prior to the consummation of such transaction do not, directly or indirectly, beneficially own a majority of the combined voting power of the outstanding voting capital stock entitled to vote generally
            in the election of directors (or Persons performing a similar function) of the entity resulting from such transaction, and in the event of such transaction, the restrictions contained in this <font style="font-family: 'Times New Roman';"><u>Section




                7.5(a)</u></font> shall not apply to such acquirer or its Affiliates; or</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; margin-left: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(C)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">acquiring any entity, assets or business that is engaged in a Restricted Business if (x) the revenues from the Restricted Business constitute less than twenty-five percent (25%) of the total revenues generated by
            such entity, assets or business or, (y) if such revenues constitute more than twenty-five percent (25%) of the total revenues generated by such entity, assets or business, Seller or its Affiliate, as applicable, divest the portion of such
            entity, assets or business that is engaged in a Restricted Business within twelve (12) months following the acquisition thereof; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, that for purposes of this
            clause (y), Seller shall first offer to sell such divested portion to Purchaser and, if Purchaser elects to make an offer for the divested portion, which offer Seller agrees to consider in good faith, but such offer is not accepted by Seller,
            Seller shall divest such portion solely for consideration that is equal or more favorable to Seller, in the aggregate, than as set forth in such rejected Purchaser offer.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">23</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Without limiting the generality of the provisions of <font style="font-family: 'Times New Roman';"><u>Section 7.5(a)</u></font>, Seller hereby agrees that during the Restricted Period, Seller will not, and will cause each of its
            Subsidiaries not to, directly or indirectly, through another Person, as employee, agent, consultant, director, equity holder, manager, co-partner or in any other capacity without Purchaser&#8217;s prior written consent, solicit any clients,
            purchasers or suppliers of Purchaser in any manner designed to take business away from Purchaser with respect to the Restricted Business.&#160; For the avoidance of doubt, in no event shall this <font style="font-family: 'Times New Roman';"><u>Section




                7.5(b)</u></font> restrict any Seller communications made in the Ordinary Course of Business or communications relating to any business of Seller or its Affiliates as of the date of this Agreement or any business Seller may have in the
            future to the extent not related to the Products.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Seller acknowledges and agrees that the territorial, time and scope limitations set forth in this <font style="font-family: 'Times New Roman';"><u>Section 7.5</u></font> are reasonable and are properly required to protect Purchaser&#8217;s
            substantial investment hereunder and for the protection of Purchaser&#8217;s legitimate interest in client relationships, goodwill and trade secrets related to the Products and Purchased Assets, and that such limitations would not impose any undue
            burden upon Seller.&#160; In the event that any such territorial, time or scope limitation is deemed to be invalid, prohibited or unenforceable by a court of competent jurisdiction, Seller agrees, and Seller submits, to the reduction of any or all
            of said territorial, time or scope limitations to such an area, period or scope as said court will deem reasonable or enforceable under the circumstances.&#160; If such partial enforcement is not possible in such jurisdiction, the provision will be
            deemed severed as to such jurisdiction, and the remaining provisions of this Agreement will remain in full force and effect.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(d)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Seller acknowledges and agrees that in the event of Seller&#8217;s, or any of its Affiliate&#8217;s actual or threatened breach of any of the provisions contained in this <font style="font-family: 'Times New Roman';"><u>Section 7.5</u></font>,
            Purchaser will have no adequate remedy at law.&#160; Seller accordingly agrees that in the event of any actual or threatened breach of any of the provisions contained in this <font style="font-family: 'Times New Roman';"><u>Section 7.5</u></font>,
            Purchaser will be entitled to injunctive relief, without the need of posting bond or proving actual damages, as may be deemed necessary or appropriate by a court of competent jurisdiction.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(e)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';">Purchaser and
            Seller each further covenant and agree that during the Restricted Period, neither party will make any disparaging remarks (whether or not such party deems such comments to be true and accurate) about the other party or its officers, directors
            or employees and each of Purchaser and Seller shall refrain from saying or doing anything that reasonably could hold the other party or its officers, directors or employees up to disrepute in the eyes of any other person or entity.&#160; This
            subsection (e) does not, in any way, (i) restrict or impede Purchaser or Seller from exercising protected rights to the extent that such rights cannot be waived by agreement or from complying with any applicable law or regulation or a valid
            order of a court of competent jurisdiction or an authorized government agency; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font> that such compliance does not exceed that required by the law, regulation or order
            or (ii) apply to Purchaser&#8217;s or Seller&#8217;s exercise of its rights under this Agreement or the Transaction Agreements.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Product Recalls</u></font></font>.&#160; Subject to the terms of the Transaction Agreements, from and after the Closing Date, Purchaser shall have the sole right to conduct all voluntary and involuntary
        recalls, corrections, market withdrawals, market refunds or replacements, &#8220;dear doctor&#8221; letters, investigator notices, stock recoveries and other field actions or notices relating to an alleged lack of safety, efficacy or regulatory compliance (&#8220;<font style="font-family: 'Times New Roman';"><u>Recalls</u></font>&#8221;) of Products (whether Products were made before or after Closing), including Recalls required by any Governmental Authority and voluntary Recalls of Products. Without limitation of,
        and subject to, Purchaser&#8217;s rights under the Contract Manufacturing Agreement, any Damages or other Liabilities arising with respect to or related to any Recall of any units of Product made on or after the Closing Date (including Products purchased
        under the Contract Manufacturing Agreement) shall be Assumed Liabilities.&#160; Upon the reasonable request of Purchaser, Seller shall cooperate and assist, and shall cause its Affiliates to cooperate and assist, Purchaser in implementing and effecting
        a Recall with respect to Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">24</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Licensed Intellectual Property</u></font></font>.&#160; <font style="font-family: 'Times New Roman';"><u>Schedule 7.7(a)</u></font> sets forth a list of the Seller Licensed Intellectual Property and <font style="font-family: 'Times New Roman';"><u>Schedule 7.7(b)</u></font> sets forth a list of the Purchaser Licensed Intellectual Property.&#160; Purchaser will have the right to utilize the Seller Licensed Intellectual Property, and Seller will have the
        right to utilize the Purchaser Licensed Intellectual Property, according to the terms of the Intellectual Property License Agreement following the Closing.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Post-Closing
              Proceedings; Privilege Matters</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">From and after
            the Closing, Seller, on the one hand, and Purchaser, on the other hand, shall use commercially reasonable efforts to, upon the reasonable written request of the other party, cooperate in connection with any Proceedings in which the requesting
            party may from time to time be involved relating to the Products prior to or after the Closing.&#160; Any such cooperation shall be provided during normal business hours at a location and in a manner reasonably calculated to minimize disruption to
            such requested party or Persons.&#160; Seller and Purchaser agree to reimburse each other for reasonable out-of-pocket expenses, including reasonable attorneys&#8217; fees, but excluding officers&#8217; or other employees&#8217; salaries, incurred by the other in
            connection with providing cooperation pursuant to this <font style="font-family: 'Times New Roman';"><u>Section 7.8(a)</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">From and after the Closing, except to the extent required by Legal Requirement or Governmental Authority, no party shall intentionally disclose to any third party, and no party shall permit any of its respective controlled Affiliates to
            intentionally disclose to any third party, any documents or other information that, if disclosed, would cause a waiver of any privilege that can be asserted under any Legal Requirement by the other party (i) if such waiver would reasonably be
            expected to have an adverse effect on the other party or any of its Affiliates, (ii) with respect to (A) the Products, the Purchased Assets or the Assumed Liabilities or (B) the process relating to the sale of the Products.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Customer
              Inquiries</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. During the Restricted Period, Seller shall notify Purchaser of each inquiry that Seller receives relating to the Products from a customer of a Product or
            any other Person that submits a written indication of interest or purchase order related to Products.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">7.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160; &#160; <font style="font-family: 'Times New Roman';"><u>Misplaced
              Mail and Communications</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">. After the Closing Date, each party to this Agreement and its Affiliates may receive mail, packages, and other communications (including
            electronic communications) properly belonging to the other party (or the other party&#8217;s Affiliates). Accordingly, at all times after the Closing Date, each party authorizes the other party and its Affiliates to receive and open all mail,
            packages and other communications received by it and not unambiguously intended for the other party (or its Affiliates) or any of the other party&#8217;s (or its Affiliates&#8217;) officers or directors, and to retain the same to the extent that they
            relate to the Products (in the case of receipt by Purchaser or its Affiliates) or Seller&#8217;s other businesses (in the case of receipt by Seller or its Affiliates), or to the extent that they do not relate to the Products (in the case of receipt
            by the Purchaser or its Affiliates) or Seller&#8217;s other businesses (in the case of receipt by Seller or its Affiliates), the receiving party shall promptly after becoming aware thereof refer, forward or otherwise deliver such mail, packages, or
            other communications (or, in case the same relate to both the Products and Seller&#8217;s other businesses, copies thereof) to the other party. The provisions of this Section 7.10 are not intended to, and shall not be deemed to, constitute an
            authorization by either party to permit the other party to accept service of process on its behalf and neither party is or shall be deemed to be the agent of the other for service of process purposes.</font></font> </div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">25</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 8</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">CONDITIONS TO CLOSING</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">8.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Conditions to the Obligations of Each Party to Close</u></font></font>.&#160; The obligations of each party to consummate the Transactions shall be subject to the satisfaction, on or prior to the Closing
        Date, of the condition, which may be waived by the parties in writing, that no Proceeding shall have been commenced by a Governmental Authority against Seller or Purchaser, which would prevent the Closing, and that no injunction or restraining
        order shall have been issued by any Governmental Authority, and be in effect, which restrains or prohibits any transaction contemplated by this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 9</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">TAX MATTERS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Purchase Price Allocation</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">No later than ninety (90) days after the date hereof, Purchaser shall provide Seller with a schedule allocating the Purchase Price (plus the Assumed Liabilities and any other Liabilities deemed assumed by Purchaser for United States
            federal income Tax purposes) among the Purchased Assets in accordance with Section 1060 of the Code, the Treasury Regulations promulgated thereunder, and any other applicable Tax laws that the Parties must satisfy with respect to an allocation
            of the Purchase Price (the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchase Price Allocation</u></font>&#8221;).&#160; If Seller provides no comments with respect to the Purchase Price Allocation by written notice to Purchaser within thirty (30)
            days after receipt by Seller of the Purchase Price Allocation, then the Purchase Price Allocation shall be deemed final, binding and conclusive for all purposes of this Agreement and with respect to any Tax filings made in connection with the
            actions and transactions contemplated by this Agreement.&#160; If Seller provides any comments with respect to the Purchase Price Allocation by written notice to Purchaser within thirty (30) days after receipt by Seller of the Purchase Price
            Allocation, and sets forth in such written notice the disputed item or items and the basis for its objection in reasonable detail, then Seller and Purchaser shall negotiate in good faith to resolve any such dispute for a period of fifteen (15)
            days thereafter.&#160; If, within fifteen (15) days of Purchaser&#8217;s receipt of a valid written notice of objection to the Purchase Price Allocation, Purchaser and Seller have not reached an agreement regarding the disputed item or items specified in
            such written notice, Purchaser and Seller shall submit (at the expiration of such fifteen (15) day period) all disputed items for resolution to an independent accountant.&#160; The independent accountant shall deliver to Purchaser and Seller a
            written determination of any disputed item within twenty (20) days of submission of the dispute to the independent accountant, which determination shall be final, binding and conclusive on the parties hereto.&#160; The fees and expenses of the
            independent accountant will be shared equally by Seller and Purchaser.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Seller and Purchaser shall report all Taxes and file all Tax Returns (including amended Tax Returns and claims for refund) consistent with the Purchase Price Allocation (as appropriately adjusted), and shall take no position inconsistent
            therewith (including in any audits or examinations by any Tax Authority), unless, and then only to the extent, required by a Final Determination.&#160; Seller and Purchaser (or any of their respective Affiliates) shall exchange completed and
            executed forms required by applicable law with respect to the allocation (including IRS Form 8594) at least thirty (30) days prior to the due date for filing such forms and shall cooperate in the filing of any such forms, including any
            amendments to such forms required as a result of any adjustment to the Purchase Price pursuant to this Agreement.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Transfer Taxes</u></font></font>.&#160; Except as provided in <font style="font-family: 'Times New Roman';"><u>Section 9.3 below</u></font>, Seller shall be responsible for all
        Transfer Taxes incurred in connection with this Agreement and the transactions contemplated hereby.&#160; The applicable Transfer Taxes shall be paid when due.&#160; All Tax Returns and other documentation with respect to all Transfer Taxes shall be timely
        filed by Seller.&#160; Seller and Purchaser shall cooperate to facilitate Seller in filing all necessary documents (including all Tax Returns) with respect to all such Transfer Taxes in a timely manner.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">26</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><font style="font-family: 'Times New Roman';"><u>Property Taxes</u></font>.&#160; In the case of any Property Taxes on the Purchased Assets for any Straddle Period, the Taxes of Seller and Purchaser shall be allocated between the Pre-Closing
            Tax Period, which shall be for Seller&#8217;s account, and the Post-Closing Tax Period, which shall be for Purchaser&#8217;s account, as follows: (a) Taxes attributable to the Pre-Closing Tax Period shall equal the Property Taxes for such Straddle Period
            multiplied by a fraction, the numerator of which is the number of days during the Straddle Period that are in the Pre-Closing Tax Period and the denominator of which is the number of days in the Straddle Period, and (b) Taxes attributable to
            the Post-Closing Tax Period shall equal the Property Taxes for such Straddle Period multiplied by a fraction, the numerator of which is the number of days during the Straddle Period that are in the Post-Closing Tax Period and the denominator of
            which is the number of days in the Straddle Period.&#160; The party required by applicable law to pay to the Tax Authority any such Property Taxes for a Straddle Period and to file any related Tax Return (the &#8220;<font style="font-family: 'Times New Roman';"><u>Paying Party</u></font>&#8221;) shall provide the other party (the &#8220;<font style="font-family: 'Times New Roman';"><u>Non-Paying Party</u></font>&#8221;) a statement setting forth the Non-Paying Party&#8217;s share of such Taxes for a Straddle
            Period as determined pursuant to this Agreement, together with such supporting evidence as is reasonably necessary to calculate such amount, and the Non-Paying Party shall reimburse the Paying Party its share of such Taxes, not later than five
            (5) Business Days before such Taxes are required to be paid.&#160; The Paying Party shall furnish the Non-Paying Party a copy of any such Tax Return and a copy of a receipt showing payment of any such Taxes to the Tax Authority.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Tax Contests</u></font></font>.&#160; Purchaser shall promptly notify Seller in writing upon receipt by Purchaser or any of its Affiliates of notice of any pending or threatened Tax audits, examinations or
        assessments which may materially affect the amount of any Tax which is, in whole or in part, an Excluded Liability; <font style="font-family: 'Times New Roman'; font-style: italic;">provided,</font> that Purchaser&#8217;s failure to provide such timely
        notice shall not negate Purchaser&#8217;s right to indemnity for such Taxes unless it impairs Seller&#8217;s legal right to contest such Taxes.&#160; Notwithstanding anything to the contrary in <font style="font-family: 'Times New Roman';"><u>Section 11.4</u></font>,
        Seller shall have the sole right to control the contest and resolution of any Tax audit, examination, assessment or other administrative or court proceeding relating to (each a &#8220;<font style="font-family: 'Times New Roman';"><u>Tax Contest</u></font>&#8221;)
        any Tax which is, in whole or in part, an Excluded Liability, and in each case to employ counsel of its choice at its expense, <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, that, if the resolution of such Tax
        Contest could increase the Tax liability of, or reduce any Tax benefit available to, Purchaser or any of its Affiliates for any Post-Closing Tax Period, Seller shall not settle, discharge, compromise, or otherwise dispose of such Tax Contest if
        such disposition would result in, or otherwise involve, shifting any receipts, revenues, income, or profits, from a Pre-Closing Tax Period to a Post-Closing Tax Period or otherwise would reasonably be expected to have a material adverse consequence
        to Purchaser or any of its Affiliates without obtaining the prior written consent of Purchaser, which consent shall not be unreasonably withheld, conditioned or delayed.&#160; Neither Purchaser nor any of its Affiliates may settle any Tax Claim
        relating, in whole or in part, to any Tax which is an Excluded Liability without the prior written consent of Seller, which consent may be withheld in the sole discretion of Seller.&#160; Each of Purchaser and Seller shall, or shall cause their
        respective Affiliates to, furnish to each other copies of all correspondence received from any Tax Authority in connection with any Tax Contest or information request with respect to any taxable period for which the other party or its Affiliates
        may have Liability under this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Tax Cooperation</u></font></font>.&#160; After the Closing, each of Purchaser and Seller shall furnish, and cause their respective controlled Affiliates to furnish, to each other, upon request, as promptly
        as practicable, such information and assistance relating to the Purchased Assets as is reasonably necessary for the preparation or filing of all Tax Returns, the making of any election related to Taxes, the preparation for any audit by or dispute
        with any Tax Authority and the prosecution or defense of any claim, suit or proceeding relating to any Tax Return.&#160; Each of Purchaser and Seller shall provide, or cause their respective controlled Affiliates to provide, timely notice to each other
        in writing of any pending or threatened Tax audit, examination, assessment or other administrative or court proceeding with respect to the Purchased Assets for any taxable period for which the other party may have Liability under this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">27</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">9.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Tax Priority Provision</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; To the extent this <u>Article 9</u> conflicts with the provisions of any other Article in this
              Agreement, this <u>Article 9</u> shall govern.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 10</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">[RESERVED]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 11</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">INDEMNIFICATION</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Indemnification by Seller</u></font></font>.&#160; Subject to the limitations set forth in this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font>, from and after the Closing, Seller
        shall indemnify, defend, compensate, reimburse and hold harmless Purchaser, its Subsidiaries, and their respective officers, directors, agents, employees and Affiliates (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser
            Indemnified Persons</u></font>&#8221;) from and against any and all Damages, including reasonable attorneys&#8217; fees (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Damages</u></font>&#8221;), from third party claims arising out of,
        relating to or resulting from (a) any breach of a covenant of Seller contained in this Agreement, or (b) any Excluded Liability.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Indemnification by Purchaser</u></font></font>.&#160; Subject to the limitations set forth in this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font>, from and after the Closing,
        Purchaser shall indemnify, defend, compensate, reimburse, and hold harmless Seller, its Subsidiaries, and their respective officers, directors, agents, employees and Affiliates (collectively, the &#8220;<font style="font-family: 'Times New Roman';"><u>Seller
            Indemnified Persons</u></font>&#8221;) from and against any and all Damages, including reasonable attorneys&#8217; fees (collectively, &#8220;<font style="font-family: 'Times New Roman';"><u>Seller Damages</u></font>&#8221;), from third party claims arising out of,
        relating to or resulting from (a) any breach of a covenant of Purchaser contained in this Agreement, (b) any Assumed Liability; and (c) the possession, ownership, use, operation and management of the Purchased Assets or the Products by Purchaser
        (or its Affiliates) from and after the Closing.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>[Reserved]</u></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Procedures for Indemnification</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Promptly after receipt by a party entitled to indemnification under <font style="font-family: 'Times New Roman';"><u>Sections 11.1</u></font> or <font style="font-family: 'Times New Roman';"><u>11.2</u></font> or any other provision of
            this Agreement (the &#8220;<font style="font-family: 'Times New Roman';"><u>Indemnitee</u></font>&#8221;) of written notice of the assertion or the commencement of any Proceeding against any Indemnitee by a third party with respect to any matter referred
            to in <font style="font-family: 'Times New Roman';"><u>Sections 11.1</u></font> or <font style="font-family: 'Times New Roman';"><u>11.2</u></font>, the Indemnitee shall give written notice describing such claim or Proceeding in reasonable
            detail in light of the circumstances then known to the Indemnitee to the party obligated to indemnify Indemnitee (the &#8220;<font style="font-family: 'Times New Roman';"><u>Indemnitor</u></font>&#8221;), <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that failure of the Indemnitee to give such written notice to Indemnitor as provided herein shall not relieve the
            Indemnitor of its obligations hereunder except to the extent that such failure has a prejudicial effect on the defenses or other rights available to the Indemnitor with respect to such claim.&#160; In connection with any such Proceeding, the
            Indemnitor shall be entitled to assume the defense thereof and shall have the sole power to direct and control such defense with counsel selected by the Indemnitor; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>,
            <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that the Indemnitor shall not have the right to assume or control the defense of any Proceeding if at any time (i) the Indemnitee shall have one or more legal or
            equitable defenses available to it which are different from or in addition to those available to the Indemnitor, and, in the reasonable opinion of the Indemnitee, counsel for the Indemnitor could not adequately represent the interests of the
            Indemnitee because such interests could be in conflict with those of the Indemnitor; (ii) the claim involves any criminal proceeding against an Indemnitee, (iii) the claim seeks an injunction, equitable relief or other non-monetary relief
            against any Indemnitee, or (iv) the Indemnitor shall not have assumed the defense of the Proceeding within twenty (20) days of notice of such Proceeding.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">28</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">If the
            Indemnitor shall assume the defense of any Proceeding, the Indemnitee shall be entitled to participate in any Proceeding at its expense, and the Indemnitor shall not settle such Proceeding unless (i) the settlement shall include as an
            unconditional term thereof the giving by the claimant or the plaintiff of a full and unconditional release of the Indemnitee from all liability with respect to the matters that are subject to such Proceeding, the settlement does not contain any
            sanction or restriction upon the conduct of any business by the Indemnitee or its Affiliates and the settlement does not include any admission of wrongdoing or misconduct by any Indemnitee or its Affiliate, or (ii) the settlement otherwise
            shall have been approved by the Indemnitee, such approval not to be unreasonably conditioned, withheld or delayed.&#160; The Indemnitor shall afford the Indemnitee the opportunity to participate in, though counsel chosen by the Indemnitee, but not
            control, any defense or settlement of any Proceeding controlled by the Indemnitor pursuant to <font style="font-family: 'Times New Roman';"><u>Section 11.4</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">If the
            Indemnitor fails to notify the Indemnitee within twenty (20) days after receipt of notice of such Proceeding pursuant to <font style="font-family: 'Times New Roman';"><u>Section 11.4(a)</u></font> that the Indemnitor elects to assume the
            defense of the Proceeding, or to the extent that the Indemnitor elects not to assume the defense or is not entitled to assume or control the defense in accordance with this <font style="font-family: 'Times New Roman';"><u>Section 11.4</u></font>,
            then the Indemnitee shall have the right to assume and control the defense of the Proceeding and shall be reimbursed for its reasonable costs and expenses (including any attorney&#8217;s fees) incurred in connection therewith.<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160; If the Indemnitee assumes its own defense of a Proceeding, the Indemnitee shall keep the Indemnitor reasonably informed as to the status of, and any material developments related
              to, the Proceeding, provide to the Indemnitor any documentation or information reasonably requested by the Indemnitor relating to such Proceeding, and shall consult with the Indemnitor, and consider in good faith the Indemnitor&#8217;s views, with
              respect to the defense strategy and budget for such Proceeding.&#160; The Indemnitee shall not, without the written consent of the Indemnitor (which written consent shall not be unreasonably withheld, delayed or conditioned), pay, compromise or
              settle any such Proceeding.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Limits on
              Indemnification; Payment of Indemnifiable Damages</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-family: 'Times New Roman';">All
            representations and warranties contained in this Agreement and all claims with respect thereto shall terminate at and shall not survive the Closing; <font style="font-family: 'Times New Roman'; font-style: italic;">provided, however</font>,
            that such termination shall not effect Purchaser&#8217;s ability to make any claim under the R&amp;W Insurance Policy.&#160; The Purchaser Indemnified Persons&#8217; remedy for breaches of representations and warranties by Seller shall be satisfied solely from
            the R&amp;W Insurance Policy and not in any event satisfied by or recoverable from Seller, except in the case of Fraud with respect to the representations and warranties set forth in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font>;
            <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that Seller shall reimburse Purchaser for an amount equal to one-half of the
            R&amp;W Policy Retention Amount to the extent required pursuant to <font style="font-family: 'Times New Roman';"><u>Section 11.9</u></font>.&#160; NOTWITHSTANDING ANYTHING TO THE CONTRARY SET FORTH IN THIS AGREEMENT, PURCHASER ACKNOWLEDGES AND
            AGREES, ON BEHALF OF ITSELF AND EACH OF ITS AFFILIATES AND OTHER PURCHASER INDEMNIFIED PERSONS, THAT NEITHER SELLER, NOR ANY OF ITS AFFILIATES SHALL HAVE ANY DIRECT OR INDIRECT LIABILITY (DERIVATIVELY OR OTHERWISE) WITH RESPECT TO ANY BREACH OR
            INACCURACY OF ANY REPRESENTATION OR WARRANTY UNDER THIS AGREEMENT, EXCEPT IN THE CASE OF FRAUD WITH RESPECT TO THE REPRESENTATIONS AND WARRANTIES SET FORTH IN <font style="font-family: 'Times New Roman';"><u>ARTICLE 4</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> AND SELLER&#8217;S OBLIGATION TO REIMBURSE PURCHASER FOR AN AMOUNT EQUAL TO ONE-HALF OF THE R&amp;W POLICY RETENTION AMOUNT TO THE EXTENT REQUIRED PURSUANT TO <u>SECTION 11.9</u>.&#160;
              PURCHASER FURTHER ACKNOWLEDGES AND AGREES, ON BEHALF OF ITSELF AND EACH OF ITS AFFILIATES AND OTHER PURCHASER INDEMNIFIED PERSONS, THAT FOLLOWING THE CLOSING PURCHASER&#8217;S ONLY RECOURSE IN THE EVENT OF ANY BREACH OR INACCURACY OF ANY
              REPRESENTATION OR WARRANTY SHALL BE TO FILE A CLAIM UNDER THE R&amp;W INSURANCE POLICY, EXCEPT IN THE CASE OF FRAUD WITH RESPECT TO THE REPRESENTATIONS AND WARRANTIES SET FORTH IN <u>ARTICLE 4</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">29</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In the event a state of facts exists that would allow a Purchaser Indemnified Person to seek recovery under either the R&amp;W Insurance Policy or <font style="font-family: 'Times New Roman';"><u>Section 11.1</u></font>, such Purchaser
            Indemnified Person must first seek recovery of such Damages under the R&amp;W Insurance Policy, whether or not there is any retention amount due.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(c)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">In the case of Purchaser Damages pursuant to <font style="font-family: 'Times New Roman';"><u>Section 11.1</u></font> or Seller Damages pursuant to <font style="font-family: 'Times New Roman';"><u>Section 11.2(a)</u></font> and <font style="font-family: 'Times New Roman';"><u>Section 11.2(b)</u></font>, the amount of indemnification payments to which an Indemnitee shall be entitled under this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font> shall be
            made within five (5) Business Days after the date: (a) the amount of such payments are determined by written agreement between the Indemnitee and the Indemnitor; or (b) both such amount and the Indemnitor&#8217;s obligation to pay such amount have
            been determined by a final Order of any court of competent jurisdiction.&#160; The Order of a court shall be deemed final when the time for appeal, if any, shall have expired and no appeal shall have been taken or when all appeals taken shall have
            been finally determined.&#160; Any indemnification of the Purchaser Indemnified Parties pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font> shall be effected by wire transfer of immediately available funds from
            Seller to an account designated by Purchaser, and any indemnification of the Seller Indemnified Parties pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font> shall be effected by wire transfer of immediately
            available funds to an account designated by Seller.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Remedies Exclusive</u></font></font>.&#160; With the exception of the rights of the parties under <font style="font-family: 'Times New Roman';"><u>Section 12.15</u></font> and any claims of Fraud with
        respect to the representations and warranties set forth in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font> and <font style="font-family: 'Times New Roman';"><u>Article 5</u></font> which are proven and upon which a judgment
        entered in the involved proceeding shall be expressly based, Seller and Purchaser expressly agree that from and after the Closing the provisions of this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font> shall be the sole and
        exclusive remedy for all claims of breach or indemnification pursuant to this Agreement; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>,
        that the foregoing shall not limit any rights or remedies and for all claims pursuant to the other Transaction Agreements.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Adjustment to Damages</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.</font></font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The amount of any Damages for which indemnification is provided under <font style="font-family: 'Times New Roman';"><u>Section 11.1</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 11.2</u></font> shall be net of
            (i) any amounts actually recovered by the Indemnitee pursuant to any indemnification by, or indemnification agreement with, any third party that is not an Affiliate of the Indemnitor, (ii) any insurance proceeds or other cash receipts or
            sources of reimbursement received from any third party that is not an Affiliate of such Indemnitor as an offset against such Damages (each third party that is not an Affiliate of such Indemnitor referred to in clauses (i) and (ii), a &#8220;<font style="font-family: 'Times New Roman';"><u>Collateral Source</u></font>&#8221;) and (iii) any Tax benefit available to such Indemnitee or its Affiliates that is attributable to such Damages.&#160; If the amount to be netted hereunder in connection with
            a Collateral Source from any payment required under <font style="font-family: 'Times New Roman';"><u>Section 11.1</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 11.2</u></font> is received after payment by the
            Indemnitor of any amount otherwise required to be paid to an Indemnitee pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font>, the Indemnitee shall repay to the Indemnitor, promptly after such receipt, any
            amount that the Indemnitor would not have had to pay pursuant to this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font> had such receipt been made at or prior to the time of such indemnification payment, and any excess
            recovery from a Collateral Source shall be applied to reduce any future payments to be made by the Indemnitor pursuant to <font style="font-family: 'Times New Roman';"><u>Section 11.1</u></font> or <font style="font-family: 'Times New Roman';"><u>Section 11.2</u></font>. The provisions of this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font> are not intended to permit duplicate recoveries on the same Damages.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">30</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Each Indemnitee must mitigate in accordance with Legal Requirements any Damages for which such Indemnitee seeks indemnification under this Agreement. If such Indemnitee mitigates its Damages after the Indemnitor has paid the Indemnitee
            under any indemnification provision of this Agreement in respect of such Damages, the Indemnitee must notify the Indemnitor and pay to the Indemnitor the extent of the value of the benefit to the Indemnitee of that mitigation, promptly after
            such benefit is received.&#160; Each Indemnitee and its Affiliates shall use reasonable efforts to collect any amounts available under insurance coverage, or from any other Person alleged to be responsible, for any Damages payable under this <font style="font-family: 'Times New Roman';"><u>Article 11</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Tax Treatment of Indemnification</u></font></font>.&#160; For all Tax purposes, Purchaser and Seller agree to treat any indemnity payment (including all payments under the R&amp;W Insurance Policy, which is
        an integral term of this transaction) under this Agreement as an adjustment to the Purchase Price unless otherwise required by a Final Determination.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">11.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Reimbursement</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">.&#160; In the event the R&amp;W Insurance Company determines that Purchaser is entitled to indemnification under the R&amp;W Insurance Policy with respect to any loss, but that the
            retention under such policy is not yet satisfied, then upon Purchaser&#8217;s delivery of written notice of such to Seller, Seller shall promptly pay to Purchaser an amount equal to one-half of such indemnifiable losses in immediately available
            funds; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, that in no event shall Seller be responsible for an amount exceeding fifty percent (50%) of the R&amp;W Policy Retention Amount.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARTICLE 12</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">MISCELLANEOUS PROVISIONS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.1</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Expenses</u></font></font>.&#160; Whether or not the Transactions are consummated, unless otherwise indicated expressly herein, each party shall pay its own costs and expenses in connection with this
        Agreement and the Transactions, including the fees and expenses of its advisers, accountants and legal counsel.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.2</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Interpretation</u></font></font>.&#160; Except as otherwise explicitly specified to the contrary, (a) references to a Section, Article, Exhibit or Schedule means a Section or Article
        of, or Schedule or Exhibit to, this Agreement, unless another agreement is specified, (b) the word &#8220;including&#8221; (in its various forms) means &#8220;including without limitation,&#8221; (c) references to a particular statute or regulation include all rules and
        regulations thereunder and any predecessor or successor statute, rules or regulation, in each case as amended or otherwise modified from time to time, (d) words in the singular or plural form include the plural and singular form, respectively, (e)
        references to a particular Person include such Person&#8217;s successors and assigns to the extent not prohibited by this Agreement, (f) &#8220;extent&#8221; in the phrase &#8220;to the extent&#8221; means the degree to which a subject or other thing extends, and such phrase
        does not mean simply &#8220;if,&#8221; (g) the headings contained in this Agreement, in any Exhibit or Schedule hereto and in the table of contents to this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation
        of this Agreement, (h) references to &#8220;$&#8221; shall mean United States dollars and (i) the word &#8220;or&#8221; is not exclusive.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.3</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Entire Agreement</u></font></font>.&#160; This Agreement, including the other documents, agreements, Exhibits and Schedules specifically referred to herein, constitutes the entire agreement between and
        among the parties hereto with regard to the subject matter hereof, and supersedes all prior agreements and understandings by or among the parties hereto or any of their respective Affiliates with regard to such subject matter, whether written or
        oral.&#160; Except for the Confidentiality Agreement, there are now no agreements, representations or warranties between or among the parties other than those set forth in the Agreement or the documents and agreements contemplated in this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.4</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Amendment, Waivers and Consents</u></font></font>.&#160; This Agreement shall not be changed or modified, in whole or in part, except by supplemental agreement or amendment signed by the parties.&#160; Any party
        may waive compliance by any other party with any of the covenants or conditions of this Agreement, but no waiver shall be binding unless executed in writing by the party making the waiver.&#160; No waiver of any provision of this Agreement shall be
        deemed, or shall constitute, a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver.&#160; Any consent under this Agreement shall be in writing and shall be effective only to the extent specifically
        set forth in such writing.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">31</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.5</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Successors and Assigns</u></font></font>.&#160; This Agreement shall bind and inure to the benefit of the parties hereto and their respective successors and permitted assigns, <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that no party hereto may assign any right or obligation hereunder without the prior written consent of all
        other parties hereto.&#160; Notwithstanding the foregoing, Purchaser may assign this Agreement or any of its rights or obligations hereunder to any Affiliate of Purchaser without Seller&#8217;s prior written consent (but with notice to Seller).&#160;
        Notwithstanding anything in this <font style="font-family: 'Times New Roman';"><u>Section 12.5</u></font> to the contrary, no assignment shall relieve the assigning party of its obligations hereunder.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.6</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Governing Law</u></font></font>.&#160; The rights and obligations of the parties shall be governed by, and this Agreement shall be interpreted, construed and enforced in accordance with, the laws of the
        State of Delaware, excluding its conflict of laws rules to the extent such rules would apply the law of another jurisdiction.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.7</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Jurisdiction;




              Waiver of Jury Trial</u>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(a)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Any judicial proceeding brought against any of the parties to this Agreement or any dispute arising out of this Agreement or related hereto shall be brought in the courts of the State of Delaware, or in the United States District Court for
            the District of Delaware, and, by execution and delivery of this Agreement, each of the parties to this Agreement accepts the exclusive jurisdiction of such courts and irrevocably agrees to be bound by any judgment rendered thereby in
            connection with this Agreement.&#160; The foregoing consents to jurisdiction shall not constitute general consents to service of process in the State of Delaware for any purpose except as provided above and shall not be deemed to confer rights on
            any Person other than the parties to this Agreement.&#160; Each of the parties to this Agreement agree that service of any process, summons, notice or document by United States mail to such party&#8217;s address for notice hereunder shall be effective
            service of process for any action, suit or proceeding in Delaware with respect to any matters for which it has submitted to jurisdiction pursuant to this <font style="font-family: 'Times New Roman';"><u>Section 12.7</u></font>.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 72pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(b)</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';">EACH OF THE
            PARTIES HERETO HEREBY IRREVOCABLY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY ACTION, PROCEEDING OR CLAIM ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.8</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Rules of Construction</u></font></font>.&#160; The parties acknowledge that each party has read and negotiated the language used in this Agreement.&#160; The parties agree that, because all parties participated
        in negotiating and drafting this Agreement, no rule of construction shall apply to this Agreement which construes ambiguous language in favor of or against any party by reason of that party&#8217;s role in drafting this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.9</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Severability</u></font></font>.&#160; If any provision of this Agreement, as applied to either party or to any circumstance, is declared by a court of competent jurisdiction to be illegal, unenforceable or
        void, this Agreement shall continue in full force and effect without said provision, and the Parties agree to negotiate in good faith to replace such illegal, unenforceable or void provision with a valid, legal and enforceable provision that
        achieves, to the greatest lawful extent under this Agreement, the economic, business and other purposes of such invalid, illegal or unenforceable provision.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.10</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Exhibits and Schedules</u></font></font>.&#160; All Exhibits and Schedules attached hereto shall be deemed to be a part of this Agreement and are fully incorporated in this Agreement by this reference.&#160;
        Disclosure in any Schedule shall qualify (a) the corresponding Section of the Agreement to which such Schedule refers and (b) any other Sections of this Agreement to the extent that it is reasonably apparent on the face of such disclosure that such
        disclosure also qualifies or applies to such other Sections.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">32</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.11</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Notices</u></font></font>.&#160; Any notice required or permitted to be given hereunder shall be sufficient if in writing and (a) delivered in person or by express delivery or internationally recognized
        overnight courier service, (b) sent by facsimile or email of a PDF document or (c) deposited in the mail registered or certified first class, postage prepaid and return receipt requested.&#160; Each notice shall be deemed given when so delivered
        personally, or sent by facsimile or email transmission (provided that in each case no &#8220;bounceback&#8221; or similar &#8220;undeliverable&#8221; message is received by the sender thereof), or, if sent by express delivery or internationally recognized courier service
        one (1) Business Day after being sent, or if mailed, five (5) Business Days after the date of deposit in the mail.&#160; A notice of change of address or facsimile number shall be effective only when done in accordance with this <font style="font-family: 'Times New Roman';"><u>Section 12.11</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">To Purchaser at:</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Merit Medical Systems, Inc.</div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">1600 West Merit Parkway</div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">South Jordan, UT 84095</div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Email: Brian.Lloyd@merit.com</div>
      <div style="text-align: left; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Brian Lloyd, Chief Legal Officer</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">With copies to: (which shall not constitute notice to Purchaser):</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: -72pt; margin-right: 177.5pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Parr Brown Gee &amp; Loveless</div>
      <div style="text-align: left; text-indent: -72pt; margin-right: 177.5pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">101 South 200 East, Suite 700</div>
      <div style="text-align: left; text-indent: -72pt; margin-right: 177.5pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Salt Lake City, Utah 84111</div>
      <div style="text-align: left; text-indent: 36pt; margin-right: 177.5pt; font-family: 'Times New Roman'; font-size: 10pt;">Email: mschefer@parrbrown.com</div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Attention: Michael J. Schefer</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">To Seller at:</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">AngioDynamics, Inc.</div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">14 Plaza Drive</div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Latham, New York 12110</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf417515f4fb1475691e208cdde8eb28f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 45pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">E-mail:</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">strowbridge@angiodynamics.com</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z15f2746b3ca340e4bef8317501cfa381" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 45pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Attention:</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Stephen A. Trowbridge, Executive Vice President</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 81pt;">and Chief Financial Officer</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">With copies to: (which shall not constitute notice to Seller):</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">Cadwalader, Wickersham &amp; Taft LLP</div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">200 Liberty Street</div>
      <div style="text-align: left; text-indent: -72pt; margin-left: 108pt; font-family: 'Times New Roman'; font-size: 10pt;">New York, New York 10281</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="z43e9381264d8419e8cac003cbeb390e5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 45pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">E-mail:</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">william.mills@cwt.com</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 81pt;">braden.mccurrach@cwt.com</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zf34e6b398d1846169d40a7d1b268b2c5" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="width: 36pt;">&#160;</td>
              <td style="text-align: right; vertical-align: top; width: 45pt;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Attention:</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">William P. Mills</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; margin-left: 81pt;">Braden K. McCurrach</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">33</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%34%%%-->
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.12</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Rights of Parties</u></font></font>.&#160; Except for Purchaser Indemnified Persons and Seller Indemnified Persons, nothing in this Agreement, whether express or implied, is intended to confer any rights or
        remedies under or by reason of this Agreement on any persons other than the parties to it and their respective successors and permitted assigns, nor is anything in this Agreement intended to relieve or discharge the Liabilities of any third person
        to any party to this Agreement, nor shall any provision give any third person any right of subrogation or action over or against any party to this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.13</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Public Announcements</u></font></font>.&#160; Except as may be required by applicable Legal Requirements or stock exchange rules, no party to this Agreement or any Affiliate or Representative of such party
        shall make any public announcements or otherwise communicate with any news media in respect of this Agreement or the Transactions without prior consent of the other parties, such consent not to be unreasonably withheld, and prior to any
        announcement or communication the parties shall cooperate as to the timing and contents of any such announcement or communication.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.14</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Counterparts</u></font></font>.&#160; This Agreement may be signed in any number of counterparts, including facsimile copies thereof or electronic scan copies thereof delivered by electronic mail, each of
        which shall be deemed an original, with the same effect as if the signatures thereto and hereto were upon the same instrument.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.15</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><u>Specific Performance</u></font></font>.&#160; The parties hereby expressly recognize and acknowledge that immediate, extensive and irreparable damage would result, no adequate remedy at law would exist and
        damages would be difficult to determine in the event that any provision of this Agreement is not performed in accordance with its specific terms or otherwise breached.&#160; It is hereby agreed that the parties shall be entitled to specific performance
        of the terms hereof and immediate injunctive relief and other equitable relief, without the necessity of proving the inadequacy of money damages as a remedy, and the parties further hereby agree to waive any requirement for the securing or posting
        of a bond in connection with the obtaining of such injunctive or other equitable relief.&#160; Such remedies, and any and all other remedies provided for in this Agreement, shall, however, be cumulative in nature and not exclusive and shall be in
        addition to any other remedies whatsoever which any party may otherwise have. Each of the parties hereby acknowledges that the existence of any other remedy contemplated by this Agreement does not diminish the availability of specific performance
        of the obligations hereunder or any other injunctive relief.&#160; Each of the parties further acknowledges and agrees that injunctive relief and/or specific performance will not cause an undue hardship to such party.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.16</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Electronic Data Room Materials</u></font></font>.&#160; No information or document will be considered to have been &#8220;made available&#8221; to Purchaser unless it was uploaded no later than
        9:00 a.m. (Eastern time) on the Business Day prior to the date of this Agreement to the electronic dataroom hosted by Sharepoint, a copy of which Seller shall deliver to Purchaser on one or more DVDs (or other digital storage device as Purchaser
        and Seller agree) at Closing, and was fully accessible to Purchaser and its Representatives through the earlier of the Closing or the termination of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.17</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';"><u>Further</u></font><font style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"><u>&#160;</u></font><font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);"><u>Assurances</u></font></font></font>.&#160; Subject to the terms and conditions of this Agreement, prior to and after the Closing, each party shall prepare, execute and deliver such further instruments and shall use
        its commercially reasonable efforts to take or cause to be taken such other further action, as any party shall reasonably request of the other party to consummate the terms and provisions of this Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">12.18</font><font style="font-size: 10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><u>Bulk Transfers</u></font></font>.&#160; Purchaser waives compliance with the provisions of all applicable Legal Requirements relating to bulk transfers in connection with the transfer
        of the Purchased Assets.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">[Signatures Follow On a Separate Page]</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">34</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; margin-right: 6pt; margin-left: 5pt; font-family: 'Times New Roman'; font-size: 10pt;">IN WITNESS WHEREOF, the Parties hereto have executed this Asset Purchase Agreement as of the date first above
        written.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zac29ce2fba9544d2961d790dc7f650cd">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">PURCHASER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">MERIT MEDICAL SYSTEMS, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">/s/ Fred P. Lampropoulos</font></div>
            </td>
            <td style="width: 27%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" id="zcaa26ab2e61c48e7ba9850f5e4d337e0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Fred P. Lampropoulos</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Chairman and CEO</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;"><br>
      </div>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="z738c15131c5a4907ace116265dd91b8d">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">SELLER:</div>
            </td>
          </tr>
          <tr>
            <td rowspan="1" style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td rowspan="1" colspan="3" style="vertical-align: top; font-size: 10pt;"><br>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td colspan="3" style="vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman'; font-weight: bold;">ANGIODYNAMICS, INC.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; font-size: 10pt;">&#160;</td>
            <td colspan="2" style="vertical-align: top; font-size: 10pt;">&#160;</td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;"><br>
            </td>
            <td style="width: 3%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">By:</div>
            </td>
            <td style="width: 20%; vertical-align: top; border-bottom: 2px solid black; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';"><font style="font-family: 'Times New Roman';">/s/ Stephen A. Trowbridge</font></div>
            </td>
            <td style="width: 27%; vertical-align: top; padding-bottom: 2px; font-size: 10pt;">&#160;</td>
          </tr>

      </table>
      <table cellspacing="0" cellpadding="0" border="0" id="zc401e04664244fbca5af05485101b0aa" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Name:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Stephen A. Trowbridge</div>
            </td>
          </tr>
          <tr>
            <td style="width: 50%; vertical-align: top; font-size: 10pt;"><br>
            </td>
            <td style="width: 5%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">Title:</div>
            </td>
            <td style="width: 45%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; font-family: 'Times New Roman';">EVP and CFO</div>
            </td>
          </tr>

      </table>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageFooter" style="width: 100%;">
          <div>
            <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 8pt; font-family: 'Times New Roman'; font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">[Signature Page to Asset Purchase Agreement]</font></div>
          </div>
        </div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <!--PROfilePageNumberReset%Num%1%A-%%-->
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><u>EXHIBIT A</u></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CERTAIN DEFINITIONS</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Accounts Receivable</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.2(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Affiliate</u></font>&#8221; of any Person shall mean any Person directly or indirectly controlling,
        controlled by, or under common control with, such Person; <font style="font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that, for the purposes
        of this definition, &#8220;control&#8221; (including, with correlative meanings, the terms &#8220;controlled by&#8221; and &#8220;under common control with&#8221;), as used with respect to any Person, shall mean the possession, directly or indirectly, of the power to direct or cause
        the direction of the management and policies of such Person, whether through the ownership of voting securities, by Contract, or otherwise.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Agreement</u></font>&#8221; shall have the meaning specified in the Preamble.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Anti-Corruption Laws</u></font>&#8221; shall mean all applicable federal, state and foreign Legal
        Requirements relating to the prevention or prohibition of corruption, bribery, kickbacks, conflicts of interest and off-label, false or misleading promotion, advertising or marketing of medical devices, including the United States Foreign Corrupt
        Practices Act of 1977, the UK Bribery Act of 2010, the United States Anti-Kickback Statute, the United States Stark Law, the United States Physician Payments Sunshine Act, and implementing regulations of these acts, statutes and similar laws.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Assigned Contracts</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.1(c)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Assignment Consent</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.5(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Assumed Liabilities</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.3</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Assumed Pre-Closing Warranty and Recall Liabilities Amount</u></font>&#8221; shall have the meaning
        specified in <font style="font-family: 'Times New Roman';"><u>Section 1.3(c)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Books and Records</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.1(f)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Business Day</u></font>&#8221; shall mean any day other than (i) a Saturday or a Sunday or (ii) a day on
        which banking and savings and loan institutions are closed in New York, New York.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Business Records</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 7.3</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Closing</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.1</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Closing Date</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.1</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Code</u></font>&#8221; shall mean the United States Internal Revenue Code of 1986, as amended.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Collected Information</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.6(h)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Confidential Information</u></font>&#8221; shall mean all Trade Secrets and other confidential and/or
        proprietary information of a Person, including information derived from reports, investigations, research, work in progress, codes, marketing and sales programs, financial projections, cost summaries, pricing formulae, contract analyses, financial
        information, projections, confidential filings with any state or federal agency, and all other confidential concepts, methods of doing business, ideas, materials or information prepared or performed for, by or on behalf of such Person by its
        employees, officers, directors, agents, representatives, or consultants.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-1</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Confidentiality Agreement</u></font>&#8221; shall mean that certain confidentiality agreement between
        Purchaser and Seller, dated March 24, 2023.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Consent</u></font>&#8221; shall mean any approval, consent, ratification, permission, waiver or
        authorization (including any Governmental Approval).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Contract</u></font>&#8221; shall mean any agreement, contract, obligation, promise, understanding,
        arrangement, commitment, lease, license or undertaking of any nature.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Contract Manufacturing Agreement</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(e)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Copyrights</u></font>&#8221; shall mean all rights in works of authorship, including all copyrights,
        mask works, and all registrations and applications for the foregoing and all statutory and common law rights related thereto, in any jurisdiction, including any prosecution and litigation files, extension, modification, or renewal of any such
        registration or application.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>COVID-19</u></font>&#8221; shall mean SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or
        related or associated epidemics, pandemic or disease outbreaks.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>COVID-19 Measures</u></font>&#8221; shall mean any quarantine, &#8220;shelter in place,&#8221; &#8220;stay at home,&#8221;
        social distancing, mask wearing, temperature taking, personal declaration, &#8220;purple badge standard,&#8221; shut down, closure, sequester or any other Law, decree, judgment, injunction or other Order, directive, guideline or recommendation by any
        Governmental Authority or industry group in connection with or in response to COVID-19 pandemic, including the CARES Act.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Damages</u></font>&#8221; shall mean and include any Liability, loss, damage, injury, settlement,
        judgment, award, fine, penalty, Tax, Proceeding, cost, fee or expense of any nature, including the cost of enforcing any right to indemnification hereunder (including reasonable fees and expenses of counsel, consultants, experts and other
        professional fees), irrespective of whether arising directly or indirectly from third-party claims and the cost of pursuing insurance providers.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Employee Plan</u></font>&#8221; shall mean any &#8220;employee benefit plan&#8221; (as defined in section 3(3) of
        ERISA, regardless of whether subject to ERISA), and each other material agreement, plan, program, fund, policy, contract or arrangement (whether written or unwritten) providing compensation, benefits, pension, retirement, profit sharing, stock
        bonus, stock option, stock purchase, phantom or stock equivalent, bonus, incentive, deferred compensation, vacation, life insurance, death benefit, sick pay, disability, severance, termination indemnity, seniority pay, holiday pay, fringe benefit
        or similar employee benefits covering any employee or former employee of Seller or any ERISA Affiliate of Seller, or the beneficiaries and dependents of any employee or former employee of Seller any ERISA Affiliate of Seller, regardless of whether
        it is mandated any applicable Legal Requirement, voluntary, private, funded, unfunded, financed by the purchase of insurance, contributory or noncontributory.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Encumbrance</u></font>&#8221; shall mean any lien, pledge, hypothecation, charge, mortgage, security
        interest, deed of trust, security interest, covenant, option, right of first refusal or other encumbrance of any kind.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Entity</u></font>&#8221; shall mean any corporation (including any non-profit corporation), general
        partnership, limited partnership, limited liability partnership, joint venture, estate, trust or company (including any limited liability company or joint stock company) or other similar entity.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-2</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Environmental Law</u></font>&#8221; means any Law relating to the environment, natural resources,
        pollutants, contaminants, wastes, chemicals or public health and safety, including any Law pertaining to (a) treatment, storage, disposal, generation and transportation of toxic or hazardous substances or solid or hazardous waste, (b) air, water
        and noise pollution, (c) groundwater or soil contamination, (d) the release or threatened release into the environment of toxic or hazardous substances or solid or hazardous waste, including emissions, discharges, injections, spills, escapes or
        dumping of pollutants, contaminants or chemicals, (e) manufacture, processing, use, distribution, treatment, storage, disposal, transportation or handling of pollutants, contaminants, chemicals or industrial, toxic or hazardous substances or oil or
        petroleum products or solid or hazardous waste, (f) underground and other storage tanks or vessels, abandoned, disposed or discarded barrels, containers and other closed receptacles, (g) public health and safety or (h) the protection of wild life,
        marine sanctuaries and wetlands, including all endangered and threatened species.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>ERISA</u></font>&#8221; shall mean the Employee Retirement Income Security Act of 1974.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>ERISA Affiliate</u></font>&#8221; shall mean any other Person that, together with Seller, would be
        treated as a single employer under section 414 of the Code.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Excluded Assets</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.2</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Excluded Liability</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.4</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Export-Import Laws</u></font>&#8221; shall mean all applicable United States and foreign Laws relating
        to export, reexport, transfer, and import controls, including the Export Administration Regulations and the EU Dual Use Regulation.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>FDA</u></font>&#8221; shall mean the United States Food and Drug Administration or any successor agency.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Final Determination</u></font>&#8221; shall mean (a) with respect to U.S. federal income Taxes, a
        &#8220;determination&#8221; as defined in Section 1313(a) of the Code or execution of an IRS Form 870-AD (or successor form) and (b) with respect to Taxes other than U.S. federal income Taxes, any final determination of liability in respect of a Tax that,
        under applicable law, is not subject to further appeal, review or modification through Proceedings or otherwise, including the expiration of a statute of limitations or a period for the filing of claims for refunds, amended Tax Returns or appeals
        from adverse determinations.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Financial Information</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.4(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Fraud</u></font>&#8221; of a party shall mean actual fraud (under the laws of the State of Delaware)
        with respect to the making of the representations or warranties contained in this Agreement (and not, for the avoidance of doubt, constructive fraud, equitable fraud or promissory fraud or negligent misrepresentation or omission, or any form of
        fraud based on recklessness or negligence).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>GAAP</u></font>&#8221; shall mean United States generally accepted accounting principles consistently
        applied.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>General Assignment and Bill of Sale</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Governmental Approval</u></font>&#8221; shall mean any permit, license, certificate, concession,
        approval, consent, ratification, permission, clearance, confirmation, exemption, waiver, franchise, certification, designation, rating, registration, variance, qualification, accreditation or authorization issued, granted or given by or under the
        authority of any Governmental Authority or pursuant to any Legal Requirement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-3</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Governmental Authority</u></font>&#8221; shall mean any: (a) nation, principality, state, commonwealth,
        province, territory, county, municipality, district or other jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; (c) governmental or quasi-governmental authority of any nature (including any governmental
        division, subdivision, department, agency, bureau, branch, office, commission, council, board, instrumentality, officer, official, representative, organization, unit, body or Entity and any court or other tribunal); (d) multinational organization
        or body; or (e) United States or non-United States, individual, Entity or body exercising, or entitled to exercise, any executive, legislative, judicial, administrative, arbitral, regulatory, police, military or taxing authority or power.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Indemnitee</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 11.4(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Indemnitor</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 11.4(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Intellectual Property License Agreement</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(f)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Intellectual Property Rights</u></font>&#8221; shall mean any or all rights in and to intellectual
        property anywhere in and throughout the world, including (i) Patent Rights, Trade Secrets, Copyrights, and Trademarks, (ii) any rights similar, corresponding or equivalent to any of the foregoing anywhere in the world, (iii) any rights in computer
        software, data, and databases, (iv) rights of publicity, and (v) any claims or causes of action, including the right to sue, for past, present and future infringement, misappropriation, dilution, or any other violation of any of the foregoing.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Legal Requirement</u></font>&#8221; shall mean any law, statute, legislation, constitution, principle of
        common law, resolution, ordinance, code, edict, decree, proclamation, treaty, convention, rule, regulation, permit, ruling, directive, pronouncement, requirement (licensing or otherwise), specification, determination, decision, opinion Order,
        regulatory guidance or interpretation issued, enacted, adopted, passed, approved, promulgated, made, implemented or otherwise put into effect by or under the authority of any Governmental Authority including any (a) technical or scientific standard
        to which adherence is required by any Governmental Authority and (b) any rules or policies of non-governmental accreditation or oversight bodies applicable to medical devices and related accessories, including the Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Liabilities</u></font>&#8221; shall mean any and all liabilities and obligations, whether accrued, fixed
        or contingent, mature or inchoate, known or unknown, reflected on a balance sheet or otherwise, including those arising under any Proceeding or Legal Requirement, and those arising under any Contract.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Licenses</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.8(c)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Material Adverse Effect</u></font>&#8221; shall mean, any event, change or effect that, when taken
        individually or together with all other adverse events, changes and effects, is or would reasonably be expected to have a materially adverse effect on the Purchased Assets, Assumed Liabilities and Products, taken as a whole; provided, however, that
        any events, changes or effects will not be deemed to constitute a Material Adverse Effect to the extent resulting from: (i) general changes or conditions in legal, tax, economic, political, regulatory or market conditions, including any changes
        affecting financial, credit or capital market conditions, or in the industries (or therapeutic areas) in which any of the Products operate, including changes in any markets that supply materials for the Products or in which customers of the
        Products operate; (ii) acts of war, terrorism or armed hostilities (or the continuation or escalation of the foregoing); (iii) any earthquake, hurricane, tsunami, tornado, flood, mudslide or other natural or man-made disaster or acts of God; (iv)
        any epidemic, pandemic or disease outbreak (including the COVID-19 pandemic), curfews or other restrictions that relate to, or arise out of, any epidemic, pandemic or disease outbreak (including the COVID-19 pandemic or any COVID-19 Measures or any
        change in such COVID-19 Measures or interpretations thereof) or material worsening of such conditions; (v) any action required or permitted by this Agreement or any action taken (or omitted to be taken) with the express written consent of or at the
        express written request of Purchaser; (vi) the announcement of this Agreement or consummation of the Transactions; and (vii) any failure by Seller or the Products to meet internal projections or forecasts for any period (provided that the
        underlying causes of such failure may be taken into account in determining whether there has been a Material Adverse Effect); <font style="font-family: 'Times New Roman'; font-style: italic;">provided further</font>, <font style="font-family: 'Times New Roman'; font-style: italic;">however</font>, that any event, occurrence, fact, condition or change referred to in clauses (i) through (iv) immediately above shall be taken into account in determining whether a Material Adverse Effect
        has occurred or would reasonably be expected to occur to the extent that such event, occurrence, fact, condition or change has a disproportionate effect on the Products or the Purchased Assets compared to other similarly situated participants in
        the industries in which the Products are sold (in which case, only the incremental disproportionate adverse effect may be taken into account in determining whether a Material Adverse Effect has occurred).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-4</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Material Contracts</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.9(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Non-Assignable Asset</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.5(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Non-Paying Party</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 9.3</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Order</u></font>&#8221; shall mean any: (a) temporary, preliminary or permanent order, judgment,
        injunction, edict, decree, ruling, pronouncement, determination, decision, opinion, verdict, sentence, stipulation, subpoena, writ or award that is or has been issued, made, entered, rendered or otherwise put into effect by or under the authority
        of any court, administrative agency or other Governmental Authority or any arbitrator or arbitration panel; or (b) Contract with any Governmental Authority that is or has been entered into in connection with any Proceeding.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Ordinary Course of Business</u></font>&#8221; shall mean the operation of the business of Seller
        relating to the Products in the usual and customary way and consistent with their past practices, giving effect to any adjustments and modifications thereto taken in response to or as a result of COVID-19 Measures.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Patent Assignment</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(c)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Patent Rights</u></font>&#8221; shall mean all patents, utility models, and industrial designs, and
        applications therefor, and all reissues, divisions, re-examinations, revisions, renewals, extensions, adjustments, reissues, provisionals, continuations, continuations-in-part thereof, and counterparts, invention disclosures, and all rights of
        priority related to any of the foregoing in any jurisdiction, including any prosecution and litigation files for any of the foregoing.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Paying Party</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 9.3</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Permit</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.11</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Permitted Encumbrance</u></font>&#8221; shall mean (a) statutory Encumbrances for Taxes or other
        governmental charges not yet due and payable or the amount or validity of which is being contested in good faith by appropriate proceedings; (b) mechanics&#8217;, materialmen&#8217;s, architects&#8217;, warehousemen&#8217;s, landlords&#8217; and other like statutory
        Encumbrances arising or incurred in the Ordinary Course of Business, either securing payments not yet due or that are being contested in good faith by appropriate proceedings and for which appropriate reserves have been set aside; and (c) zoning,
        building codes and other land use laws that do not materially impair the value, merchantability or continued use of the Purchased Assets.&#160; For the avoidance of doubt, any Encumbrance arising under the Code or ERISA in connection with any Employee
        Plan is not a Permitted Encumbrance.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-5</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Person</u></font>&#8221; shall mean any individual, Entity or Governmental Authority.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Post-Closing Tax Period</u></font>&#8221; shall mean any taxable period (or portion of a Straddle
        Period) beginning after the Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Pre-Closing Tax Period</u></font>&#8221; shall mean any taxable period (or portion of a Straddle Period)
        ending on or before the Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Proceeding</u></font>&#8221; shall mean any action, claim, charge, complaint, demand, suit, litigation,
        arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate proceeding), prosecution, contest, hearing, inquiry, inquest, audit, examination or investigation brought, conducted or heard at law or in equity
        before any Governmental Authority.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Products</u></font>&#8221; shall have the meaning specified in the Recitals.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Promotional Material</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.1(h)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Property Tax</u></font>&#8221; shall mean all real property Taxes, personal property Taxes, intangible
        property Taxes and similar ad valorem Taxes.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchase Price</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 2.1</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchase Price Allocation</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 9.1(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchased Assets</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.1</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchased Intellectual Property</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.8(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchased Inventory</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 1.1(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser</u></font>&#8221; shall have the meaning specified in the Preamble.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Assignment and Assumption Agreements</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(b)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Damages</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 11.1</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Indemnified Persons</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 11.1</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Material Adverse Effect</u></font>&#8221; shall mean any event, change or effect that, when
        taken individually or together with all other such events, changes or effects, would reasonably be expected to have, individually or in the aggregate, (a) a material adverse effect on the ability of Purchaser to consummate the Transactions
        contemplated hereby or (b) cause a material delay in the ability of Purchaser to consummate the Transactions contemplated hereby.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Purchaser Licensed Intellectual Property</u></font>&#8221; shall mean Purchased Intellectual Property
        listed on <font style="font-family: 'Times New Roman';"><u>Schedule 7.7(b)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Recalls</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 7.6</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-6</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Registered Intellectual Property Rights</u></font>&#8221; shall mean, in any jurisdiction, all: (i)
        Patent Rights; (ii) registered Trademarks and pending applications to register Trademarks; (iii) Copyright registrations, pending applications to register Copyrights, and Copyright renewals; (iv) domain name registrations; (v) branded accounts on
        any social medial networks; and (vi) any other Intellectual Property Rights that are the subject of a pending application, certificate, filing, registration or other document issued by, filed with, or recorded by, any Government Authority or other
        organization at any time.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Regulatory Authority</u></font>&#8221; shall mean any federal, national, state, foreign or multinational
        Governmental Authority (including the FDA) that has jurisdiction or oversight over (a) the research, development, approval, clearance, marketing, manufacture, labeling, sale, import, export and distribution of medical devices and technology, (b)
        federal healthcare programs under which such medical devices are purchased or reimbursed, or (c) the protection of personal healthcare information.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Representatives</u></font>&#8221; shall mean, as to any Person, its officers, directors, employees,
        counsel, accountants, financial advisers, consultants and agents.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Restricted Business</u></font>&#8221; shall mean the researching, testing, designing, developing,
        manufacturing, commercializing, distributing and/or selling of products that directly compete with the Products as existing as of the Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>R&amp;W Insurance Company</u></font>&#8221; means the provider of R&amp;W Insurance Policy selected by
        Purchaser, prior to Closing on the terms and subject to the conditions set forth herein.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>R&amp;W Insurance Policy</u></font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#8221; shall mean the </font><font style="font-size: 10pt;">buyer<font style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">-side representation and warranty insurance policy obtained by </font>Purchaser.</font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>R&amp;W Policy Retention Amount</u></font>&#8221; means the aggregate amount of retention set forth in
        the R&amp;W Insurance Policy.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Sanctioned Country</u></font>&#8221; shall mean any country or region that is the target of
        comprehensive United States economic sanctions, including currently Cuba, Iran, Sudan, Syria, North Korea, and the Crimea region of Ukraine.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Sanctioned Person</u></font>&#8221; shall mean any Person that is the target of sanctions or
        restrictions under Sanctions Laws or Export-Import Laws, including: (a) any Person listed on any applicable United States or foreign sanctions- or export-related restricted party list, including OFAC&#8217;s Specially Designated Nationals and Blocked
        Persons List and the EU Consolidated List; (b) any entity that is, directly or indirectly, Controlled by a Person or Persons described in clause (a); or (c) any national of a Sanctioned Country.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Sanctions Laws</u></font>&#8221; shall mean all United States and foreign Laws relating to economic
        sanctions, including those administered or enforced by the United States (including by OFAC or the United States Department of State), the United Nations Security Council, and the European Union.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Seller</u></font>&#8221; shall have the meaning specified in the Preamble.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Seller Damages</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 11.2</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Seller Disclosure Schedule</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Article 4</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Seller Indemnified Persons</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 11.2</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-7</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Seller R&amp;W Premium Amount</u></font>&#8221; shall mean fifty percent (50%) of the total premium
        costs of the R&amp;W Insurance Policy.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#160;&#8220;<font style="font-family: 'Times New Roman';"><u>Seller Licensed Intellectual Property</u></font>&#8221; shall mean the Intellectual Property Rights
        listed on <font style="font-family: 'Times New Roman';"><u>Schedule 7.7(a)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Seller&#8217;s Knowledge</u></font>&#8221;, &#8220;<font style="font-family: 'Times New Roman';"><u>Knowledge of
            Seller</u></font>&#8221; and similar phrases shall mean the actual knowledge of the following persons, after due inquiry: (i) James Clemmer; (ii) Stephen Trowbridge; (iii) Benjamin Davis; (iv) Peter Flora; (v) Chad Campbell; (vi) Chris Davis; (vii)
        David Helsel; (viii) Russ Howie; (ix) Stuart Holbrook; and (x) Warren Nighan.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Shared Contracts</u></font>&#8221; shall mean all Contracts listed on <font style="font-family: 'Times New Roman';"><u>Schedule 1.6</u></font>, which relate in part, but not exclusively, to the Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Straddle Period</u></font>&#8221; shall mean any taxable period that includes (but does not end on) the
        Closing Date.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Sublicense Agreement</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(h)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Subsidiary</u></font>&#8221; shall mean, with respect to any Person, any Entity in which (a) such first
        Person directly or indirectly owns or controls at least a majority of the securities or other interests having by their terms ordinary voting power to elect a majority of the board of directors or others performing similar functions or (b) such
        first Person is a general partner or managing member.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Tax</u></font>&#8221; (and, with correlative meaning, &#8220;<font style="font-family: 'Times New Roman';"><u>Taxes</u></font>&#8221;
        and &#8220;<font style="font-family: 'Times New Roman';"><u>Taxable</u></font>&#8221;) shall mean all forms of taxation imposed by any Tax Authority, including all national, state or local taxation (including income, value added, occupation, real and personal
        property (tangible and intangible), social security (or similar), gross receipts, sales, use, ad valorem, franchise, profits, license, withholding, payroll, employment, excise, severance, occupation, windfall profit taxes, stamp duty, customs,
        estimated and other taxes), together with any interest, penalties, and additions to tax related thereto. For clarity, Taxes include any amounts described in the immediately preceding sentence imposed on or assessed against any Person for which
        Seller or its Affiliates have Liability by Contract, as successor or transferee, or otherwise under applicable Legal Requirements.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Tax Authority</u></font>&#8221; shall mean a Governmental Authority responsible for the imposition,
        assessment or collection of any Tax (domestic or foreign).</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Tax Claim</u></font>&#8221; shall mean any action, suit, proceeding, investigation, audit or claim with
        respect to Taxes made or initiated by any Tax Authority.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Tax Contest</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 9.1(d)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Tax Return</u></font>&#8221; shall mean any report, return, statement, declaration, notice, certificate
        or other document filed or required to be filed with any Tax Authority in connection with the determination, assessment, collection or payment of any Tax.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Third Party Intellectual Property</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.6(c)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Trade Control Laws</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 4.16</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Trade Secrets</u></font>&#8221; shall mean all trade secrets under applicable law and other rights in
        know-how and confidential or proprietary information, clinical study data, formulae, processes, manufacturing information, procedures, inventions, or marketing information, and all other non-public information primarily related to the Products, and
        all claims and rights related thereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div class="BRPFPageNumberArea" style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-8</font></div>
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Trademark Assignment</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(c)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Trademarks</u></font>&#8221; shall mean any and all trademarks, service marks, trade dress, logos,
        slogans, trade names, and other source identifiers, all applications and registrations therefor, all common law rights therein and thereto, and all goodwill associated with any of the foregoing in any jurisdiction, including any prosecution and
        litigation files, extension, modification, or renewal of any such registration or application.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Transaction Agreements</u></font>&#8221; shall mean this Agreement and the General Assignment and Bill
        of Sale, the Purchaser Assignment and Assumption Agreements, the Patent Assignment, the Trademark Assignment, the Transition Services Agreement, the Contract Manufacturing Agreement, the Intellectual Property License Agreement, the Sublicense and
        any other agreements or instruments executed pursuant hereto.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Transaction Confidentiality Agreement</u></font>&#8221; shall mean any right or interest of Seller or
        any Affiliate of Seller under any confidentiality agreement entered into by Seller or any Affiliate of Seller, solely to the extent relating to information of a proprietary or confidential nature concerning the Products.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Transaction(s)</u></font>&#8221; shall mean, collectively, the transactions contemplated by this
        Agreement.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Transfer Taxes</u></font>&#8221; shall mean all federal, state, local or foreign sales, use, transfer,
        real property transfer, mortgage recording, stamp duty, or similar Taxes that may be imposed in connection with the transfer of Purchased Assets.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Transition Services Agreement</u></font>&#8221; shall have the meaning specified in <font style="font-family: 'Times New Roman';"><u>Section 3.2(d)</u></font>.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;<font style="font-family: 'Times New Roman';"><u>Treasury Regulation</u></font>&#8221; shall mean the regulations promulgated under the Code by the
        United States Treasury and Internal Revenue Service.</div>
      <div style="font-size: 10pt;">&#160;</div>
      <div> <font style="font-size: 10pt;"><br>
        </font></div>
      <div style="text-align: center;"> <font style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal;">A-9</font></div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>brhc20054314_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 23.5.1.5152
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="font-weight: bold; text-align: right;"> Exhibit 99.1<br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">AngioDynamics, Inc.</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Unaudited Pro Forma Condensed Consolidated Financial Statements</div>
      <div><br>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AngioDynamics, Inc. and Subsidiaries</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS<br>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Nine Months Ended February 28, 2023</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands of dollars, except per share data)</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z81604f49ef904aaaa080a12d1f9d74f5" class="cfttable">

            <tr>
              <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 55%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As Reported (a)</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td nowrap="nowrap" style="vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); text-align: center;" colspan="2">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Pro Forma Adjustments</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Notes</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> As Adjusted</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Net sales</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">247,678</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(23,690</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">223,988</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cost of sales (exclusive of intangible amortization)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">119,791</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(9,322</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">110,469</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">127,887</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(14,368</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">113,519</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Operating expenses:</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Research and development</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">22,023</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(167</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,856</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Sales and marketing</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">77,956</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(45</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">77,911</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">General and administrative</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">29,775</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">29,783</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Amortization of intangibles</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">14,384</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,450</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,934</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Change in fair value of contingent consideration</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,084</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,084</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Acquisition, restructuring and other items, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">12,009</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(17</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">11,992</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Total operating expenses</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">158,231</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,671</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">156,560</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Operating loss</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(30,344</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(12,697</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(43,041</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Other expense:</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Interest expense, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,801</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,801</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Other expense, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(427</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(427</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total other expense, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2,228</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2,228</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Loss before income tax benefit</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(32,572</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(12,697</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(45,269</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Income tax benefit</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,597</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(c)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,597</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Net loss</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(30,975</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(12,697</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(43,672</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Loss per share</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Basic</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(0.79</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1.11</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 4px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Diluted</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(0.79</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 4px;">&#160;&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1.11</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted average shares outstanding</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Basic</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,436</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,436</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Diluted</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,436</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,436</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AngioDynamics, Inc. and Subsidiaries</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNAUDITED PRO FORMA CONSOLIDATED STATEMENTS OF OPERATIONS</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Year Ended May 31, 2022</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands of dollars, except per share data)</div>
      <div><br>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;" id="z23b36783a9b8470b910fb22a78b812b9" class="cfttable">

            <tr>
              <td valign="bottom" style="vertical-align: top; padding-bottom: 2px; width: 55%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As Reported (a)</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Pro Forma Adjustments</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Notes</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> As Adjusted</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Net sales</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">316,219</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(27,694</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">288,525</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Cost of sales (exclusive of intangible amortization)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">150,487</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(10,472</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">140,015</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Gross profit</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">165,732</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(17,222</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">148,510</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Operating expenses:</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Research and development</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,739</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(347</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,392</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Sales and marketing</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">95,301</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(85</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">95,216</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">General and administrative</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">38,451</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">38,451</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Amortization of intangibles</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">19,458</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,820</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">17,638</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Change in fair value of contingent consideration</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,212</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,212</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Acquisition, restructuring and other items, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9,042</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(69</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(b)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,973</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Total operating expenses</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">194,203</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2,321</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">191,882</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 18pt;">Operating loss</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(28,471</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(14,901</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(43,372</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Other expense:</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Interest expense, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(688</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(688</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Other expense, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(790</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(790</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 2px;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Total other expense, net</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,478</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,478</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Loss before income tax benefit</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(29,949</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(14,901</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(44,850</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Income tax benefit</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3,402</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 2px;">
                <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(c)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 2px solid rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3,402</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Net loss</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(26,547</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(14,901</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 4px; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(41,448</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Loss per share</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Basic</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(0.68</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 4px;">&#160;&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1.06</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; padding-bottom: 4px;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Diluted</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(0.68</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; padding-bottom: 4px;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; padding-bottom: 4px;">&#160;&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftcurrcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: 4px double rgb(0, 0, 0);" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1.06</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;" colspan="1" class="cftfncell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
              </td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Weighted average shares outstanding</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%;">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Basic</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,009</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%;">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,009</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%;" colspan="1" class="cftfncell">&#160;</td>
            </tr>
            <tr>
              <td valign="bottom" style="vertical-align: top; width: 55%; background-color: rgb(204, 238, 255);">
                <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; text-indent: 9pt;">Diluted</div>
              </td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell"><br>
              </td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,009</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">&#160;</td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
              <td valign="bottom" style="vertical-align: top; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftguttercell">&#160;</td>
              <td valign="bottom" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftcurrcell">&#160;</td>
              <td valign="bottom" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" colspan="1" class="cftnumcell">
                <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">39,009</div>
              </td>
              <td valign="bottom" nowrap="nowrap" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" colspan="1" class="cftfncell">&#160;</td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">AngioDynamics, Inc. and Subsidiaries</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">UNAUDITED PRO FORMA CONSOLIDATED BALANCE SHEET</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As of&#160;February 28, 2023</div>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(in thousands, except share data)</div>
      <div>&#160;</div>
      <table cellspacing="0" cellpadding="0" border="0" class="cfttable" id="z1171e909ea3742e3982821c3065d44d5" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; width: 100%;">

          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; padding-bottom: 2px; width: 55%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">As Reported (a)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> Pro Forma Adjustments</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0); width: 9%;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Notes</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle; border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> As Adjusted</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Assets</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Current assets</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" colspan="2" style="vertical-align: middle;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Cash and cash equivalents</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">30,111</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">46,790</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(d)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">76,901</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Accounts receivable, net of allowances of $2,030</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">50,892</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">50,892</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Inventories</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">63,532</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3,663</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(e)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">59,869</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; padding-bottom: 2px;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Prepaid expenses and other</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">8,039</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(1,807</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 9%; padding-bottom: 2px;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(e)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">6,232</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current assets</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">152,574</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">41,320</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">193,894</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Property, plant and equipment, net</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">45,559</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(52</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 9%;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(e)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">45,507</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Intangible assets, net</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">134,011</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(18,113</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(e)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">115,898</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Goodwill</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">199,976</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">199,976</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other assets</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,729</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10,729</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; padding-bottom: 4px;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total assets</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">542,849</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,155</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">566,004</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Liabilities and stockholders' equity</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Current liabilities</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Accounts payable</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,600</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">35,600</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Accrued liabilities</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,775</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">21,775</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Current portion of contingent consideration</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9,877</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9,877</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; padding-bottom: 2px;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 16.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Other current liabilities</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,380</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">2,380</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total current liabilities</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">69,632</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">69,632</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Long-term debt</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">49,807</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(49,807</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" style="vertical-align: bottom; width: 9%;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(d)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Deferred income taxes</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">13,490</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" style="vertical-align: bottom; width: 9%; background-color: rgb(204, 238, 255);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;(c)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">13,490</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Contingent consideration, net of current portion</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9,182</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">9,182</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Other long-term liabilities</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,083</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; padding-bottom: 2px; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">3,083</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total liabilities</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">145,194</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(49,807</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">95,387</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Stockholders' equity</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Preferred stock, par value $.01 per share, 5,000,000 shares authorized; no shares issued and outstanding</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" style="vertical-align: bottom; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Common stock, par value $.01 per share, 75,000,000 shares authorized; 39,976,422 shares issued and
                39,606,422 shares outstanding</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">382</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">382</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Additional paid-in capital</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">596,225</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">596,225</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 55%;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accumulated deficit</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(189,388</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">72,962</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(116,426</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 55%; background-color: rgb(204, 238, 255);">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Treasury stock, 370,000 shares</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(5,714</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(5,714</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 55%; padding-bottom: 2px;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Accumulated other comprehensive loss</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3,850</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">-</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3,850</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">)</div>
            </td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 55%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Stockholders&#8217; Equity</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">397,655</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">72,962</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); border-bottom: 2px solid rgb(0, 0, 0);">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">470,617</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); padding-bottom: 2px;">&#160;</td>
          </tr>
          <tr>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: bottom; width: 55%; padding-bottom: 4px;">
              <div style="text-align: left; text-indent: -7.2pt; margin-left: 25.2pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Total Liabilities and Stockholders' Equity</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">542,849</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">23,155</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" style="vertical-align: middle; width: 9%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftguttercell" colspan="1" style="vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
            <td valign="bottom" nowrap="nowrap" class="cftcurrcell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">$</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftnumcell" colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;">
              <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">566,004</div>
            </td>
            <td valign="bottom" nowrap="nowrap" class="cftfncell" colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px;">&#160;</td>
          </tr>

      </table>
      <div><br>
      </div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE 1. Basis of Presentation</div>
      <div style="text-align: left; text-indent: 18pt; margin-right: 7.2pt; margin-left: 7.2pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><br>
      </div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company&#8217;s historical consolidated financial statements have been adjusted in the unaudited consolidated pro forma financial
        statements to present events that are (i) directly attributable to the sale of the Business, (ii) factually supportable and (iii) are expected to have a continuing impact on the Company&#8217;s consolidated results following the sale of the Business. The
        pro forma consolidated statements of operations do not reflect the estimated gain on the sale of the Business.</div>
      <div><br>
      </div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The Company determined that this sale of the Business did not constitute a strategic shift that had a major effect
        on the Company&#8217;s operations or financial results and as a result, this transaction will not be classified as discontinued operations.</div>
      <div style="text-align: left; text-indent: 18pt; margin-right: 7.2pt; margin-left: 7.2pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><br>
      </div>
      <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">NOTE 2. Pro Forma Adjustments</div>
      <div style="text-align: left; text-indent: -7.2pt; margin-left: 7.2pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The following adjustments have been reflected in the unaudited consolidated pro forma financial statements:</div>
      <div style="text-align: left;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><br>
      </div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">(a)&#160;&#160; Reflects the Company&#8217;s historical US GAAP consolidated financial statements, as reported, before pro forma adjustments
        related to the sale of the Business for the nine month period ended February 28, 2023 and the year ended May 31, 2022.</div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><br>
      </div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">(b)&#160;&#160; Reflects the elimination of revenues and expenses representing the historical operating results of the Business.</div>
      <div><br>
      </div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">(c)&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">There are no adjustments for income tax
          expense or deferred taxes when considering valuation allowances on the Company&#8217;s deferred taxes.</font></div>
      <div><br>
      </div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">(d)&#160;&#160; Reflects estimated net cash proceeds from the sale of the Business of $46.8 million, representing the gross sale price of
        $100.0 million less estimated transaction costs and the payoff of long-term debt.</div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 18pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> </font><br>
      </div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;">(e)&#160;&#160; Represents the assets conveyed to Merit in the sale of the Business.&#160; The intangible assets relate specifically to the
        identifiable intangible assets related to BioSentry product technologies, trademarks, licenses and customer relationships.</div>
      <div style="text-align: left; text-indent: 27pt; margin-right: 7.2pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-weight: bold;">NOTE 3. Transition Services Agreement</font> </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-weight: bold;"> <br>
        </font></div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to a transition services agreement and a contract manufacturing agreement entered into and effective on the closing of the sale of the Business, the Company will
        supply certain services to Merit. No pro forma adjustments have been made associated with these agreements as services to be provided with a defined monetary value are not considered material, will not have a continuous impact and the variable
        elements are not estimable at this time.<br>
      </div>
      <div><br>
      </div>
      <div>
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>ango-20230608.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.5.1.5152 Broadridge-->
<xs:schema targetNamespace="http://angiodynamics.com/20230608" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:ango="http://angiodynamics.com/20230608" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ango-20230608_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="ango-20230608_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://angiodynamics.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>ango-20230608_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.5.1.5152 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>ango-20230608_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.5.1.5152 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://angiodynamics.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="ango-20230608.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://angiodynamics.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140559298626784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Jun. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun.  08,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-50761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AngioDynamics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001275187<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">11-3146460<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">14 Plaza Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Latham<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">12110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">795-1400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ANGO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>brhc20054314_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ango-20230608.xsd" xlink:type="simple"/>
    <context id="c20230608to20230608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001275187</identifier>
        </entity>
        <period>
            <startDate>2023-06-08</startDate>
            <endDate>2023-06-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230608to20230608"
      id="Fact_7f2310eebefa42dea4e79bed9cd055f8">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20230608to20230608"
      id="Fact_e666d032772a4f4791bcb4e795a34a3d">0001275187</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20230608to20230608"
      id="Fact_9bd1a0af0efb4b1fb03e15cf1a4b5f7e">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230608to20230608"
      id="Fact_a589e0744e104d95b2696c497912b12e">2023-06-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230608to20230608"
      id="Fact_b5ac18b575524f888ce0afb490008a95">AngioDynamics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230608to20230608"
      id="Fact_7b362d60a6ce416db51233b3cae0c753">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230608to20230608"
      id="Fact_6812f995445c4cf5afb79f7fedbd411c">000-50761</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230608to20230608"
      id="Fact_320a795c45994f22a62ad78a9d0e1f0e">11-3146460</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230608to20230608"
      id="Fact_693416b0ae1345b58df72a9dbe92dbc9">14 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20230608to20230608"
      id="Fact_accc128d94284e27a6460a920db45b33">Latham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230608to20230608"
      id="Fact_683982c8a8b94a73a1a335e376712870">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230608to20230608"
      id="Fact_9cc890dfc6584739b6c0b9e2af8f8c9e">12110</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230608to20230608"
      id="Fact_4a45b3228e7a434c90534c4d36ab008c">518</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230608to20230608"
      id="Fact_f6da9534cdd64aeb835aada8bc53a457">795-1400</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230608to20230608"
      id="Fact_31cccc1a7c434f36a6d09f97373d8092">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230608to20230608"
      id="Fact_d387839b7bd84e2ab611c640fe906607">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230608to20230608"
      id="Fact_5d58972fa4e848a8b4157e566605e893">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230608to20230608"
      id="Fact_121cfebeec5b4c69a40ce89b11651c80">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230608to20230608"
      id="Fact_8ce8650cde7e4a81bbbb6e2703e12fc0">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230608to20230608"
      id="Fact_15963d72694940c49175d8c2d5cebbb7">ANGO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20230608to20230608"
      id="Fact_e882436fe299497687d7a63eaa441b8f">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230608to20230608"
      id="Fact_0c2045b1bab84e23a769d613cc9ab602">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MQ]?B<L49L+D.\'RAE'UON#-L^2^(X;]02P,$%     @ [H3.5I^@&_"Q @
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M\SR. !9GD*88 J<11S &P %#TG1X#SY['R73>RHY_U=3_ 102P,$%     @
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M&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ [H3.5@=!36*!
ML0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M    " #NA,Y6U+--+>\    K @  $0              @ &O    9&]C4')O
M<',O8V]R92YX;6Q02P$"% ,4    " #NA,Y6F5R<(Q &  "<)P  $P
M        @ '- 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( .Z$
MSE85DC.S3@0  (X0   8              " @0X(  !X;"]W;W)K<VAE971S
M+W-H965T,2YX;6Q02P$"% ,4    " #NA,Y6GZ ;\+$"  #B#   #0
M        @ &2#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .Z$SE:7BKL<
MP    !,"   +              "  6X/  !?<F5L<R\N<F5L<U!+ 0(4 Q0
M   ( .Z$SE8<.&7J/P$  #P"   /              "  5<0  !X;"]W;W)K
M8F]O:RYX;6Q02P$"% ,4    " #NA,Y6)!Z;HJT   #X 0  &@
M    @ '#$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4
M" #NA,Y699!YDAD!  #/ P  $P              @ &H$@  6T-O;G1E;G1?
@5'EP97-=+GAM;%!+!08     "0 ) #X"  #R$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="brhc20054314_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://angiodynamics.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="brhc20054314_8k.htm">brhc20054314_8k.htm</File>
    <File>ango-20230608.xsd</File>
    <File>ango-20230608_lab.xml</File>
    <File>ango-20230608_pre.xml</File>
    <File>brhc20054314_ex2-1.htm</File>
    <File>brhc20054314_ex99-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "brhc20054314_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "brhc20054314_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ango-20230608_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ango-20230608_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ango-20230608.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ango",
   "nsuri": "http://angiodynamics.com/20230608",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc20054314_8k.htm",
      "contextRef": "c20230608to20230608",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://angiodynamics.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "brhc20054314_8k.htm",
      "contextRef": "c20230608to20230608",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://angiodynamics.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001140361-23-029854-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-029854-xbrl.zip
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M>ZVE]95\]YJK+'9R_!U6>6^:XXL>8TY8?$/CMR_<G.JUBI_DB'\'JU0G.Y[
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ME#H:"NY7"K;5SS_&WU,N<7/]RCS!-,GST*S-HNQ+_7*VU:]$JRZA]AD_WI,
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M"#GNN+==$'+"F[8CR.^=4$[+AL"G@(,*%D(!FM.B1A]2-WHIMC:5 /AU=?#
M!89NNY?1%O-:MZ(+*&L![V:&R..A>RX?:OX\D>.+\[I1-!'W L)\HP:8J@"?
M4J&41@(@PA0M99L$&4.)FN(&Y/, RS+0WRUSSF8X;BAA:3"P<@ON,UD@#,3!
MP"8,3>SS$?]'\#68^)7<1ZA15'MW-VQR9[Q+/(B05Q#X:.=N<V1ML9CE!4F9
M6=+< ./<L+:/Z^KXLH\8*_1'!IJW0#QI$\:WC(#"#J3E1'$-2.NH=3YW(*TG
M5RQ+@,PO^D##32]6E:#8NTL?EK5W-Q0:OMCSH)UR37<JMD *WYIOOXKB_@2Z
MQ?[&'??>V 5?#!+RT;"I"6M=9,,2J^]Z01*.X12C@%3QG7\:9*-QA< \6*5X
M?,/8(@)L<P#)_/TFS".\R\8NY-)0< M<3?")K\(?04)H((9H,?*^9SYW/N48
M-WJSL'"1ZR#@E\-20)\4M,0:!X:!X4-<KR",;K'0.= AS@;  6ZF=*H,'1H_
M8EJKNF;85L;U Q0J[>G1DM1)H-3/48&E20^A0H$:P*H9;,#L5PB*1QUHTQ1?
M]QN\7A;9,H+Z;3JB970S3 #2Y<WZ@$V1_L4@,Y;K+8OT7ZBRRM.Z.#< >Q9N
M1$7-#*KJDAE-F](6_-[4)5\,$F&9)Y?4$G'%5IQ*9\U@G"5(.X,U5[&FJNG?
MVSS=9B[78Q/%K0NUV-UI2_@$TJ 8/7$)QH-7X1<Z=6V/"[/^[ 0&]NN6:[.V
M<&.E8S$IVL?#"";%H%C5.JE)_+1?P1%-=(JY0?$D^(F++J@Y)#6L:%V;;^PB
M+R@/N9S-GRMP]TP:09M\!2.2C'IVP4Z)"B4-[U_+#&/PMQNL1#)W6F; [VG7
M-5GHNBYE=4]'XR2[5[#9DE!LK_I^9E*WC5VDT8,7J6UY%K<Z-8Q+=I>JO+B)
MQ[:&&C-!WI84^"&X1 7AT3=SP=)E'(D+6+#::=8HGV 7_'$U;6M9 8;_++L*
M; 'U0-MB363K[?]9Q@Z[IIHVQ.?ZEL"3Q +:*H=]NN$-6\?QDUN%/_TJ !-_
MKQ/:1','R[Z.N9[*8Z_M!>4"!&9FQ)N'83NBZ:M^?5&7CM4(R;17;<C(ZA!M
MK]:0P[0E/-<-8/MLP$TU#ALZ;/*(8DD4S*8STB$CL*RG+0"W6OD?\BK>]S ^
MC&<KG\%Q =_(K^'N-RK%,G".CJ<J)@%EL;1[)?6/JN,A$DK D52X!88<,"_&
MR,)([\XD.4XM>3TN[P.\G"E;,/77A!59"FOI-H,S7K4JIATXX\D/X<4@#!_L
M&[*]M(!3U%43?G&!!O\ACC0;DK-0):6! SHYXXZ2[F;2I<$(XQ3^6(\6*]E0
MU8UK[/>U^]=)P:8_SO6K)KVK>3?GB]A/X3J52D"?P(?K$N5#PP#7\^A\>OJM
M-*4/^>,&7%<?Z?)IR9XW9O+1%>$3G!!W1TRD+=1"TR)GZL= C<N:D%'YLWMW
MO(&JRYPR@?*<ZD=M)!4W(7QK"/X^%LT22\P(^6#0$,  0)SE^I%F))16$SY#
MWX"H-9P(;(EVXUTWUB5^+,1N57+H:%I1&IK!TB1-$2I1MPB-@B&*KS8!09$@
M>(06YOHM?#7/1BFFXW7A&W[A0@UPP)U/=[2B/PI?_MI8)VOS,!3+V:!@<M7'
M+6-"G^&(@<1@HQ.,.4[-B$3I\O"I=G3Z[.R!QQKF$;?_P@(]);$\I<GA\"%F
M*;!;%!>6X(CB$0;K&(*BKV364.21PT'7]E_C>/3U!^,;8+"WIM><\^4Z7Q'\
M%22#ZAY1-#0.AOTA^+_K:WPWF#N>LJ :<^TKLI+?'WS&*MLKY&_'"S^!^Q#F
M<*-_>?NF!R;;/K;3>[0/43_  P_#\X>>5(F4UD7AF(:]6ICX<X6:+C4/N' ]
MU7*>KEQ+-<?@2^L*5!2,8LJ\;*RD/QQC.R$SNEBI=P,Q'@]!:\A:!WRV-&*]
M5H23,ZHRW,<,0FTZPEK3D&)J"\/-46MO.6,U0)>T JJQX%M6E"V@5L^/O3%$
M=%I]7(+-'D7(6,D0V+ZZCM/4>"HU,AS'W/@$K]6(BV]O0/SU&@;$31GP3!'Q
MEI)N:E7J$.:!K.3WS8:ZAA)0L^0A[++GE&KWE8U.)Y3;P0.-#FL)C6L^-!T=
MIW/;C8\[5)DUACVJ/:6M0A1''>'P82;5WNYNZ@21M6R]^2JFEQ10UROJ;\L5
MAM<W+HZZ+>'4+G^^!A!:5#BU/;ZTIA%5&6Q[)Q%7'S1>>VX7M.EP3CDY%[/A
MYN;P>[QP!WZ?47JOIWCUIZW47PRXCS1.I\[OF8"1WD<<,R(\5M;&K3^W>JD1
MBFRL+[F8*NIG$CK9A7CG#?'.&C7U3S<* -<CJ)H?VWD;_^TQ*Z2BPC-'YS]O
M5K13NUI%KEUP<Z'YF,:^;!2F.G6B_2S/LSND?446GXW5H(OO_?/(]:FM255:
M!U<3R6CE,%,"MU5K8C!DQSBS%%#3Z];YW(&:GGRG+R%.^V!OO-,VECV-!WUC
M3_.A/6E;:V-(HJX(P&@QIJ4]X@Z<\9PI"AXK@;.8 <1VX6-X;>)@2J%)KS7,
M,V^*H)WV8B$EO%2R4P^0)*TY$C-"LM'O<.MHYLY<G!H3XX5-XP6CDO"N/6LV
M]VN+O,P5A.V*=>#KR_UH%O3_NK02S85NF\>3XD+,'USR_AZI9MVV=9NYV1]+
M3K$TD]_O8(RPGF:3!53.7L&LX]]B!R/,9U!B@;?"WO&^E[?@)I$%UMAYS#O$
MUC2*B9@>?NEG:254Y<@G7I$OKY(A]7[!AQ*G#UA$+K=GKD95:C8;;#Z5JF'L
M6,C8X$Z&CMD3_^5M:9VOY#ZP9_R1WR,Q[Q&/QEG!93=VOW=6.X B"&M-):OR
M)M,-@6W&G M7ZS$M8>W/<F< SIO#+"$(<W,C6P\G"'D<&_]C]I8N1093OGX\
MLA1JN$2N,-#B9+6-D.HF*.XG49PK;K--&S12V,(5[^1VX#:G]H?.>9M[$;2$
MS'T_.E\W'.6]4(Z2940.? S/I)K3Z0">%0$G6L)R2P5!O%E#$,1YEAZP&X0G
M6-U M03IJ\:R/,ND^0K/@CH<I584++U FTZ]"?W7/*@ZCW5K?^J)U<"Z*70/
MH=N".A&Q(G],['GZ?0\]?O#9#=*C*8CM7H(12GR2AG 8P D%!$ #D9;A(,)=
M2&T-^MCL !51'E%O/S:*6.U,,IWT0%-GI#Q*4F7R,'<PO4 J5<,";LMFEH8)
M.$TT2VEK@,.PZ/<OZAH>?X&D([D2NU67Z&/$HF5_UH:B)S_K"[D;FZJ=8=E>
M&R- 23U5V:)P6?+Q-;1;9M%%8!? IBVQ#RJ"X>V0G%4W"1U_F;7L,2%'QY^=
M1_4;&LIPI<5UPEW671J^=09C5"%W?8-U84I*7A=X\V#OU7YPKQ"7WU:!A.$I
MO80@/&A[,6&/# W1$Y;M@V@QI/TUF&)#[(A!"!9>$\K2.>$G=_7:ZOHH>!X\
MQ,QR \;-?L*U)L+SJ1_=<MCSWTBFR8G3U=J\U:;5:!/^C42>#%CPID3@1TTO
M*I V#RX$A7E=$'N'-]8Q1]Y5-+ A^F/E_3@>T.J,PSCB7:_%4ZE]E-91^%U)
M(#$U3<SPI6 )%VWG:D5,\9T0MY^.AX9Z-F&"[[(J:>!JP@B6K4!*SG XQ%PM
M29-1:_X<DQ:T7[!<1_4ORE\,J9PJ/*A3\2 Y,3W%2*QK@=>:Y&/$2VLM#S$I
M76K<P%=]2N1M& >E5+<RX>!2"C,=1;$T7D0%!EN"W[/)@&!&;55;SWQ@._3T
M$8:E* _=QJH[KG+TYUMH$?03%R=A5V@,A)+$=^/H6@/!&\F\^^=^VX%BM&]/
M4Q#S/E:)@<;0'W0<O_E^&^Z:+1(*M0B[OF.<G^<]^.14-FW!)91F,(\BY<&W
M/![X+8<7$ZT]\OI ];SC5Q2#@5!35T+\1EQ3#0)GP1(\BE\@UCARCR"L/!AD
MK.:$TH3%F,X7V2Q=ASN!3*[9<!+=PT<8'[)^X,Y34!SKY$Z+9&Y)/T,=4X2?
MJAQD5ZB:?>\:+VA7;E.J$L FC8>ZY#+/P"K$EV[3QC<A%CNHU*IDAZI,(1?:
M@%][*+D6&;A?P"/Q)LU8UN"DZC0,PFML9U:ZC=/H>*M!89WT8;T"=(#AWR0)
MW;C7A%.A+W_U'H8$Z_&0C!-5E,R4['9'&Y0RJ50$2GL#W D%$CFLS0.Y W5H
MOCW_C4C=:TO(:T$&C[U&-!.1<5=]S?VI73F>UGJ.,PI@S'#+N+AA4*,1U0(1
MD=0VKEL^Q;#%^$V)5A$NL9-211D7UAZ.\30A(4N,&&PSX.--ZWSN !_/L"CJ
MY_6R&_CPK=&-3Z((>^;VA.=CS.C"&SM#]SCFDP(3?W@(U6;/:8CYR':Q+E4[
M V+8.*\#@\D^"A,O"H/3FQ6JBQ&2CKWZP%T0LX95D">)3D3;L54SH>S2Q6D+
M+9$SHZ0^D5\7GY3"#.@T$]^(1N?-=88]QOL8^"QYI7 UBG#DS +SSX7((!&#
M$=']GC7$,CC<S;%B]PL80<&A,?5CC*VYZ,*[FUA?:1SLVN3774/C8KF@H_D0
M)I.C.JXF]P,\4T(V\#EXQ419(:.>9J--#MN8=IP3HRK!'&&09MQ#K/,1# <L
M62<CI4'L73GW7DMMU]P!$=="BS69-_X!":0[A%<BL#4Q=#M/ZP+DS@JV(0ML
MZ[;%&66I;&H%#%IB]2<WIJ3V5$:'3!9?6BQ6YU:2X:J^:I5GBHUJ8"%;T#;$
M75.[=S<9;F%^)*V*C,+YD <GT^*AGQK$+2;<A*7;-#=V$MHGR;>+P?P=Y'%?
MAY/C8E'M-7CJ.80-3A4I/7J*B2'C9':$O^V1^=#1^+X!92*7WWI<+.-6\^<!
MW>F/+Z[.3KZ<!D?+'N_\0SOY>GYY]NGTXOCJ[.MY\/GK17!U<7Q^^?GT8GMK
M_LG:6COSMF9DXHE.(-&Q#A/,Q9)[7 3#*JD%D$U$!(MI>XVFZQB6Z+DZEIGG
MJ?OZO:_>:H9Q9&,5=C_K+L3UV *"MYV>[AIB6]8,<EUOI9 F'K_X-57!7T!Y
MHW;Z/4X2?"%+605N'G)6+8"WRE^(EKI\VVU.V L:8R?N#F1 L+,!9RT8"&TT
MQ:6A)7;2K25G\2;2$'?@B-TCNR941I_K/--=G"LO$QJ/B,J_)%/F-HP3&@WW
M&9?SWK\FC*)<>-/T2CI=H,JLC?ZA,^6[-(7_')32T1HJI3] 0+%=CP"P)VF<
M+B0HQ^W(8&Q+KR)JHTS8:HN4Z6UQ)P\.]C2"(JI,UG3?:57O"[@)/)JVEHX?
M8$41GDL4?:V[T2=(X6R:%*-ZD=+8NWGKX-M(@\#GH##Q4)NV'&JPY2X&BH'?
M&:J(^V: 5XF0B"0;@#;,J#)18>H18?$-;,8+,C/I_C06Y69J&;5N%J $ [ID
MJD&P!+D('>Q TA".>B[(_&V/B#PW.^W5&MII7[Y>GIW_%AR??PKTSY].OYS]
M[?3B[/1R>]7BJ[6TU30S7X!_IBW_+0D]6Z&F'/$L'NC:--Y"#KRT>)S!(J-I
MLU0DFS,85%0CD-&YWK^7(G?8PNDU5<-'V8"!5%9-4$B4-'>58YT\FXYQ[O0
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M&1A-"MYH?_F)S'EWPLHRWZ_7DC#I:WX=IO$_^$1$D?@MRZ+@4EH$=B? 101
MR"F'G?%MD,CD%E8DHK1V7)2:PAWDYQIO;'H/ZBZ?"MN/%[H8R2VK#JC3G1W=
MBV OW*\_%Y.EW%O099%#PB*D?-,LS+,.@5A7O#$8N6>"..U &]-'N-_U!.KB
M4DV\3$<^$W ZK5#:"#KW69UI"!B_ )-'WZ6&SZ[@K21O/;"KMM??K_-[!C>A
M4(V.LSNI_0I-DT*7( ^>T NH00@WCA%2]IAX];A%3!HQDWV>WVONH@?,!K89
MO!,E+J^HHAJ?NN@MZC;"H G;B@KT=Y$Y:\Y<E423['<Z;'MCY@-'.F5'+2-G
MTP_4_)J=&D<#*B:.*D*B9\U$?<]PAS=YMO/V?H+;K/36D=G)].K\$'R,61F<
M$YL:L?G.0#'A[# VX&$S%3$Y03EB^TO5*H)8#,"NF,O:U.6L3&AV7!@+I+'K
MXT+.[WM&&<_B,%G2J&[7:<)HK#G4& --$=%6DKK&F^GS07MV@J:CYE*WXJ-V
MS*DFJ$L-[YO7ZU&@=DZ\8P4O#P=1I@K1*Z13;:\L;'\K2K! 9GFD'E4NPA:7
MR'M@]W1U\GUUO?]I:V.]^:2K94%MYU;NB%"-L]3.L\],?8<HC#WB8L8]%F'(
M0%8]Y%7IN+"MS93;B<$#Q^U[![\,CEN_)<B_*B8)/:$OV]UI2V46H^>1O>AN
M8GH&FK F'!310_?TH14R"6$?:P-'L80\^F'Z/:_&Y> >SQ;P]&]5BC_GRK5N
M>L$P#ROT5=+28_T>H>C#C%5,,BV>"=P>C7,R7.!C.P,H@B6]P#@'BR,>)ZIP
M^T+ 9-+8Z @& 8HQY**[5DBWEVO&U(@ 8B,Q =DXMT1K"1]UO]##;9N!-.]V
M0)I-L7E6#7%^2.R-#*'S#-.#0U"D9?%!\U1'IJ-CMP%T+LV:NT*RR-$Z,2)K
M^CM/,"OLR9RR9>TK>C>0*[3F#?I>/(%VX.DE 7 &(CIT'/;\N/9MG"7D+#G=
M?IW&F]3$WFT"#Z(S#/&+[)43N3PQ$0O)/-A70B.?A..")0I&M.^NO.%G-]$P
M]X2%\\N0*3N'_J9FOM:MP_ :B8O'XX\?Z.I+I\=;EAMS/C1MK6TK@,85&YLQ
M7P+1W<,@-\A2=TW4VNF]+SR_$>T&;FP$@AMOV[2<^ 8^E_B,9.&*'YX/J']<
MBL&PD8KX MOL'(SF6 V=-6\T<]#]-+[F$9?ZU'VF/MI 3M>-ULX\<:&[=?68
M,T[V@HB\W3+-%W<%6416[QXJ]-2[I]<Q?K>MC2E4<B7?]GS76T7F<LJLP'O
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MQ@BF&:>:L:UM]_/0.OB%*B5K98R>$A-#T\A M>/L$[%MEO"GXPS.)($?-]/
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ME3#WUMHH-,&.0YB<T:WV71 *65SN>R"L89#EN6Z/8"!:M5HL6WY%D"2>#?7
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MI;7%X=S5OYNF+%(=W',\#?_=Y<46DG)SK0;;*M(6M"-Z]C:,$YQ1XZO!NQW
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M*)8[9[OA$+!]LBGCEF+!<-0 X3'G&.<(AP;B$4K%.$(*&5MJWJ,^ F9 ;H[
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MFY8+'4V$"+ )6D@U"4:Z0#%"<AL)SV.3P:0$\881[QT>[2/Y:'E#S4*X#-^
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M=FPJ-\B;%^O88.D\PWJ*(:C@LOB@DQY$)EI,KF_2O&QEAW&$-7&.;=0\N_S
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MCDW_>/*TJD=[U7/4O]W?;CEXW0N@<_0FSJ,#GDE46AI7S#08"OY@X$ 6SV?
MG@7CLS#I5:6E%'Y=A3],Y+*G*P8U&:S$^\(JBDO6< Z<F6.T'37[>]Q-A2BG
MW+XX33B9]$T(N0%[#0)CHJ1N1X8'XU&\IMJX^@^^TZ$;^6Z<A7@0J#!:1(3]
ME?.<_?G,1"].%\/RQ .XNVS,R(S]\;>\R>Y B^3FCH)F]O1!S<H1L@0W6GU?
M(WBK)T%KC9_IWI-J5W7?'*;=M75:XSR^C1-UK?1A:P+:(]J0LMU1--$VOJ'
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M5"4\&/QB$%+0.D?(N[ \N$J?+L)V>@##MUE2Q#%!J?<T>0L1T.S$F)AYW>E
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MJ:]<>%$*4@".KJA5KH_ZZ*S$W8BHTTVMPV3Q;9&H47TTUZNX:Z:WHQV^3)$
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MN2A@@<ZR68R(^W%DX<CQ%S G, 4ZZ:77,R3N1(,LYYYE._P^F,7%1^OAT&V
M +YGR<JTP__[6"$XG4K_IRMN']+<WW7BT?4Q7= ?F[:5A,>#"_()V.7[9_,?
M^3B?3H97(E> S\?M:SCL^[YN4D\=L3EKF9[*:S3&RJ#7AL,HK%UHG=3EH/#K
MFU)P95\W2O7I YBJW0$VH$0U NR7\ ^G)C'@F9N.Z>"CN?J$?26OE7MI]X67
MI\0KQ("M58A'32M[OY:1M3=GE.*T1.4PF,U4U:,J&YJ*6=)9" ?.3IV'I!$
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M28@/0P@[DJE)"7V*8]]*'/O%^E,<^WY:"S](')NH'IPKBF*Y<+ )@Z:O%.B
MX"".^5J5,$ZOC1&J20Q#T(\ %; ?H%(4_ESWB4M=].NLT\D1UXBHPA>]=_V&
MY;FIJGIU?A?S*<R4)AP@=BL&P>W.94\SV5/'5K);K5<'</,PQ50X3_+6V U:
M'^UB"-$#B5DZPGCP]8G 9,"NZ^8<K<NC  GB;8&6RS=L6WMX' H+3?D^%=1)
MWR@SBK16;+7-PZG&$ZZS-;HK6S^29P"O4Q.CRC'54IT1-8PFXC#1X&3NO.4&
M[\*G,(;UBKVY7Q+.T#*<(B=,IT#%8@;V!S4^B*\36P"%#]GRZKB? D?<WW (
M\4VN$&FLN>46#R)ACM8T5TN"86XUAPNI(.UK4FDL 2V;&NM]'?1*4S'=$\\!
MZ 9CD<9BI#3408_I1$'N#Q2%WE5.><6#<O&^O8>;^=AUYMP.M8B7Q]:_*7?@
M%N'Z?8GTBX/#'@W8;I>C/"Y-7^N#',S+NF9< 6WCAC:@S@;C%W!N";<G7J>Y
M<JI:8BXUIK!9MPXH57FFD]:Z<(M<652:"IB0"XOO6;G379FQM%+#MW^9MIY
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M<YDGZEP1TEVWL_!$RN3\'STU_%Z:OL\%+?])0\ZX% -@LFTT6J$K1CCGG?:
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M])_W?T;[Q\=[OW_:V7Y_\&?TQ_;^[_  (M,>[__Z&Z,?1W__?/QG='J\OWV
M@*H[GPX/!2N7L%D10W:;_HXQ_VUG;X^0IS\="P#L]O$^8=-^^DR0L_#Y\=[!
M]JD!I7;1D"/!=CX]WCX\X48)LGKOXQ'\9&]7^OQ4+&"UT?M8+'#,R29C"G^
MW3):GHQTZLCP9(1LWKE*)R*WG;PY%%V52@1^#>[$)F-";S(^BDF;P(_:NC=@
MUO<J<SG$AFR6$_,$(LQ2MCD15TS>E5=KEWI:)6-FP0GTD:(D4TGR(LQ,:)\_
M6TZ=2XM%M3;Y,"MGF$U:3$DR@T2HP.2<R[,I4FL51)ZJX5R*ATP!DW];51A
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MIWT673X&+L'N=-=U;/-@D9\8;BOD*8IU_J.04$HA%NSS;"SXWY,B0090Z8,
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M('RZ8G@:?-K@)N( ,JYW20IK2QE".:_'A.8QG7I[_Q2S=WD8]3OQ$.@3,$[
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M*IA,,(KMNQOKTX?M'5TC%YV@MY8B++M"0 >_.Q2+E16']WDY^N("34N$+SJ
MAET>\!WX$ 1'2FW@E^\, KGB$A"9Z=AJDQ37T7_%#+A1YKG F^LI@J?T2T'I
M'8'2RNYEAL3#"7VG;3]AC1*B),K:[YSS1W(2ZA6IYE?DER?F)Q%9=C/TRB[!
M^)9$>XW^HM#@'FF<SG!_.]X/^!XWJ:XY]9_;-7Q>A/Z!'PYB][E#<2">4/EE
M0R6:S.1E]FJ+[CKF07WPQC_CHSRE\JPV3]\Q<V3S\005]5P;#(U(QU?O:MZW
M$>03[MBM1S?I]R-7Y]8V^^..[KY^BN[^< ?2F/R5FF;M=+&E[ZAMXVS<$$CW
MB$B87J[_/-#^UJ9LJ&B(&G,-T;HQ/MD?WN+'-W_CM']+QA'.X;+X[\VG'#VF
M_'->(&.B_J,H+\ @G/3H!G%TW7>81CUO#?YOH;[L%M7-SBID\0OW1,*[X8O3
MN !QY7EY05 P?./&4IB/0#!2.,QD)G]/L+<[N<)8C21AG#1JAJPSIU5Y,:PR
M:%=G5+Q7Q5]87 Q:ZWFF<R".$/4S^@ R,^&LAQT0TM$.G/@A#$V8"';.JJPV
M/T,J 3L+^&D:_:;R6O'C^*KCMJZCWV 0]/*OV*L6P=)^*_-A599?)$<"OO@C
M0<=5= @G(7GPQM49X<E?#B=MC&WSZ(V(A@TO32Z6P+F0A&0%>8"0[KHA+!OU
M%2QL=$2BJR6 QWSH"^5#-UP9"X(]5^2A0%\%SFA:"ER60I"D8N"S8SRBL.<)
M49=^?R;?QU1@#G->9VF67!*TB#E,CVBS#E:MSNM@ *V&>2I%=A"6')&X9%7M
MD'^()[;?<1N5%X4FWD+_;4W8%0IQ<S%!_B_#E$GI<.R7RQQ,.B:F4:BAPOX0
M%R"#[W( N]1P:^<EN2*) YX<DJB!];QD6"*"!F*%Z6P5\[(:SS2F_M#NDPM]
MW%IO/WFM<0Z<E"6<##T'&8+U:M8QE+ %4^[ ZB03;'2JT"Q\X#NP']E@C5!;
M:-,1X7+.J"IRV*^OKQ%T0?=];O9F^BV-HZSO-C\(;V_<-FQ%P4^8@'8Z*VO+
MQHIP0R:CS\-O108\/U40]PR6S.>V-<<)#O\JIRIF(+T(+B]*<!N-VIDDC1)J
M!*?B<G);#QS$FH:*$*1>_2?R\W*J:ZV]Y(AV)*<!O@73NT;7_TAE,\S?PDQ
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M[#ECL?_6__KW?QN6Z9S^<=9,<_C'_P]02P,$%     @ [H3.5O//S.&#(P
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MCD7QS.+::<XY+*2"@F/Y;IYE=$Q 7IX^#AV"HK*@ +11LA2K#^OPU%'J414
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M?TS#GRS>X<$ML-@!L&52.NJ[3<,Q 9TEA4%+E-A7#.8.H-R]>AC%-3%W=>,
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MTHY3+"^,Y861>&I!/!VCVW8TIQYH+H!&<7.KDTK!=Q%3GX@G!;RP #& &H.
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M%=2#"E#O5]JKVGWBQ,,64ECND6[LI[6C4SZK64:C#2CZHWD:& (24S&KYF/
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M."YX<V102P$"% ,4    " #NA,Y679BFWGX(  !T6   %0
M@ %U P  86YG;RTR,#(S,#8P.%]L86(N>&UL4$L! A0#%     @ [H3.5LH7
M:+;=!0  ^SX  !4              ( !)@P  &%N9V\M,C R,S V,#A?<')E
M+GAM;%!+ 0(4 Q0    ( .Z$SE9KJ[1@Z1@  *.9   3              "
M 382  !B<FAC,C P-30S,31?.&LN:'1M4$L! A0#%     @ [H3.5G8T1+*R
MX0  1JX& !8              ( !4"L  &)R:&,R,# U-#,Q-%]E>#(M,2YH
M=&U02P$"% ,4    " #NA,Y6\\_,X8,C   $  0 %P              @ $V
M#0$ 8G)H8S(P,#4T,S$T7V5X.3DM,2YH=&U02P4&      8 !@"/ 0  [C !
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
